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Abstract
PART I. There are few reports on the synthesis of 2-aryl-2-nitroacetates, highlighting a need for development
in this area. This section describes a high-throughput experimentation (HTE) approach to discover suitable
conditions for the coupling of aryl bromides and α-nitroacetates to generate 2-aryl-2-nitroacetates. The best
reaction conditions are 2.5 mol % Pd2dba3•CHCl3, 10 mol % t-BuXPhos, 1.2 equiv CsHCO3 in toluene at
75 °C, which afford products in isolated yields of 52–96%.
2-Aryl-2-nitroacetates are central precursors to other small molecules making them valuable building blocks
in synthesis. Efficient methods were developed for the conversion of 2-aryl-2-nitroacetates to several product
classes that are difficult to make: aryl nitromethanes (76–98% yield), α-keto esters (51–86% yield), and α-aryl
α-amino acids (63–85% yield).
PART II. Small molecule organocatalytic anion-binding chemistry is in its early stages of development in the
organic laboratory, and research in this field is important for its advancement. This section describes synthesis
of a new class of anion-binding catalysts focused on a xanthene scaffold.
Over twenty potential catalysts were made and include three types: unsymmetrical catalysts, C2-symmetrical
catalysts, and bifunctional catalysts. These compounds are better at promoting the Pictet-Spengler-type
reaction previously reported by Jacobsen. Because of this fact the cyclization of 3- and 2-substituted furans
into N-acyliminium ions was investigated. The top catalyst for 2-substituted furans is a bisamide xanthene
compound (60% conversion), and the top catalyst for 3-substituted furans is a thiourea-amide xanthene
compound (42% conversion, 24% ee).
PART III. The discovery of new materials is an exciting and important field of organic synthesis. A
tetrachlorinated bisbenzo[a]phenazine was accessed in seven steps and 14% overall yield (99% ee). It has
unique chromic properties that justify its application in functional materials. The color-changing transitions
and the corresponding solid phases were studied using single crystal x-ray diffraction, powder x-ray diffraction,
photo-image processing, and differential scanning calorimetry. These properties arise from two polymorphs
and the ability of the phenazine to form weak OH•••Cl interactions.
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better at promoting the Pictet-Spengler-type reaction previously reported by Jacobsen.  
Because of this fact the cyclization of 3- and 2-substituted furans into N-acyliminium 
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1.  FORMATION OF 2-ARYL-2-NITROACETATES THROUGH 
PALLADIUM-CATALYZED CROSS-COUPLING. 
1.1.  Introduction 
Formation of C–C bonds by metal-catalyzed cross-coupling reactions is widely used 
for the construction of organic molecules.  In the catalytic versions (i.e. Stille, Negishi, 
Kumada, Suzuki, etc.) many alkyl nucleophiles have been successfully coupled with a 
range of halide electrophiles (Table 1.1).1 
Table 1.1  Summary of common redox neutral cross-coupling reactions. 
 
 
In addition, difficulties such as metal coordination and cross reactivity, have also 
been solved in the coupling of nucleophiles generated in situ from acidic species.2,3  For 
example, thiolation of aryl halides was among one of the first intermolecular cross 
couplings to be developed. 4,5  It involves in situ nucleophile formation and utilizes the 
different acidities of the coupling partners.  Subsequently, Hartwig and Buchwald were 
the first to cross couple aryl halides with amines and alcohols without the need to 
preform the corresponding stannyl nucleophiles (Table 1.2).6,7  When amines are used, a 
transmetallation step is not necessary.  They are nucleophilic enough to coordinate to the 
X1–R2R1–MY1–3 + R1–R2
Pd0Ln
metal/metalloid (M)
ZnII
B
MgII
SnIV
Si
InIII
reaction name
Negishi
Suzuki
Kumada
Stille
Hiyama
R1 = alkyl            
Y = alkyl, halide
X1 = halide, OTf, OTs, OPO(OEt)2
R2 = alkenyl, alkynyl, alkyl, aryl
Heck
--
--
Buchwald-Hartwig--
  
  
2 
metal center (Scheme 1.1).  Subsequent deprotonation of the amine by NaOt-Bu is a 
prerequisite for reductive elimination.   
Table 1.2  Summary of Buchwald and Hartwig concurrent discovery of cross coupling of 
amines with aryl halides in 1996. 
 
Scheme 1.1  Proposed catalytic cycle of cross coupling aryl halides with amines. 
 
Concurrently, reductive elimination utilizing carbon nucleophiles was being 
accomplished; preactivation through deprotonation of these coupling partners is 
necessary to increase their nucleophilicity.  However, in the case of activated methylene 
compounds only a mild base is needed.  Intermolecular cyanoacetate coupling with 
phenylbromide was reported in 1985.3,8  Since then couplings have been expanded to 
include α-arylation of silyl ketene acetals, azlactones, glycine imines, 1,3-dicarbonyls, 
sulfones, imines, sulfoximines, and nitroalkanes (Scheme 1.2).9   In the past decade, 
Walsh and coworkers have done much work in the area of cross coupling using activated 
+ NH2RArX ArNHR
ArX R yield (%)
4-MeC6H4I Ph
Ph
s-Bu
4-PhC6H4Br
4-PhCOC6H4Br
92
94
84
NaOt-Bu, THF, 100 ºC, 3 h
(DPPF)PdCl2 (5 mol %)
DPPF (15 mol %) + NHR2ArX ArNR2
ArX NHR2 yield (%)
4-CNC6H4Br NH2n-Hex
NHMePh
2-MeOC6H4Br
2,5-MeC6H4Br
98
75
94
NaOt-Bu, THF, 80 ºC, 1–29 h
Pd2(dba)3 (0.5 mol %)
BINAP (1 mol %)
NHMePh
BuchwaldHartwig
Ar–X
LnPd0
NaOt-Bu
NaBr,  
HOt-Bu
NHR2
ArNR2
LnPdII
Ar
X
+
+
LnPdII
Ar
NHR2
Br
LnPdII
Ar
NR2
no 
preactivation 
of amine by 
metal
  
  
3 
methylene compounds and have expanded this area to include:  benzyl thioethers,10 1,1,3-
triaryl-2-azaallyl anions, 11  diarylmethane compounds, 12  allylarenes, 13  benzylic 
phosphonates, 14  benzylic phosphine oxides, 15  aryl benzylic sulfoxides, 16  methyl 
sulfones,17 and methyl sulfoxides.18   
Scheme 1.2  Brief overview of cross coupling with select activated methylene 
compounds. 
 
There are few reports19 on the synthesis of 2-aryl-2-nitroacetates.  One method 
involves a double deprotonation of an aryl nitromethane followed by reaction with an 
electrophilic alkyl carbonate source (Scheme 1.3A).  Until recently,20 this pathway was 
limited primarily by the accessibility of aryl nitromethanes.  A second method involves 
arylation of methyl nitroacetate with phenyllead triacetate (Scheme 1.3B).  This approach 
is limit by the need to prepare aryllead(IV) tricarboxylates and by the toxicity of lead.  
The final approach involves nitrite displacement of a bromide in 2-bromo-2-
phenylacetate and is limited by availability of the starting material and moderate yields 
that result from the ambident reactivity of the nitrite anion.21   
EWG
Ar
R1R
2
NC R1
O/(NAr)
R1(R3)/H
O
R1R3O/(R3N)
O
NO
R3
R1 = EWG, alkyl, H
R2 = alkyl, H, F, Ar
R3 = alkyl, aryl
EWG = carbonyl, Ar and in 
some cases CN, NO2, SO2Ph
R2
R2
R2
R1O2N
R1S
O/(NBz)
O
(Ph)/R3MeN N R3EWG
Ar Ar/(CHCH2)
R1S
O
R3
R1P
O
(R3)2/(R3O)2
Ph SR3
R2
R3
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Scheme 1.3  Overview of common methods to make 2-aryl-2-nitroacetates. 
 
 
At the time of this work (2011), it was apparent widely applicable methods to prepare 
2-aryl-2-nitroacetates were lacking in the literature.  This thesis describes how we solved 
this issue using palladium-catalyzed cross-coupling methods.  Initially, we hypothesized 
this strategy would be straightforward due to the precedent set by Buchwald and Hartwig 
in this area (Table 1.3).22  In these methods, Hartwig is able to couple a variety of aryl 
bromides and chlorides with malonates (79–95% yields, Table 1.3, top).  Moreover, 
Buchwald and coworkers developed methods to cross-couple nitroalkanes with aryl 
bromides and chlorides in good yield (62–98%, Table 1.3, bottom).  Notably Buchwald’s 
method was unsuccessful in coupling nitromethane. 
NO2
step 1
NO2
2
2Li
step 2 NO2EtO2C
A.
1.   n-BuLi (2 equiv), THF/HMPA, 
–78 to –30 ºC, 30 min
1.  LDA (2 equiv), THF,
 –78 ºC, 30 min
2.  diethyl carbonate (1 equiv),
 –78 ºC, 30 min
2. ClCO2R, then HCl in ether,
 –78 ºC, 30 min
83%
43%
NO2MeO2C
B.
DMSO, 40 ºC,
2 h
PhPb(OAc)3 NO2MeO2C
70%
Ph
BrMeO2C
C.
DMSO, rt,
2.5 h
NaNO2 NO2MeO2C
PhPh
49%
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Table 1.3  Summary of Hartwig’s (top) and Buchwald’s (bottom) intermolecular cross 
coupling with activated methylene compounds in 2002. 
 
 
Aside from the deficiency of methods to make 2-aryl-2-nitroacetates, we were also 
interested in accessing this class of compounds because of their dense functionality.   2-
Aryl-2-nitroacetates are precursors for a variety of other small molecular building blocks 
that are surprisingly difficult to make (Scheme 1.4).   
O
R2
OR1
O
R1O
ArX
+ Pd(dba)2 (2 mol %)
P(t-Bu)3 (4 mol %)
NaH or NaOt-Bu, THF, 
1–21 h, 70–100 ºC
    R1      Ar                  R2           X              yield(%)
Et
t-Bu
Et
t-Bu
Et Ph
Ph
2,5-Me-C6H3
2-Me-C6H6
H
H
F
H
H
2-Me-C6H6
Br
Cl
Br
90
85
84
Br
Br
89
84
O
R2
OR1
O
R1O
Ar
P(t-Bu)2
Me
ligand
ArX
+
Pd(dba)2 (0.75–5 mol %)
ligand (1.5–10 mol %)
CsCO3, DME, 8–30 h, 
rt–60 ºC
NO2R1 NO2R1
Ar
    R1                     Ar                           X     yield(%)
Et
n-Pr
(CH2)2CO2Me
Et 2-MeO-C6H4
4-MeOC-C6H4
4-MeO-C6H4
4-MeOC-C6H4
4-MeO2C-C6H4
Br
Br
Br
72
67
80
Br
Cl
95
71
(CH2)3CHCH2
pKa 13
pKa 10 R1 ≠ H or CO2Et
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Scheme 1.4  2-Aryl-2-nitroacetates as precursors to other small molecules. 
 
 
One class of compounds we particularly wished to generate was aryl nitromethanes.  
The most direct methods to access these compounds (Scheme 1.5), afforded low yields 
(30-60%), produced multiple by-products, and required lengthy purification processes. 
23,24  Low yields in these approaches are a result of forming a nitrite ester by-product or 
the corresponding aldehyde of the nitromethane product via the Nef reaction.  Buchwald 
circumvents these problems in the generation of phenyl 2-nitroethane by utilizing cross 
coupling (Table 1.3).22  Unfortunately, Buchwald reported that directly forming aryl 
nitromethanes by coupling of nitromethane with aryl halides failed due to the formation 
of many byproducts.22  Given Buchwald’s results it was hypothesized, at that point, any 
attempt to couple nitromethane directly with aryl halides would lead to double arylation.  
Despite this hypothesis, the work described in this thesis led to methods that were 
developed in the Kozlowski lab, which made this coupling possible (Scheme 1.6).20  
 
 
O
RO
NO2
Ar
2-nitro-2-arylacetates
O
RO
N
Ar
OH
O
RO
R
O
H
N
Ar
R
NO2
Ar
O
RO
Ar
[Pd], H2
O
RO
NH2
Ar
–H2O
–CO2[H]
O
RO
NO2
pKa 5.8
+
X
Pd-catalyzed
cross-coupling
O
RO
O
Ar
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Scheme 1.5  Summary of most direct methods to access phenylnitromethanes in 2011. 
 
Scheme 1.6  Kozlowski’s direct monoarylation of nitromethane. 
 
 
Another class of compounds that have been widely used in the Kozlowski lab is α-
ketoesters.25  These substrates are utilized in a variety of synthetic endeavors. 26,27,28  
Unfortunately, there is no uniform method to generate a broad range of α-ketoesters 
(Scheme 1.7).  Many reported protocols use strong oxidizing reagents, which may be 
incompatible with other functionality (Scheme 1.7A–C).  These methods oxidize α-
hydroxy-α-arylacetate29 with Jones reagent or phenylethane-1,2-diols and aryl alkynes in 
the presence of KMnO4.30   Other reported protocols utilize very basic or acidic 
conditions, either of which may also be incompatible with other sensitive functionality 
(Scheme 1.7D and E).31  For example, aroylformates can be generated by Friedel-Crafts 
acylation of benzene derivatives using ethyl chlorooxoacetate.32  However, the Friedel-
Crafts protocol calls for AlCl3 and is restricted to arenes with electron-donating 
30-60% X = OH,  X = Br
R R
X = OH: NaNO2, H+
X = Br: NaNO2, urea
X O2N
+
R
O
R
O
+
by-product
from Nef 
reaction
nitrite ester
by-product
HN
O
MeNO2
P(Cy)2
i-Pr
ligand: XPhos
ArX
+
Pd2(dba)3 (2.5–5 mol %)
ligand (6–10 mol %)
K3PO4, 1,4-dioxane, 
70 ºC, 7–18 h
NO2
Ar
 Ar                           X     yield (%)
5-indole
2,4,5-Me-C6H4
4-NO2-C6H4
2-MeO2C-C6H4
2-MeOC-C6H4
Br
Cl
I
50
24
90
Br
Br
80
70
i-Pr
i-Pr
(2 equiv)
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substituents.  Alternatively, aroylformates can also be formed by nucleophilic acyl 
substitution of a dialkyl oxalate with an organolithium reagent.  
Scheme 1.7  Common methods to access aroylformates. 
 
Formation of α-ketoesters from 2-aryl-2-nitroacetates would require transformation of 
the nitro functionality into a carbonyl through a disproportionation reaction; this method 
is known as the Nef reaction.33,24b It is typically carried out under basic conditions to 
form the nitronate salt; subsequent acid-catalyzed hydrolysis affords the desired carbonyl 
(Scheme 1.8A).  The mechanism to this reaction is shown in Scheme 1.8B.  The Nef 
reaction has also been successfully run in the presence of an oxidant such as H2O2 
(Scheme 1.9A).34  Alkyl α-ketoesters have been generated by a harsher version of the 
Nef reaction proceeding via formation of the nitronate salt and subsequent ozonolysis 
A.
B.
C.
D.
E.
H KMnO4 TDA-1,
CH3CO2H (20 mol %)
CH2Cl2, 4 h
COCO2H
KMnO4 TDA-1,
CH3CO2H (3 mol %)
CH2Cl2, 4 h
COCO2H
OH
OH
44%
84%
PhLi
O
O
OEtEtO + batchTHF, –20 ºC, 
15 min
O
O
OEtPh
flow
55%
93%
OMeMeO OMeMeO
COCO2Et
1.8 : 1
O
O
ClEtO
1 : 1
+
98%
CH2Cl2, rt, 
1 h
AlCl3 (1 equiv)
COCO2EtNa2Cr2O7
shake, rt, 
20 min
95%
CO2Et
OH
TDA-1 = (CH3OCH2CH2OCH2CH2)3N
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(Scheme 1.9B).35  At the time of this work, the Nef reaction had not been used to form 
aroylformates. 
Scheme 1.8  Select examples of the Nef reaction. 
 
Scheme 1.9  Select examples of the Nef reaction with oxidant. 
 
Cleavage of the benzylic nitro bond of 2-aryl-2-nitroacetates leads to phenyl acetates.  
A similar disconnection was known at the time but had not been used to make this class 
of compounds (Scheme 1.10).36  If we could successfully cleave the benzylic-nitro bond, 
this method would serve as an alternative entry to aryl acetates relative to the 
Arndt−Eistert rearrangement (Scheme 1.11, top).37  This procedure utilizes an acid 
chloride formed from the corresponding benzoic acid and is not viable on scale due to the 
ensuing addition of diazomethane.  The use of our approach would also be more efficient 
Py Ph
NO2
1.  10% KOH (aq),   
     36 h, rt
2. 4 M HCl, rt to 
    90 ºC, 3.5 h
Py Ph
O
R
N
O
O
R
HX
H
R
N
O
OK
HX
R
N
O
OH
R R
R
N
OH
OH
R
NH
OH
OH
OH
HNO + H2O + H+
H2O
proton 
transferR R
R
R O
X
K
KX
A.
B.
HX
H2O2, K2CO3
MeOH, H2O, rt 8 h
O
MeO COCH3
NO2 1.  NaOMe, MeOH,    
     rt, 10 min
2.  O3 ,0 ºC, 30 min,          
     then Me2S, rt, 18 h O
MeO COCH3
O
73%
A.
B.
88%
NO2 O
  
  
10 
than a three-step sequence from the benzyl halide involving displacement with cyanide, 
cyanide hydrolysis, and esterification (Scheme 1.11, bottom). 38 
Scheme 1.10  Carreira’s cleavage of benzylic nitro bond. 
 
Scheme 1.11  Alternate methods to make phenyl acetates. 
 
Another useful set of compounds is unnatural amino acids.  The generation of these 
molecules enables modification of molecular structures in medicinal chemistry.39  For 
this reason, the synthesis of α-aryl-α-amino acids has been extensively studied (Scheme 
1.12).40  One of the most common and widely applicable ways to access these compounds 
is through the Strecker reaction,41 which brings in the acid moiety as a cyano group.  
Hydrogen cyanide has been used directly in these reactions and generated in or ex situ 
from TMSCN.  Additionally, one might imagine introducing the side chain by coupling a 
cyclic azlactone or acyclic Schiff base with an electrophile.42,40  The side chain can also 
be introduced via nucleophilic addition into α-ketoimines.43  Lastly, hydrazination of 
ketones and aldehydes have been used to bring in the amine portion of the α-amino 
acid.44  Our approach to this class of compounds would be different and complementary 
to past approaches, because it masks the amine moiety as a nitro group (Scheme 1.3). 
R
NO2 Pd(OH)2/C, 
H2 (1 atm),
EtOH
R
R = alkyl, benzyl
50–95%
O
Arndt-Eistert Homologation
Ar Cl
CH2N2 (2 equiv)
O
Ar
H
N2 Ag2O, H2O
O
HO
H
Ar
Three-Step Sequence
ArBr NaCN ArNC
esterification O
RO Ar
strong 
acid ArHO2C
esterification O
RO Ar
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Scheme 1.12  Selected methods to making unnatural α-aryl-α-amino acids. 
 
Scheme 1.13  Our approach to unnatural α-aryl-α-amino acids. 
 
 
α,α-Disubstituted α-amino acid units, in particular, exhibit unique stability and 
conformational properties when incorporated into peptides.45,46  It is these properties that 
make them highly valued by pharmaceutical, biological, and organic chemists.  Because 
of this fact, disubstituted α-amino acids have become a popular area of research in the 
past decade.47  We envisioned accessing disubstituted α-amino acids through alkylation 
of 2-aryl-2-nitroacetates or by two successive cross-coupling reactions (Scheme 1.14).  
Scheme 1.14  Accessing disubstituted α-amino acids using 2-aryl-2-nitroacetates. 
 
 
R1
O
R2
N
H
R3 R4 R5NC
R1, R2 = aldehyde or ketone;  R3, R4 = H, alkyl, 
aryl, heteroaryl; R5 = H, TMS
N R
3R4
R2NC R1
+
Strecker Reaction PTC alkylation or metal-catalyzed cross-coupling
N
Ph
Ph
t-BuO2C
ArBr, Pd source, base
or
R1Br, base N
Ph
Ph
t-BuO2C R1/Ar
R1 = allyl, benzyl, alkyl
Nucleophilic addition into α-iminoesters
NPG
HEtO2C
R1M
R1 = carbon nucleophile
M = metal
+
NPG
R1EtO2C R1
O R2
R1 = H, OR
R3 = ester
R2/ R4/ R5 = alkyl, aryl
N
H
R4 R5
N
N
R3
R3
+
R1
O R2
NR3NHR3
Electrophilic amination
strong
acid N R
3R4
R2HO2C R1
NH2
ArEtO2C
NO2
reduction NO2
ArEtO2C
NO2EtO2C
Pd-catalyzed
cross-coupling
NO2EtO2C NO2EtO2C
Pd-catalyzed
cross-coupling
Ph Ph
RBr R = alkyl, allyl, benzyl
NO2EtO2C
R Ph
PhBrPhBr
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Chapter one of this thesis discusses the development of a good method to form 2-
nitro-2-aryl acetates aided by high-throughput experimentation (HTE).  It utilizes the 
functionality of these compounds, and new methods to aryl nitromethanes, α-ketoesters, 
and α-amino acids are described. 
1.2.  Results and Discussion 
1.2.1.  Development of a Cross-Coupling Method Between Ethyl Nitroacetates and 
Aryl Bromides to Afford Nitroarylacetates 
The coupling of aryl bromides 1.1 and α-nitroacetates 1.3 to generate 2-aryl-2-
nitroacetates 1.5 (Scheme 1.15) is reported in this section.48   A high-throughput 
experimentation (HTE) approach was used to discover suitable conditions for this 
method, which had not been reported previously.  The higher acidity of α-nitroacetates 
(pKa 5.8)49 unpredictably posed a new set of challenges compared to other activated 
methylene compounds such as acyclic 1,3-dicarbonyls (pKa 13) and nitroalkanes (pKa 10) 
(Table 1.3).22,50 
Scheme 1.15  Nitroacetate coordination to palladium. 
 
 
This increased acidity would lead to the hypothesis that only a very mild base would 
be needed.  Because of this characteristic, the resultant anion is expected to be a very 
poor nucleophile and is poised to form highly favorable O,O’-bound intermediate 1.4-I 
(Scheme 1.15).  Substantial reorganization and, potentially, the participation of a second 
Ar–X
LnPd0
LnPdII
Ar
X
BH+ X-BH
O2N CO2R
O
OR
N OO N
ORO
O
O LnPd
0
O2N CO2R
Ar
1.1 1.2
1.3
1.4-I 1.4-II 1.5
LnPdII
Ar
LnPdII
Ar
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ligand may be necessary for 1.4-I to rearrange to the C-bound form 1.4-II, a prerequisite 
for C-C reductive elimination and formation of 1.5.50  Initial trials using NaH with tris-
tert-butylphosphine and with Pd2dba3 as reported for the related malonates22a (Table 1.3)  
Table 1.4  Initial benchtop screen results. 
 
proved unsuccessful (Table 1.4, entry 1).  A range of alternate bases was examined, with 
the hypothesis that milder bases could be used; however conversions were still 
insignificant (entries 2–5).  A more electron-rich aryl bromide was utilized to determine 
if the reductive elimination step was problematic, but no improvement was seen (entries 
6–7).  Finally, the optimal ligand for nitroalkanes22 (Table 1.3) was tried with similar 
poor results (Table 1.4, entry 8).  While the preliminary results secured that conversion 
of 1.1to 1.5 is possible, it was evident that the conditions highly effective for malonates 
and nitroalkanes were not applicable to α-nitroacetates. 
A range of palladium sources, ligands, and bases needed to be examined, since our 
understanding of how the reaction variables affect the mechanism was inadequate.  To 
effectively complete this study, high-throughput experimentation was utilized. 51  It was 
O
OEtO2N+
Br Pd2dba3 (5 mol % Pd)
ligand (10 mol %),
base (1.2 equiv)
solvent, 50–80 °C, 18 h
O
EtO NO2
conversion by 
1H NMR (%)
R
R
ligandentry
1
baseR solvent
2
3
4
5
6
7
8
H
H
H
H
H
OMe
OMe
H
NaH (4 equiv)
Cs2CO3
Cs2CO3
CsHCO3
NaOAc
CsHCO3
NaOAc
Cs2CO3
THF
THF
DME
DME
DME
toluene
toluene
toluene
P(t-Bu)3
P(t-Bu)3
P(t-Bu)3
P(t-Bu)3
P(t-Bu)3
P(t-Bu)3
P(t-Bu)3
t-BuMe Phos
0
0
7
2
4
3
7
6
1.31.1 1.5a R = H
1.5b R = OMe
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straightforward and efficient (3 d total time for set-up, reaction and analysis) to undertake 
96 reactions in a single plate by using 1-mL vials with 100 µL reaction volumes at 0.2 M 
concentration.  Additionally, only 422 µL (3.84 mmol) of ethyl nitroacetate was needed 
to screen 96 sets of conditions against 202 µL (1.92 mmol) phenyl bromide. 
Based upon the results in Table 1.4 an unbiased screen of various phosphines 
(monodentate, bidentate, hindered, biphenyl, etc.) was carried out at 75 °C in 
combination with two palladium sources and four bases spanning a broad pKa range.  The 
3-D plot in Figure 1.1 illustrates the conversion as indicated by the product/internal 
standard ratio.  Table 1.5 lists the top screening results along with selected isolated yields 
when performed on a larger scale. 
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Figure 1.1  Graphical summary of HTE screen #1 results. 
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Table 1.5  Top screening results from HTE #1. 
aRelative conversions from screen (IS = internal standard).  bIsolated yields upon scale up (0.25 
mmol scale).  cNot isolated because conversion by 1H NMR was low.  dNot scaled up. 
 
This screen disclosed that only three ligands, BrettPhos L10, Me4 t-BuXPhos L15, 
and t-BuXPhos L14 (Figure 1.1) provide any product with the latter two proving 
superior.  This ligand selectivity suggests that the biphenyl η-1 coordination52 is critical 
to forming a reactive species.  In addition, blocking of palladacycle formation with the 
isopropyl groups is necessary.53,9   Most surprising was the narrow range of sterically 
acceptable ligands with the smaller XPhos L9 failing while the two methoxy groups of 
BrettPhos L10 offset the smaller phosphine cyclohexyl substituents (L9 < L10 << L15 < 
L14).  On the other end, Me4 t-BuXPhos L15 appears too large. 
   
Entry 
 
Ligand Pd Base Solvent Product/ ISa, Yieldb 
1 t-BuXPhos Pd2dba3 • CHCl3 CsHCO3 Toluene 6.9, 93% 
2 t-BuXPhos (allylPdCl)2 CsHCO3 DME 5.1, 46% 
3 Me4t-Bu XPhos Pd2dba3 • CHCl3 Cs2CO3 Toluene 4.5, N/A
c 
4 Me4t-BuXPhos Pd2dba3 • CHCl3 CsHCO3 Toluene 3.7, N/A
c 
5 t-BuXPhos (allylPdCl)2 K3PO4 DME 3.0, N/A
d 
6 Me4t-BuXPhos (allylPdCl)2 Cs2CO3 DME 1.8, N/A
d 
7 t-BuXPhos (allylPdCl)2 Cs2CO3 DME 1.8, 53% 
8 Me4t-BuXPhos (allylPdCl)2 CsHCO3 DME 1.04, N/A
d 
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Figure 1.2  Graphical summary of HTE screen #2 results. 
Holding the t-BuXPhos ligand and the CsHCO3 base constant, additional high-
throughput experimentation was carried out to identify the optimal temperature, Pd 
source, and solvent (Figure 1.2).  From this screen it was discovered that lower 
temperatures (75 °C versus 110 °C) provided better results.  This result was hypothesized 
to be due to product decomposition at the higher temperature.  With every solvent 
combination, Pd2dba3 and a preformed palladacycle containing the optimal t-BuXPhos 
ligand:  {chloro(2-di-tert-butylphosphino-2',4',6'-trisisopropyl-1,1'-biphenyl)[2-(2-amino 
ethyl)phenyl] palladium(II)} 54  gave consistent results, whereas [(allyl)PdCl]2 and 
Pd(OAc)2 were less reliable.  Upon scale up, Pd2dba3•CHCl3 provided high isolated yields 
(93%) with the preformed catalyst being slightly lower (88%).  Nonpolar solvents 
(toluene and cyclopentyl methyl ether) perform better than polar solvents (dioxane, 
DME, tert-amyl alcohol, THF).  
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In accordance with other results involving enolates, additional experiments indicated 
that a 2:1 ligand:palladium ratio was the most effective.22a  This result is hypothesized to 
be from undesired decomposition or oxidation of the ligand.  For this reaction, where 
deprotonation of the α-nitroacetate is a key step, a base was crucial to the success of the 
process (Table 1.6, entry 1).  An examination of bases (Table 1.6) found that relative to 
CsHCO3 (entry 2) stronger bases (K3PO4, Cs2CO3, Figure 1.1; CsOH, NaOt-Bu, Table 
1.6, entries 3-4) were not as successful.  We hypothesize that stronger bases produce 
larger amounts of the nitroacetate anion, which may facilitate substrate precipitation.22a  
Bases with harder cations (KHCO3, NaHCO3, Li2CO3, entries 5-7) provided little or no 
product formation, either due to lower solubility or stronger bonding to the nitronate 
anion, which would inhibit ligand exchange.  On the other end of the continuum, even 
softer counterions (Rb2CO3, entry 8) performed similarly relative to cesium.  The anion 
may remain involved since CsF (entry 9), with the optimal cation and a similar pKa 
relative to CsHCO3, was only partly effective.  A variety of amine bases were ineffective 
(entries 10–13), presumably due to competitive binding to the palladium. 
Table 1.6  Bench-top screen of various bases.a 
Entry Base 
Conversionb(%), 
Yieldc(%) Entry Base 
Conversionb 
(%), Yieldc(%) 
1 none 0, 0 8 Rb2CO3 100, 90 
2 CsHCO3 100, 93 9 CsF 60, 60 
3 CsOH 41, N/Ad 10 (i-Pr)2NEt 0, 0 
4 NaOt-Bu 0, 0 11 DMAP 0, 0 
5 KHCO3 19, N/Ad 
12 2,6-(t-Bu)2- 4-MePy 0, 0 6 NaHCO3 0, 0 
7 Li2CO3 0, 0 13 DBU 10, N/A
d 
aReaction conditions:  Pd2dba3•CHCl3 (2.5 mol %), ethyl nitroacetate (2 equiv), phenyl bromide (1 equiv), 
base (1.2 equiv), and toluene (0.2 M) at 75 °C.  bConversion by 1H NMR with respect to remaining ethyl 
nitroacetate.  cIsolated yields.  dNot isolated.  
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The best reaction conditions were found to be 2.5 mol % Pd2dba3•CHCl3, 10 mol% t-
BuXPhos, 1.2 equiv CsHCO3 in toluene at 75 °C, which afforded the products from 
various aryl bromides and ethyl nitroacetate in isolated yields of 52-96% (Table 1.7).  
Since electron-rich and electron-poor aryl halides reacted well it can be hypothesized that 
oxidative addition and reductive elimination are not the problematic step in catalytic 
cycle.  In addition, heterocyclic compounds (entries 7 and 11) could be utilized.  
However, the indole substrate required N-protection before undergoing coupling.  
Interestingly, ketones do not compete with the nitroacetate anion in coupling to the aryl 
bromide (entry 4), in line with its higher acidity (pKa 20).  Reaction selectivity was 
observed for aryl bromides over aryl chlorides (entry 12) with isolation of only a small 
amount of the dicoupled product (16%) in accordance with the bond strengths of aryl 
chlorides versus bromides (95 kcal/mol vs. 80 kcal/mol).55 
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Table 1.7  Reaction of ethyl nitroacetate with aryl bromides.a 
 
aReaction conditions:  5 mol % Pd, 10 mol % ligand, ethyl nitroacetate (2 
equiv), aryl bromide (1 equiv), CsHCO3 (1.2 equiv), and toluene (0.2 M).  b20 
mol % Pd. cSelective for aryl bromide with 16% of the dicoupled product 
isolated. 
 
The method is not useful for aryl iodides, triflates, and chlorides.  We speculate that 
the nature of the counterion is critical to the transmetallation of 1.3 to 1.4 (Scheme 1.15), 
since such species undergo oxidative addition under these conditions.  This hypothesis is 
in line with related reports on other enolates.56  To try to gain insight into this theory, the 
reaction was tested with additives (Table 1.8).  Initially tetrabutylammonium bromide 
(TBAB) was added to a reaction with aryl iodide to see if bromide anion in the reaction 
mixture would facilitate transmetallation (entry 2).  This reaction did not work; however, 
it was determined that the tetrabutylammonium cation hinders the reaction (entry 3).  
Because of this fact, cesium counter anions were utilized.  Addition of CsBr did not 
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inhibit the reaction mixture (entry 4).  However, CsBr did not facilitate reaction progress 
(entry 5).  This result, along with the fact that CsI completely inhibited product formation 
(entry 6), suggests close involvement of the counteranion.  Presumably, this downfall is 
due to its competing affinity for the palladium relative to the nitroacetate anion.   
Table 1.8  Top conditions with counter-anion additives. 
 
This method was also not suitable for halopyridines.  Additional screening was 
performed around these substrates (see 1.4 Experimental section, HTE #8, for more 
detail), but no leads were identified. 
Moderately hindered aryl bromides couple (Table 1.7, entry 3).  However, more 
hindered compounds such as 1-bromonaphthalene or ortho-bromotoluene provided no 
desired product.  Additional screening was performed around these substrates (see 1.4 
Experimental section, HTE #3–7, Table 1.19–Table 1.22 for more detail).  Hartwig and 
Culkin observed similar results in the α-arylation of ketones50 and suggest it arises from 
steric hindrance further slowing exchange of the O,O-bound palladium intermediate 1.4-I 
to the carbon-bound intermediate 1.4-II, an already difficult stage in the catalytic cycle of 
this system (Scheme 1.14). 
A hypothesis was formed based on this idea where the rearrangement of the O,O-
bound palladium intermediate 1.4-I to the carbon-bound intermediate 1.4-II would be 
X
O
OEtO2NO
OEtO2N +
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t-Bu XPhos (4 mol %)
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assisted with a urea or metal additive (Scheme 1.16).  Conceptually, the ethyl nitroacetate 
would bind to the additive in a bidentate fashion while remaining on the palladium.  The 
results of the screen are displayed in Table 1.9.  The top two hits, which were CuO and 
Ag2O, gave less than 10% of the desired product on larger scale.  The metal additives 
may be interfering with ligand exchange, or if intermediate 1.4-II is accessed, the 
nitroacetate may now be too electron deficient to undergo reductive elimination.  
Reactions with urea additives also did not provide product.  Similarly to amine bases and 
pyridyl substrates, the urea may be competitively binding to the palladium.  At this 
juncture, a reliable method to promote the O- to C-bound rearrangement remains an 
unsolved problem in this field. 
Scheme 1.16  Assisted rearrangement of the O,O-bound palladium intermediate 1.4-I 
to C-bound intermediate 1.4-II. 
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Table 1.9  Metals used in additive screen. 
Additive Solvent Product/IS 
iron (II) bromide dioxane 0.00 
iron (II) chloride dioxane 0.00 
iron (II) chloride toluene 0.00 
magnesium (II) Br • Et2O toluene 0.00 
calcium (II) bromide toluene 0.00 
copper (II) bromide toluene 0.02 
copper (I) bromide dioxane 0.05 
copper (II) bromide dioxane 0.07 
magnesium (II) Br • Et2O dioxane 0.09 
iron (II) bromide toluene 0.09 
silver (I) oxide toluene 0.10 
copper (I) bromide toluene 0.10 
calcium (II) bromide dioxane 0.11 
zinc (II) bromide toluene 0.12 
zinc (II) chloride toluene 0.13 
magnesium (II) sulfate toluene 0.13 
copper (II) oxide toluene 0.13 
calcium (II) carbonate toluene 0.13 
zinc (II) bromide dioxane 0.16 
calcium (II) carbonate dioxane 0.19 
zinc (II) chloride dioxane 0.19 
magnesium (II) sulfate dioxane 0.19 
copper (II) oxide dioxane 0.20 
silver (I) oxide dioxane 0.27 
  
A N,O-Bis(trimethylsilyl)acetamide (BSA)57 additive screen was also performed 
under the notion that BSA could act as both a base and silylating reagent.  We 
hypothesized if the nitroacetate could be silylated in situ then 1.4m-I could be prevented 
and C-bound intermediate 1.7m-II could be formed (Scheme 1.17).  Reductive 
elimination would afford 1.8m.  The desired product would be formed during work-up, 
after removal of the acid-labile TMS group.  However, this screen (see 1.4 Experimental 
section, HTE #6, Table 1.21 and Table 1.22 for more detail) did not afford a significant 
amount of the desired product. 
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Scheme 1.17  Assisted rearrangement of the O,O-bound palladium intermediate 1.4-I to 
carbon-bound intermediate 1.4-II. 
 
Methyl, tert-butyl, and benzyl nitroacetates were synthesized using the same 
conditions from Table 1.7 to further test the reactivity of this system. 58   These 
nitroacetate couplings afforded product in moderate to good yields (Table 1.10). 
Apparently, the increased disposition of methyl nitroacetate to hydrolyze and 
decarboxylate reduces its effectiveness (entry 1). 
Table 1.10  Reaction of various nitroacetates with bromobenzene. 
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1.2.2.  Optimization of the Decarboxylation of Nitroarylacetates to Generate Aryl 
Nitromethanes59 
Aryl nitromethanes can be readily synthesized from aryl nitroacetates by 
decarboxylation.23c  These methods afford aryl nitromethanes 1.9 in 76–98% (Table 
1.11). Hydrolysis and decarboxylation conditions were initially optimized for the 
formation of phenyl nitromethane and consisted of initial treatment with NaOH in EtOH 
at 80 °C, followed by exposure to 1 M HCl in THF after solvent removal (Table 1.11, 
entry 1).  For substrates with neutral or electron-withdrawing substituents (entries 1-5), 
these conditions worked well.  On the other hand, electron-rich substrates were more 
disposed to undergo the Nef reaction (Scheme 1.18),33 forming an aldehyde by-product 
1.15.  This observation conflicts with Kornblum’s report that stabilization of the nitronate 
anion, as by an aryl group, inhibits the Nef reaction.24  The presence of electron donating 
groups on the aromatic ring would lead to less stable anions favoring O-protonation.  To 
avoid this problem, less acidic conditions that stabilize the nitro by hydrogen bonding 
(acetic acid/urea) and do not facilitate protonation of the corresponding nitronic acid 1.12 
(Scheme 1.18),24 were used in the second step for this group of substrates.  These 
conditions decelerated the competing elimination of dihydroxyamine [HN(OH)2] and 
formed aryl nitromethanes in 77–80% yield (Table 1.11, entries 6-9). 
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Table 1.11  Decarboxylation to form aryl nitromethanes.a 
 
aReaction conditions Method A:  1) 1 M NaOH, EtOH (0.14 M), 85 °C, 1 h; 
2) 1 M HCl, THF (0.17 M), 85 °C, 1 h.  Method B:  1) 1 M NaOH, 
EtOH:toluene (1:1, 0.14 M), 85 °C, 1 h; 2) urea (17 equiv as a 2.8 M 
solution in 20% aq AcOH), THF (0.17 M), 0 °C to rt, 1 h. 
 
Scheme 1.18  Formation of aryl nitromethanes instead of aldehyde (EDG = electron 
donating group). 
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1.2.3.  Transformation of Nitroarylacetates to Their Corresponding α-Ketoesters 
Through the Use of Mild Conditions59 
The application of conventional Nef conditions34 to the 2-aryl-2-nitroacetates did not 
provide the expected α-ketoesters.  When 2-aryl-2-nitroacetates were deprotonated with 
NaOH (aq) in THF at rt followed by acidification with 5 M HCl, as shown in the 
literature (Scheme 1.8), decarboxylated aryl nitromethane 1.9 was formed as a result of 
ester hydrolysis.34  Futhermore, only a 20% conversion by 1H NMR to the α-ketoester 
was observed when 2-aryl-2-nitroacetates 1.5 were exposed to 30% H2O2 in the presence 
of aqueous K2CO3 in MeOH at rt for 24 h (see lit. example in Scheme 1.9).34 
All efforts to access quaternary nitroacetates were not successful.  The coupling of 
ethyl 2-fluoro-2-nitroacetate and 2-methyl-2-nitroactate failed to give any desired 
product.  Additionally, attempts to α-methylate 2-aryl-2-nitroacetates 1.5 with MeI in the 
presence of a weak or moderate base (K2CO3 or Bu4NOH) led to mixtures of O-
methylated products (Scheme 1.19).  Attempts to benzylate or allylate 2-aryl-2-
nitroacetates 1.5 also provided complex mixtures.   
Scheme 1.19  Methylation of 2-aryl-2-nitroacetates. 
 
Intriguingly, during these efforts, we had observed formation of the α-ketoesters 1.19 
using phase transfer catalysis (PTC) conditions (Table 1.12).60  Tishkov and coworkers 
had reported a similar Nef transformation on diphenylnitromethane, but these conditions 
have not been utilized in the synthesis of α-ketoesters.21  Ultimately TBAF, MeI, and KF 
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in THF proved very efficient in generating α-ketoesters.  Both electron-poor and electron-
rich substrates gave the α-ketoesters in good yields (Table 1.12).  Additionally, α-
ketoesters with electron rich groups in the meta-position (entry 9), which would be 
difficult to make via Friedel-Crafts protocols, could be generated. 
Table 1.12  Disproportionation of 2-aryl-2-nitroacetates.a 
 
aReaction conditions: 5 mol % TBAF (1M solution in THF), MeI (2.5 equiv), 
KF (12.5 equiv), THF (0.3M). 
 
The result of this combination of reagents was unexpected and experiments 
definitively indicated that all the reagents play a role in the efficiency of the 
transformation (Table 1.13).  The fact that the reactions including MeI are superior (entry 
2 vs 3) strongly suggests involvement of a nitronic ester (1.16, Scheme 1.20).  
Compounds similar to 1.5 have been reported to undergo the Nef reaction. 61   In many 
cases, less than 100% isolated was observed due to a variable amount of an undesired O-
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(entry 4), because the reaction still progresses well without MeI.  TBAF is necessary to 
increase anion solubility (entry 9); this notion was supported by the observation of a thick 
precipitate during reaction progression.  Without KF (entry 6) the reaction rate 
decelerates, but significant product was observed after 3 h (entry 7).  The amount of 
water present has a large affect on the reaction.  Addition of 5 equiv of water inhibited 
product formation, while 1 equiv of water promoted it.  Concentrations higher than 0.3 M 
give an O-methylated product with less than 10% of the desired product observed, while 
those lower than 0.3 M lead to a slower rate.  Tetrabutylammonium hydroxide is also 
adequate for the transformation (entry 10).  However it needs to be added as a solution in 
THF (similar to TBAF) to avoid excess water in the reaction.  Interestingly, when phenyl 
nitromethane or diphenyl nitromethane are exposed to these conditions, the nitronic ester 
is formed to a greater extent than the aldehyde or ketone. 
Table 1.13  Exploring Nef reaction conditions.a 
 
aReaction conditions: 5 mol % TBAF (1M solution in THF), MeI 
(2.5 equiv), KF (12.5 equiv), THF (0.3M)   bDetermined by 1H NMR 
with respect to nitroarylacetate starting material. 
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Scheme 1.20  Formation of α-ketoester. 
 
1.2.4.  Conversion of Nitrophenylacetates to the Corresponding Ethyl 
Phenylacetates and α-Amino Esters59 
Reduction of 2-aryl-2-nitroacetates using Zn0/AcOH (Table 1.14) provides an 
additional entry to unnatural α-aryl-α-amino acids 1.22.  The reduction works well for 
electron-rich (entry 2) and heteroaromatic substrates (entry 4).   
Table 1.14  Reduction of 2-aryl-2-nitroacetates to α-amino esters.a 
 
 aReaction conditions: Zinc dust (4 x 6 equiv added in 30 min intervals), 
AcOH (glacial, 0.2 M) 
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on carbon, rhodium on alumina, and platinum dioxide) provided mainly the phenyl 
acetate.  Under certain conditions, phenyl acetate 1.23 could be produced quantitatively 
(Scheme 1.21). 
Table 1.15  Identifying conditions for nitro group reduction. 
 
Entry Reaction Conditions   1.5 : 1.23: 1.22a 
1 NiCl2 • 6H2O, NaBH4, MeOH  5 : 1 : 0 
2 Pt2O hydrate, H2 (1 atm), THF  16 : 3 : 1 
3 Zn0, HCl, EtOH   1 : 0 : 2 
4 Zn0, AcOH,EtOH   0 : 0 : 1 
5 Rh/Al2O3, H2 (1 atm), EtOAc  2 : 1 : 1 
6 Rh/Al2O3, H2 (1 atm), EtOH  0 : 1 : 1 
7 Raney Nickel, H2 (1 atm), EtOH  10 : 1 : 3 
8 Raney Nickel, H2 (10 atm), EtOH   0 : 2 : 7 
9 Pd, H2 (1 atm), EtOH  0 : 1 : 0 
10 Pd, H2 (1 atm), EtOAc  0 : 1 : 0 
11 Lindlar's catalyst,  H2 (1 atm), EtOAc  1 : 0 : 0 
12 Fe0, AcOH, MeOH   1 : 0 : 0 
 
Scheme 1.21  Forming phenyl acetate efficiently. 
 
1.3.  Conclusions 
In summary, conditions were developed for the catalytic cross coupling of α-
nitroacetates with aryl bromides to generate 2-aryl-2-nitroacetates.  This research was 
undertaken due to the lack of literature methods to make 2-aryl-2-nitroacetates.  It was 
determined the most suitable ligand in this palladium-catalyzed coupling is t-BuXPhos.  
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reductive elimination.  It is also hypothesized this ligand plays a crucial role in the 
competing κ2-O,O’-coordinated vs. C-bound intermediates in the catalytic cycle.  
Following the above accomplishment, conditions were developed for selective 
transformation of 2-aryl-2-nitroacetates to useful small molecules.  Decarboxylation 
afforded aryl nitromethanes, disproportionation produced α-ketoesters, and reduction 
generated α-amino esters in good isolated yields.   
Even with these successes, it is still imperative to gain a better understanding of the 
exact role of the ligand in the catalytic cycle of the palladium-catalyzed cross-coupling 
methods.  This insight will enable the substrate scope to be expanded to aryl iodides, 
halopyridines, and hindered aryl bromides.  Additionally, the scientific community would 
benefit from mechanistic insight into the Nef reaction and cleavage of the benzylic nitro-
bond during the formation of the α-ketoesters and phenyl acetates, respectively. 
1.4.  Experimental Section48,59 
 General Methods.  Unless otherwise noted, all non-aqueous reactions were 
carried out under an atmosphere of dry argon in dry glassware and all solvents and 
reagents were HPLC grade and used without further purification.  When necessary, 
solvents and reagents were dried prior to use.  Moisture sensitive reagents were added via 
syringe.  Toluene was distilled from CaH2 and degassed with freeze-pump-thaw cycles (3 
x).  THF was distilled from NaH/benzophenone prior to use.  Flash column 
chromatography was performed on EM Reagents Silica Gel 60 (230-400).  Analytical 
thin layer chromatography (TLC) was performed on EM Reagents 0.25 mm silica-gel 
254-F plates.  Visualization was accomplished with UV light and/or KMnO4 stain.  
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 1H NMR and 13C spectra were recorded on a Bruker AM-500 (500 MHz) 
spectrometer.  Chemical shifts are reported from the solvent resonance peak (CDCl3 7.27 
ppm).  Data are reported as follows:  chemical shift, multiplicity (s = singlet, d = doublet, 
t = triplet, q = quartet, bs = broad singlet, m = multiplet), coupling constants, and number 
of protons.  Mass spectra were obtained on a high resonance VG autospec with an 
ionization mode of either CI or ES.  IR spectra were taken on an ASI ReactIR 1000FT-IR 
spectrometer.  Melting points were obtained on a Thomas Scientific Unimelt apparatus 
and are uncorrected. All yields reported refer to isolated yields unless otherwise 
indicated, and the product purity was determined by 1H NMR.  Compounds described in 
the literature were characterized by comparison of their spectra to reported data.  New 
compounds were also characterized by high resolution mass. 
 
Procedures for Parallel Microscale Experimentation. Reactions of ethyl nitroacetate 
with bromobenzene, o-bromotoluene or halopyridine. 
 
 The following procedure is representative of the high-throughput experimentation 
protocols used.  The ligands (2 µmol) were dosed into the 96-well reactor 1-mL vial as 
solutions (50 µL of a 0.04 M solution in THF or toluene depending on the solubility of 
the ligand).  These ligands may be plated in advance of the screen; the solvent is removed 
by evacuation on a Genevac, and the plates are stored in the glovebox.  Palladium source 
(1.0 µmol Pd, 50 µL of a 0.02 M solution in THF) was then added to the reaction vials 
and the solutions were evacuated to dryness on a Genevac or JKem-blow-down block.  
Base (24 µmol, 25 mg/mL slurry in THF) was then added to the ligand/catalyst mixture, 
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and this mixture was evacuated to dryness on a Genevac or JKem-blow-down block.  A 
parylene stir-bar was added to each reaction.  The aryl halide (20 µmol/reaction), ethyl 
nitroacetate (40 µmol/reaction) were then dosed together in the reaction solvents (100 µL 
of a 0.20 M and 0.40 M solution respectively).  The vials were sealed and heated at 80 ºC 
for 18 h. After cooling to ambient temperature, the reaction mixtures were evacuated to 
dryness on a Genevac or JKem-blow-down block.  The residues were diluted with a 
solution of internal standard and acetic acid in MeCN (2 µmol biphenyl or tert-butyl 
biphenyl, 60 µmol acetic acid, 500 µL of solution), and the contents were stirred. Into a 
separate 96-well plate LC block was added 750 µL of MeCN and then 20 µL of the 
diluted reaction mixtures.  The 96-well plate LC block was then sealed with a 
polypropylene 1 mL cap mat.  The mixtures were analyzed using an Agilent 
Technologies 1200 series HPLC with a 96-well plate auto-sampler.  
 
High throughput experimentation (HTE) #1 consisted of one 96-well plate in toluene and 
one in 1,2-dimethoxyethane (DME) and screened the variables listed below.  Top leads 
and select ligands are represented in Figure 1.1, Table 1.5, and Table 1.16.  All table 
results are listed in order of least to most product formation as measured against an 
internal standard (IS). 
 
Ligands 
X-Phos: 2-(Cy2P)-2',4',6'-i-Pr-biphenyl S-Phos: 2-(Cy2P)-2',6'-MeO-biphenyl 
JohnPhos: 2-(t-Bu2P)-biphenyl  DavePhos: 2-(Cy2P)-2'-(Me2N)-biphenyl 
RuPhos: 2-(Cy2P)-2',6'-i-PrO-biphenyl BrettPhos: 2-(Cy2P)-3,6-MeO-2',4',6'-i-Pr-
biphenyl cataCXium A: Ad2Pn-Bu  Q-Phos: 1'-(t-Bu2P)-1,2,3,4,5-Ph-ferrocene 
[HP(t-Bu)3]BF4             AmPhos [A-taPhos]: 1-(t-Bu2P)-4-(Me2N)-Ph  
dtbpf: 1,1'-(t-Bu2P)-ferrocene   (o-Tol)3P 
dppf: 1,1'-Ph2P-ferrocene   dippf: 1,1'-(i-Pr2P)-ferrocene 
dppp: 1,3-(Ph2P)-Pr    dppb: 1,4-(Ph2P)-Bu  
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DPEPhos: (2-Ph2PPh)2O XantPhos:  4,5-Bis(diphenylphosphino)-9,9-
dimethylxanthene 
(R)-BINAP Me4 t-Bu XPhos: 2-(t-Bu2P)-3,4,5,6-Me-
2',4',6'-i-Pr-biphenyl  
SL-J009-1 : (R)-(S)-Cy2PF-Pt-Bu2   cataCXium PtB: 2-(t-Bu2P)-1-Ph-pyrrole 
t-Bu XPhos: 2-(t-Bu2P)-2',4',6'-i-Pr-biphenyl [HP(Cy)3]BF4 
 
Bases 
CsCO3, CsHCO3, NaOAc, K3PO4  
Palladium Sources 
[allylPdCl]2, Pd2dba3 • CHCl3  
Table 1.16  All results that gave product from HTE #1. 
Palladium Source Ligand Base Solvent Product/IS 
Pd2dba3 • CHCl3 BrettPhos K3PO4 toluene 0.13 
Pd2dba3 • CHCl3 Me4 t-Bu XPhos K3PO4 toluene 0.45 
Pd2dba3 • CHCl3 BrettPhos Cs2CO3 toluene 0.83 
(PdallylCl)2 Me4 t-Bu XPhos CsHCO3 DME 1.04 
(PdallylCl)2 t-Bu Xphos Cs2CO3 DME 1.82 
(PdallylCl)2 Me4 t-Bu XPhos Cs2CO3 DME 1.84 
(PdallylCl)2 t-Bu Xphos K3PO4 DME 3.03 
Pd2dba3 • CHCl3 Me4 t-Bu XPhos CsHCO3 toluene 3.73 
Pd2dba3 • CHCl3  Me4 t-Bu XPhos Cs2CO3 toluene 4.52 
(PdallylCl)2 t-Bu Xphos CsHCO3 DME 5.08 
Pd2dba3 • CHCl3 t-Bu Xphos CsHCO3 toluene 6.91 
 
High throughput experimentation (HTE) #2 consisted of 2 identical 96-well plates.  One 
was stirred at 75 °C and the other was stirred at 110 °C to study temperature effects.  
Variables are listed below.  Top leads are represented in Table 1.17 and Table 1.18. 
Ligands           Base 
t-Bu XPhos: 2-(t-Bu2P)-2',4',6'-i-Pr-biphenyl     Cs2CO3 
Me4 t-Bu XPhos: 2-(t-Bu2P)-3,4,5,6-Me-2',4',6'-i-Pr-biphenyl  CsHCO3 
 
Palladium Sources 
t-Bu XPhos Preformed54, 62 :  [2-(t-Bu2P)-2',4',6'-i-Pr-1,1'-biphenyl][2-(2-
aminoethyl)phenyl] PdCl (only with ligand t-Bu XPhos) 
[PdallylCl]2 
Pd(OAc)2  
Pd2dba3  
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Solvents 
toluene    tetrahydrofuran (THF)   
t-amyl alcohol (t-AmylOH)  1,2-dimethoxyethane (DME)  
cyclopentyl methyl ether (CPME) 1,4-dioxane 
 
Table 1.17  Top results that gave product from HTE #2 at 75 ºC. 
Pd Ligand Base Solvent Product/IS 
Pd2dba3  Me4 t-Bu XPhos CsHCO3 dioxane 1.89 
Pd(OAc)2  Me4 t-Bu XPhos Cs2CO3  t-AmylOH 2.02 
Pd(OAc)2 t-Bu XPhos CsHCO3 DME 2.24 
Pd(OAc)2 t-Bu XPhos Cs2CO3 CPME 2.28 
Pd(OAc)2  Me4 t-Bu XPhos CsHCO3 dioxane 2.28 
t-Bu XPhos Preformed t-Bu XPhos Cs2CO3 toluene 2.38 
t-Bu XPhos Preformed t-Bu XPhos Cs2CO3  t-AmylOH 2.74 
 
Table 1.18  Top results that gave product from HTE #2 at 110 ºC. 
Pd Ligand Base Solvent Product/IS 
Pd(OAc)2  Me4 t-Bu XPhos Cs2CO3 CPME 1.28 
Pd(OAc)2 t-Bu XPhos CsHCO3 toluene 1.29 
Pd(OAc)2  Me4 t-Bu XPhos CsHCO3 DME 1.34 
Pd2dba3 t-Bu XPhos CsHCO3 CPME 1.39 
Pd(OAc)2  Me4 t-Bu XPhos Cs2CO3  t-AmylOH 1.51 
Pd2dba3 t-Bu XPhos CsHCO3 toluene 1.57 
Pd(OAc)2  Me4 t-Bu XPhos Cs2CO3 THF 2.37 
 
High throughput experimentation (HTE) #3-7 were screens using o-bromotoluene in 
place of bromobenzene with the intention of finding conditions suitable for the coupling 
of hindered aryl bromides.   
High throughput experimentation (HTE) #3 consisted of a 24-well plate at 80 °C with 
Pd2dba3CHCl3.  Variables are listed below.  Top hits are represented in Table 1.19.   
Ligands 
[HP(t-Bu)3]BF4 
Me4 t-Bu XPhos: 2-(t-Bu2P)-3,4,5,6-Me-2',4',6'-i-Pr-biphenyl  
t-Bu XPhos: 2-(t-Bu2P)-2',4',6'-i-Pr-biphenyl  
2-(t-Bu2P)biphenyl 
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2-(t-Bu2P)-2’-Me-biphenyl 
2-(t-Bu2P)-2’-(N,N-Me2N)biphenyl 
DavePhos: 2-(Cy2P)-2'-(Me2N)-biphenyl  
t-Bu BrettPhos: 2-(t-Bu2P)-3,6-MeO-2',4',6'-i-Pr-biphenyl 
QPhos: 1'-(t-Bu2P)-1,2,3,4,5-Ph-ferrocene 
MePhos: 2- (Cy2P)-2′-Me-biphenyl 
BrettPhos: 2-(Cy2P)-3,6-MeO-2',4',6'-i-Pr-biphenyl 
 
Bases 
Cs2CO3     CsHCO3 
 
Table 1.19  HTE #3:  Selected data from conditions that gave product. 
Ligand Base Product/IS 
2-(t-Bu2P)-2’-Me-biphenyl Cs2CO3 0.059 
XPhos CsHCO3 0.076 
[HP(t-Bu)3]BF4 Cs2CO3 0.079 
XPhos Cs2CO3 0.086 
BrettPhos Cs2CO3 0.106 
BrettPhos CsHCO3 0.106 
[HP(t-Bu)3]BF4 CsHCO3 0.131 
t-Bu XPhos CsHCO3 0.139 
t-Bu XPhos  Cs2CO3 0.216 
 
High throughput experimentation (HTE) #4 consisted of a 96-well plate at 80 °C and 
screened around the top 4 ligands from HTE #3.  Variables are listed below.  Top hits are 
represented in Table 1.20.   
Palladium Sources  
[allylPdCl]2  
Pd2dba3•CHCl3  
Pd(OAc)2 
 
Ligands 
[HP(t-Bu)3]BF4 
Me4 t-Bu XPhos: 2-(t-Bu2P)-3,4,5,6-Me-2',4',6'-i-Pr-biphenyl  
t-Bu XPhos: 2-(t-Bu2P)-2',4',6'-i-Pr-biphenyl  
BrettPhos 
 
Bases   Solvents 
Cs2CO3         1,2-dimethoxyethane (DME) 
CsHCO3         toluene 
K3PO4 
NaHCO3 
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Table 1.20  HTE #4:  Selected data from conditions that gave product. 
Pd Source Ligand Base Solvent Product/IS 
Pd2(dba)3•CHCl3 t-Bu XPhos Cs2CO3 DME 0.04 
[PdallylCl]2 t-Bu XPhos K3PO4 toluene 0.05 
Pd2(dba)3•CHCl3 [HP(t-Bu)3]BF4 K3PO4 DME 0.05 
Pd2(dba)3•CHCl3 [HP(t-Bu)3]BF4 CsHCO3 toluene 0.05 
Pd2(dba)3•CHCl3 t-Bu XPhos CsHCO3 DME 0.05 
[PdallylCl]2 XPhos Cs2CO3 toluene 0.06 
Pd2(dba)3•CHCl3 [HP(t-Bu)3]BF4 Cs2CO3 toluene 0.06 
[PdallylCl]2 XPhos CsHCO3 toluene 0.06 
Pd2(dba)3•CHCl3 XPhos CsHCO3 toluene 0.07 
[PdallylCl]2 [HP(t-Bu)3]BF4 CsHCO3 toluene 0.08 
Pd2(dba)3•CHCl3 BrettPhos CsHCO3 toluene 0.08 
[PdallylCl]2 BrettPhos Cs2CO3 toluene 0.09 
Pd2(dba)3•CHCl3 XPhos Cs2CO3 toluene 0.09 
[PdallylCl]2 BrettPhos CsHCO3 toluene 0.09 
Pd2(dba)3•CHCl3 BrettPhos Cs2CO3 toluene 0.13 
Pd2(dba)3•CHCl3 t-Bu XPhos CsHCO3 toluene 0.14 
Pd2(dba)3•CHCl3 t-Bu XPhos Cs2CO3 toluene 0.16 
[PdallylCl]2 t-Bu XPhos CsHCO3 toluene 0.24 
[PdallylCl]2 t-Bu XPhos Cs2CO3 toluene 0.32 
 
High throughput experimentation (HTE) #5 consisted of one 96-well plate at 80 °C.  
Variables are listed below.  There were no confirmed hits from this screen.   
 
Palladium Sources and Ligand 
Preformed Pd62 with Pt-Bu3: (2-biphenylamino)(Pt-Bu3)PdCl with Pt-Bu3 
Preformed Pd62 with PCy3: (2-biphenylamino)(PCy3)PdCl with PCy3 
[allylPdCl]2 with t-Bu XPhos 
Pd2(dba)3•CHCl3 with t-Bu XPhos 
 
Bases (at 1.2, 2, and 3 equiv)  Solvents 
N,N-Diisopropylethylamine (DIPEA, Hünig’s)  1,4-dioxane 
CsHCO3         toluene 
KOt-Bu 
NaOt-Bu 
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High throughput experimentation (HTE) #6 consisted of two 24-well plates run at 80 °C 
using [PdallylCl]2, t-Bu XPhos, bis(trimethylsilyl)acetamide (BSA) as a base and 1.1 
equiv or 11 mol % of a base additive.  Variables are listed below.  Top results are 
represented in Table 1.21 and Table 1.22.  
Base additive     BSA equiv  Solvent  
CsOAc      1.2   toluene 
Tetrabutylammonium fluoride (TBAF) 3   1,4-dioxane 
NaOAc 
LiOAc 
KOAc 
None 
Table 1.21  HTE #6:  Screen with 1.1 equiv of base additive.  Selected data from 
conditions that gave product. 
base additive solvent BSA equiv Product/IS 
CsOAc toluene 3 0.01 
KOAc toluene 3 0.02 
TBAF dioxane 3 0.02 
KOAc dioxane 3 0.03 
 
Table 1.22  HTE #6:  Screen with 11 mol % of base additive.  Selected data from 
conditions that gave product. 
base additive sovent BSA equiv Product/IS 
NaOAc toluene 3 0.01 
CsOAc toluene 3 0.02 
KOAc toluene 3 0.03 
 
High throughput experimentation (HTE) #7 consisted of a 24-well plate at 80 °C 
using [PdallylCl]2, t-Bu XPhos, and CsHCO3 as a base.  Variables are listed below.  All 
reactions are represented in Table 1.9. The top hit corresponded to less than 10% 
conversion by 1H NMR.  
Lewis Acid Additive         Solvent 
copper (I) bromide  zinc (II) bromide   toluene 
copper (II) bromide  zinc (II) chloride   1,4-dioxane 
copper (II) oxide  magnesium (II) Br • Et2O 
iron (II) bromide  magnesium (II) sulfate 
iron (II) chloride  calcium (II) bromide 
silver (I) oxide  calcium (II) carbonate 
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High throughput experimentation (HTE) #8 was a screen using 3-bromopyridine or 3-
chloropyridine in place of bromobenzene with the intention of finding conditions suitable 
for the coupling of pyridyl substrates.  It consisted of two 24-well plates run at 80 °C.  
Variables are listed below.  There were no confirmed hits from this screen. 
Palladium Sources  Bases  Ligand   Solvents 
[allylPdCl]2    Cs2CO3                 Me4 t-Bu XPhos     toluene 
Pd2dba3 • CHCl3            CsHCO3          t-Bu XPhos  DME 
              K3PO4 
 
Formation of Nitroarylacetates (Table 1.7 and Table 1.10). 
 Method A. In a glove-box, to an oven-dried microwave vial was added Pd2(dba)3 
 CHCl3 (6.5 mg, 6.3 µmol), t-Bu XPhos (10.6 mg, 25.0 µmol), and CsHCO3 (58.0 mg, 
0.30 mmol).  Next, a solution of ethyl nitroacetate (0.50 mmol, 0.63 mL of 0.80 M 
solution in toluene) and additional toluene (0.63 mL) were added to give a heterogenous 
reaction mixture.  At this point, the vial was sealed using a biotag cap equipped with a 
septum and removed from the glovebox.  Aryl bromide (0.25 mmol) was added via 
syringe.  The solution was then heated at 75-80 °C and stirred vigorously for 18 h.  After 
cooling, the reaction mixture was diluted with EtOAc (1 mL) and acidified with HCl (2 
mL, 1 M).  The layers were separated and the aqueous layer extracted with additional 
EtOAc (5 x 1 mL).  The combined organic layers were concentrated in vacuo.   The 
residue was chromatographed (5:95 EtOAc:hexanes) to afford the desired product.  
 Method B. In a glove-box, to an oven-dried microwave vial was added Pd2(dba)3 
 CHCl3 (9.8 mg, 9.50 µmol), t-Bu XPhos (16.1 mg, 38.0 µmol), and CsHCO3 (88.0 mg, 
0.427 mmol).  Next, a solution of ethyl nitroacetate (0.38 mmol, 0.48 mL of 0.80 M 
solution in toluene) and additional toluene (1.42 mL) were added to give a heterogenous 
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reaction mixture.  At this point, the vial was sealed using a biotag cap equipped with a 
septum and removed from the glovebox.  Aryl bromide (0.570 mmol) was added via 
syringe.  The solution was then heated at 75-80 °C and stirred vigorously for 18 h. After 
cooling, the reaction mixture was diluted with EtOAc (1 mL) and acidified with HCl (2 
mL, 1 M).  The layers were separated and the aqueous layer extracted with additional 
EtOAc (5 x 1 mL).  The combined organic layers were concentrated in vacuo.   The 
residue was chromatographed (5:95 EtOAc:hexanes) to afford the desired product. 
 
 
  
Ethyl 2-nitro-2-phenylacetate (Table 1.7, entry 1, 1.5a)  
Using method A of the general procedure the title compound was obtained as yellow oil 
(48.6 mg, 93%).  In addition to the above scale, this reaction was performed on large 
scale using bromobenzene (379 µL, 3.60 mmol), ethyl nitroacetate (800. µL, 7.20 mmol), 
Pd2(dba)3  CHCl3 (37.0 mg, 36.0 µmol, 2 mol %), t-Bu XPhos (61.0mg, 144 µmol), and 
CsHCO3 (838 mg, 4.32 mmol) to yield the title compound (627 mg, 83%).  Spectral data 
were in agreement with reported literature values.19a 
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Ethyl 2-(4-methoxyphenyl)-2-nitroacetate(Table 1.7, entry 6 1.5b) 
Using method B of the general procedure, the title compound was obtained as a 
yellow oil (44.3 mg, 74%).  1H NMR (500 MHz, CDCl3) δ 7.43 (d, J = 8.8 Hz, 2H), 6.97 
(d, J = 8.8 Hz, 2H), 6.23 (s, 1H), 4.37-4.29 (m, 2H), 3.85 (s, 3H) 1.31 (t, J = 7.2 Hz, 3H); 
13C NMR (125 MHz, CDCl3) δ 164.2, 161.3, 131.3, 120.9, 114.4, 90.3, 63.1, 55.3, 13.8; 
IR (film) 2981, 2935, 2858, 1746, 1560, 1367, 1251, 1213, 1027 cm–1; HRMS-ESI (m/z): 
[M – H]– calcd for C11H12NO5, 238.0715; found, 238.0715. 
 
 
 
  
Ethyl 2-nitro-2-(p-tolyl)acetate (Table 1.7, entry 2, 1.5c) 
Using method A of the general procedure, the title compound was obtained as a yellow 
oil (44.1 mg, 79%).  1H NMR (500 MHz, CDCl3) δ 7.39 (d, J = 8.0 Hz, 2H), 7.28 (d, J = 
8.0 Hz, 2H), 6.14 (s, 1H), 4.39-4.28 (m, 2H), 2.41 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 164.4, 141.3, 129.98, 129.97, 126.3, 90.9, 63.4, 21.5, 14.1; IR 
(film) 2989, 2927, 1746, 1568, 1367, 1259, 1205, 1020 cm–1; HRMS-ESI (m/z): [M – H]– 
calcd for C11H12NO4, 222.0766; found, 222.0764. 
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Ethyl 2-(2-methoxyphenyl)-2-nitroacetate (Table 1.7, entry 3, 1.5d) 
Using method A of the general procedure, the title compound was obtained as a yellow 
oil (41.0 mg, 69%).  1H NMR (500 MHz, CDCl3) δ 7.47 (dt, J = 1.6, 7.9 Hz, 1H), 7.36 
(dd, J = 1.6, 7.7 Hz, 1H), 7.05 (t, J = 7.7 Hz, 1H), 6.97 (d, J = 7.9 Hz, 1H), 6.64 (s, 1H), 
4.40-4.33 (m, 2H), 3.87 (s, 3H) 1.33 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
164.9, 157.8, 132.4, 130.3, 121.1, 118.0, 111.2, 85.3, 63.2, 55.9, 14.1; IR (film) 2927, 
2858, 1753, 1568, 1367, 1205, 1112, 1020 cm–1; HRMS-ESI (m/z): [M + Na]+ calcd for 
C11H13NO5Na, 262.0691; found, 262.0688. 
 
 
 
 
Ethyl 2-(4-acetylphenyl)-2-nitroacetate (Table 1.7, entry 4, 1.5fe) 
Using method A of the general procedure, the title compound was obtained as a yellow 
oil (60.3 mg, 96%).  1H NMR (500 MHz, CDCl3) δ 8.01 (d, J = 8.4 Hz, 2H), 7.60 (d, J = 
8.4 Hz, 2H), 6.24 (s, 1H), 4.36-4.28 (m, 2H), 2.61 (s, 3H) 1.28 (t, J = 7.1 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 197.4, 163.5, 138.7, 133.3, 130.3, 128.9, 90.2, 63.7, 26.8, 
13.9; IR (film) 3059, 2989, 1753, 1692, 1568, 1359, 1205, 1020 cm–1; HRMS-CI (m/z): 
[M – H]– calcd for C12H12NO5, 250.0715; found, 250.0723. 
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Ethyl 2-nitro-2-(4-(trifluoromethyl)phenyl)acetate (Table 1.7, entry 5, 1.5f) 
Using method A of the general procedure, the title compound was obtained as a yellow 
oil (40.3 mg, 71%).  1H NMR (500 MHz, CDCl3) δ 7.74 (d, J = 8.2 Hz, 2H), 7.65 (d, J = 
8.2 Hz, 2H), 6.23 (s, 1H), 4.41-4.29 (m, 2H), 1.31 (t, J = 7.1 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 163.4, 132.9 (q, J = 32.9 Hz), 132.5, 130.5, 126.3 (q, J = 3.7 Hz), 123.6 
(q, J = 272.7 Hz), 90.1, 63.8, 13.9; IR (film) 2989, 2927, 1753, 1568, 1328, 1213, 1166, 
1128, 1066, 1020 cm–1; HRMS-ESI (m/z): [M – H]– calcd for C11H9F3NO4, 276.0472; 
found, 276.0475. 
 
 
  
Ethyl 2-(benzofuran-5-yl)-2-nitroacetate (Table 1.7, entry 7, 1.5g) 
5-Bromobenzofuran was prepared according to literature procedure. 63  Using method B 
of the general procedure, the title compound was obtained as a yellow oil (26.0 mg, 
58%).  1H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 1.8 Hz, 1H), 7.71 (d, J = 2.2 Hz, 1H), 
7.59 (d, J = 8.6 Hz, 1H), 7.44 (d, J = 8.6, 1.8 Hz, 1H) 6.83 (d, J = 2.2 Hz, 1H), 6.28 (s, 
1H), 4.42-4.31 (m, 2H), 1.32 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 164.4, 
156.0, 146.6, 128.3, 126.1, 123.8, 123.6, 112.3, 107.0, 91.1, 63.5, 14.1; IR (film) 2929, 
2850, 2363, 1753, 1568, 1305, 1205, 1128, 1027 cm–1; HRMS-ESI (m/z): [M – H]– calcd 
for C12H10NO5, 248.0559; found, 248.0563. 
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Ethyl 2-nitro-2-(3-(trifluoromethyl)phenyl)acetate (Table 1.7, entry 8, 1.5h) 
Using method A of the general procedure, the title compound was obtained as a yellow 
oil (55.4 mg, 80%).  1H NMR (500 MHz, CDCl3) δ 7.78 (m, 2H), 7.74 (d, J = 7.9 Hz, 
1H), 7.63 (t, J = 7.9, 1H), 6.22 (s, 1H), 4.41-4.32 (m, 2H), 1.31 (t, J = 7.2 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 163.4, 133.4, 131.2 (q, J = 33.1 Hz), 129.90, 129.88, 127.8 
(q, J = 3.6 Hz), 127.0 (q, J = 3.7 Hz), 123.6 (q, J = 272.9 Hz), 90.2, 63.9, 14.0; IR (film) 
2989, 1753, 1568, 1328, 1259, 1166, 1128,1020 cm–1; HRMS-ESI (m/z): [M – H]– calcd 
for C11H9F3NO4, 276.0484; found, 258.0494. 
 
 
  
Ethyl 2-(naphthalen-2-yl)-2-nitroacetate (Table 1.7, entry 9, 1.5i) 
Using method A of the general procedure, the title compound was obtained as a yellow 
oily solid (49.9 mg, 77%).  1H NMR (500 MHz, CDCl3) δ 7.98 (d, J = 1.2 Hz, 1H), 7.95 
(d, J = 8.6 Hz, 1H), 7.90 (d, J = 7.5 Hz, 2H), 7.62-7.55 (m, 3H), 6.34 (s, 1H), 4.43-4.26 
(m, 2 H), 1.32 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 164.3, 134.3, 133.1, 
130.8, 129.3, 128.7, 128.04, 127.98, 127.2, 126.4, 126.0, 91.2, 63.6, 14.1; IR (film) 2989, 
1746, 1568, 1359, 1197, 1020 cm–1; HRMS-ESI (m/z): [M – H]– calcd for C14H12NO4, 
258.0766; found, 258.0757. 
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Ethyl 2-(6-methoxynaphthalen-2-yl)-2-nitroacetate (Table 1.7, entry 10, 1.5j) 
2-Bromo-6-methoxynaphthalene was prepared according to literature procedure. 64  Using 
method B of the general procedure, the title compound was obtained as an orange oily 
solid (83.5 mg, 76%).  1H NMR (500 MHz, CDCl3) δ 7.98 (d, J = 1.7 Hz, 1H), 7.81 (d, J 
= 8.8 Hz, 1H), 7.80 (d, J = 8.8 Hz, 1H), 7.56 (dd, J = 1.7, 8.7 Hz, 1H), 7.22 (dd, J = 2.5, 
8.7 Hz, 1H), 7.17 (d, J = 2.5 Hz, 1H), 6.30 (s, 1H), 4.41-3.97 (m, 2 H), 3.95 (s, 3H), 1.32 
(t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ164.6, 159.2, 135.7, 130.5, 130.1, 
128.4, 128.0, 126.6, 124.1, 120.0, 105.8, 91.2, 63.5, 55.6, 14.1; IR (film) 3059, 2989, 
2912, 2842, 1746, 1560, 1267, 1197, 1027 cm–1; HRMS-ESI (m/z): [M – H]– calcd for 
C15H14NO5, 288.0872; found, 288.0862. 
 
 
 
Ethyl 2-(1-methyl-1H-indol-5-yl)-2-nitroacetate (Table 1.7, entry 11, 1.5k) 
5-Bromo-1-methylindole was prepared according to literature procedure.65  Using method 
A of the general procedure, the title compound was obtained as a yellow oil (62.4 mg, 
95%).  1H NMR (500 MHz, CDCl3) δ 7.76 (d, J = 1.6 Hz, 1H), 7.40 (d, J = 8.5 Hz, 1H), 
7.35 (dd, J = 1.6, 8.5 Hz, 1H), 7.13 (d, J = 3.1 Hz, 1H), 6.56 (d, J = 3.1 Hz, 1H), 6.29 (s, 
1H), 4.41-4.28 (m, 2 H), 3.82 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) 165.0, 137.7, 130.5, 128.7, 123.6, 122.9, 120.1, 110.1, 102.0, 91.9, 63.2, 33.2, 
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14.1; IR (film) 2981, 2927, 1746, 1560, 1359, 1189, 1020cm–1; HRMS-ESI (m/z): [M + 
Na] + calcd for C13H14N2O4Na, 285.0851; found, 285.0857. 
 
 
 
  
Ethyl 2-(4-chlorophenyl)-2-nitroacetate (Table 1.7, entry 12, 1.5l) 
Using method A of the general procedure, the title compound was obtained as a yellow 
oil (38.3 mg, 63%).  1H NMR (500 MHz, CDCl3) δ 7.45 (s, 4H), 6.13 (s, 1H) 4.40-4.30 
(m, 2H), 1.31 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ163.7, 137.3, 131.4, 
129.5, 127.4, 90.1, 63.7, 14.0; IR (film) 2989, 2927, 2858, 1753, 1568, 1359, 1205, 1097, 
1020 cm–1; HRMS-ESI (m/z): [M – H]– calcd for C10H9NO4Cl, 242.0220; found, 
242.0211. 
 
 
 
Methyl 2-nitro-2-phenylacetate (Table 1.10, entry 4, 1.5n) 
Method A of the general procedure was utilized with tert-butyl nitroacetate (59.5 mg, 
0.500 mmol), which was prepared according to literature procedure.63  The title 
compound was obtained as a yellow oil (25.6 mg, 53%). The spectral data were in 
agreement with reported literature values.66 
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tert-Butyl 2-nitro-2-phenylacetate (Table 1.10, entry 4, 1.5o) 
Method A of the general procedure was employed with tert-butyl nitroacetate (80.6 mg, 
0.500 mmol), which was prepared according to literature procedure.63  The title 
compound was obtained as a yellow oil (21.7 mg, 98%). The spectral data were in 
agreement with reported literature values. 66 
 
 
 
  
Benzyl 2-nitro-2-phenylacetate (Table 1.10, entry 4, 1.5p) 
Method A of the general procedure was employed with benzyl nitroacetate (97.6 mg, 
0.500 mmol), which was prepared according to literature procedure.63  The title 
compound was obtained as a yellow oil (64.6 mg, 95%).  1H NMR (500 MHz, CDCl3) δ 
7.49-7.43 (m, 5H), 7.40-7.30 (m, 5H), 6.22 (s, 1H), 5.33 (d, J = 12.2 Hz, 1H) 5.28 (d, J = 
12.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 163.9, 134.3, 130.9, 130.0, 129.2, 129.0, 
128.9, 128.8, 128.5, 90.9, 68.9; IR (film) 3043, 2966, 2970, 1753, 1560, 1359, 1290, 
1197 cm–1; HRMS-ESI (m/z): [M – H]– calcd for C15H12NO4, 270.0766; found, 270.0768. 
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Diethyl 2,2'-(1,4-phenylene)bis(2-nitroacetate) (1.5r) 
In addition to the preceding desired product, the title compound was also obtained as a 
yellow oil (13.3 mg, 16%). 1H NMR (500 MHz, CDCl3) δ 7.63 (s, 4H), 6.20 (s, 2H) 4.42-
4.29 (m, 4H), 1.31 (t, J = 7.1 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ163.5, 131.5, 130.8, 
90.3, 63.8, 14.0; IR (film) 2927, 2858, 1753, 1568, 1359, 1205, 1097, 1020 cm–1. 
 
Formation of Aryl Nitromethanes (Table 1.11).  
Method A.  To a flask was added nitroarylacetate as a solution in EtOH (0.14 M) 
followed by an equal volume of 1 M aq NaOH.  The mixture was stirred at 85 °C for 1 h 
at which point the reaction was cooled to rt and the solvents were removed in vacuo.  To 
the remaining salts were added THF (0.17 M with respect to the nitroarylacetate) and an 
equal volume of aq HCl (1 M).  The mixture was heated at 85 °C for 1 h.  The reaction 
mixture was diluted with EtOAc (1 mL).  The layers were separated and the water layer 
was extracted with EtOAc (3 x 1 mL), dried with NaSO4, and concentrated in vacuo to 
yield a crude residue.  The residue was chromatographed (2:98 to 5:95 EtOAc:hexanes) 
to afford the desired product.  
Method B. To a flask was added nitroarylacetate as a solution in EtOH:toluene (1:1, 
0.14 M) followed by an equal volume of 1 M aq NaOH.  The mixture was stirred at 85 °C 
for 1 h at which point the reaction was cooled to rt and the solvents were removed in 
vacuo.  To the remaining salts was added THF (0.17 M with respect to the 
NO2EtO2C
NO2EtO2C
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nitroarylacetate) and urea (17 equiv as a 2.8 M solution in 20% aq AcOH) at 0 °C.  The 
mixture was warmed to rt and stirred for 1 h.  The reaction mixture was diluted with 
EtOAc (1 mL).  The layers were separated and the water layer was extracted with EtOAc 
(3 x 1 mL), dried with NaSO4, and concentrated in vacuo to yield a crude residue.  The 
residue was chromatographed (2:98 to 5:95 EtOAc:hexanes) to afford the desired 
product. 
 
 
(Nitromethyl)benzene (Table 1.11, entry 1, 1.9a) 
Method A of the general procedure was carried out on ethyl 2-nitro-2-phenylacetate (25.0 
mg, 0.120 mmol).  The title compound was obtained as a yellow oil (13.0 mg, 79%). The 
spectral data were in agreement with reported literature values.67   1H NMR (500 MHz, 
CDCl3) δ 7.47-7.45 (m, 5H), 5.46 (s, 2H). 
 
 
1-Methoxy-4-(nitromethyl)benzene (Table 1.11, entry 7, 1.9b)  
Method B of the general procedure was carried out on ethyl 2-(4-methoxyphenyl)-2-
nitroacetate (30.0 mg, 0.126 mmol).  The title compound was obtained as a yellow oil 
(16.0 mg, 76%). The spectral data were in agreement with reported literature values.68  1H 
NO2
OMe
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NMR (500 MHz, CDCl3) δ 7.39 (d, J = 8.8 Hz, 2H), 6.95 (d, J = 8.8 Hz, 2H), 5.38 (s, 
2H), 3.84 (s, 3H). 
 
 
1-Methyl-4-(nitromethyl)benzene (Table 1.11, entry 3, 1.9c) 
 Method A of the general procedure was carried out on ethyl 2-nitro-2-(p-tolyl)acetate 
(43.7 mg, 0.200 mmol).  The title compound was obtained as a yellow oil (24.2 mg, 
79%). The spectral data were in agreement with reported literature values. 69   1H NMR 
(500 MHz, CDCl3) δ 7.35 (d, J = 8.0 Hz, 2H), 7.25 (d, J = 8.0 Hz, 2H), 5.41 (s, 2H), 2.39 
(s, 3H). 
 
 
1-Methoxy-2-(nitromethyl)benzene (Table 1.11, entry 9, 1.9d) 
Method B of the general procedure was carried out on ethyl 2-(2-methoxyphenyl)-2-
nitroacetate (46.5 mg, 0.190 mmol).  The title compound was obtained as a brown oil 
(27.9 mg, 88%). The spectral data were in agreement with reported literature values. 70  
1H NMR (500 MHz, CDCl3) δ 7.44 (ddd, J = 1.6, 7.5, 7.5 Hz, 1H), 7.31 (dd, J = 1.6, 7.5 
Hz, 1H), 7.01 (dd, J = 7.5, 7.5 Hz, 1H), 6.96 (d, J = 7.5 Hz, 1H), 5.49 (s, 2H), 3.86 (s, 
3H). 
 
NO2
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1-(4-(Nitromethyl)phenyl)ethanone (Table 1.11, entry 5, 1.9e)  
Method A of the general procedure was carried out on ethyl 2-(4-acetylphenyl)-2-
nitroacetate (28.0 mg, 0.110 mmol).  The title compound was obtained as a yellow oil 
(14.9 mg, 76%).  1H NMR (500 MHz, CDCl3) δ 8.03 (d, J = 8.3 Hz, 2H), 7.57 (d, J = 8.3 
Hz, 2H), 5.52 (s, 2H), 2.64 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 197.3, 138.3, 134.1, 
130.4, 129.1, 79.5, 26.8; IR (film) 3059, 2966, 2927, 2858, 1684, 1552, 1367 cm–1; 
HRMS-ESI (m/z): [M – H]– calcd for C9H8NO3,178.0504; found, 178.0503. 
 
 
1-(Nitromethyl)-4-(trifluoromethyl)benzene (Table 1.11, entry 2, 1.9f) 
Method A of the general procedure was carried out on ethyl 2-nitro-2-(4-
(trifluoromethyl)phenyl)acetate (30.0 mg, 0.108 mmol).  The title compound was 
obtained as a yellow oil (21.7 mg, 98%). The spectral data were in agreement with 
reported literature values.20  1H NMR (500 MHz, CDCl3) δ 7.72 (d, J = 8.2 Hz, 2H), 7.61 
(d, J = 8.2 Hz, 2H), 5.51 (s, 2H). 
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2-(Nitromethyl)naphthalene (Table 1.11, entry 8, 1.9i) 
Method A of the general procedure was carried out on ethyl 2-(naphthalen-2-yl)-2-
nitroacetate (21.8 mg, 0.080 mmol).  The title compound was obtained as a white solid 
(15.4 mg, 98%). mp 83-84 °C; 1H NMR (500 MHz, CDCl3) δ 7.94-7.88 (m, 4H), 7.58-
7.55 (m, 3H), 5.62 (s, 2H);13C NMR (125 MHz, CDCl3) δ133.9, 133.3, 130.3, 129.3, 
128.5, 128.0, 127.5, 127.2, 127.1, 126.7, 80.5; IR (film) 3066, 2927, 2858, 1552, 1367 
cm–1; HRMS-CI (m/z): [M + H]+ calcd for C11H10NO2, 188.0712; found, 188.0719. 
 
 
2-Methoxy-6-(nitromethyl)naphthalene (Table 1.11, entry 8, 1.9j) 
Method B of the general procedure was carried out on ethyl 2-(6-methoxynaphthalen-2-
yl)-2-nitroacetate (30.0 mg, 0.100 mmol).  The title compound was obtained as a white 
solid (19.5 mg, 90%). mp 66-71 °C; 1H NMR (500 MHz, CDCl3) δ 7.86 (s, 1H), 7.79 (d, 
J = 8.5 Hz, 1H), 7.78 (d, J = 8.5 Hz, 1H), 7.51 (d, J = 8.7 Hz, 1H), 7.21 (dd, J = 2.1, 8.7 
Hz, 1H), 7.17 (d, J = 2.1 Hz, 1H), 5.58 (s, 2H), 3.95 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 158.9, 135.3, 130.0, 129.8, 128.6, 127.9, 127.2, 124.9, 119.9, 105.8, 80.4, 55.5; 
IR (film) 2920, 1552, 1375, 1267 cm1; HRMS-CI (m/z): [M – H]– calcd for C12H10NO3, 
216.0661; found, 216.0675. 
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1-Methyl-5-(nitromethyl)-1H-indole (Table 1.11, entry 6, 1.9k)   
Method B of the general procedure was carried out on ethyl 2-(1-methyl-1H-indol-5-yl)-
2-nitroacetate (28.5 mg, 0.108 mmol).  The title compound was obtained as white solid 
(15.4 mg, 77%). mp 64-66 °C; 1H NMR (500 MHz, CDCl3) δ 7.73 (s, 1H), 7.37 (d, J = 
8.5 Hz, 1H), 7.31 (d, J = 8.5 Hz, 1H), 7.12 (d, J = 3.1, 1H), 6.53 (d, J = 3.1, 1H), 5.55 (s, 
2H), 3.83 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 137.3, 130.3, 128.8, 123.4, 123.3, 
121.0, 109.9, 101.7, 81.1, 33.1; IR (film) 2920, 1552, 1375 cm1; HRMS-CI (m/z): [M – 
H]– calcd for C10H9N2O2, 189.0664; found, 189.0661.  
 
Formation of α-Keto Esters (Table 1.12).    
To a flask under Ar was added nitroarylacetate as a solution in THF (0.3 M) followed 
by tetrabutylammonium fluoride (5 mol %, 1 M solution in THF at 0 °C) and KF (12.5 
equiv).  The reaction mixture was cooled to 0 °C and MeI (2.5 equiv) was added.  The 
mixture was warmed to rt and stirred for 16 h at which point aq HCl (1 mL, 5 M) was 
added.  The aqueous layer was extracted with Et2O (3 x 2 mL), dried with NaSO4, and 
concentrated in vacuo to yield a crude residue.  The residue was chromatographed (2:98 
to 5:95 EtOAc:hexanes) to afford the desired product. 
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Ethyl 2-oxo-2-phenylacetate (Table 1.12, entry 1, 1.19a)   
The general procedure was employed with ethyl 2-nitro-2-phenylacetate (25.0 mg, 0.120 
mmol).   The title compound was obtained as a yellow oil (15.5 mg, 72%). The spectral 
data were in agreement with reported literature values. 71  1H NMR (500 MHz, CDCl3) δ 
8.02 (dd, J = 1.1, 8.0 Hz, 2H), 7.67 (td, J =1.1, 7.8 Hz, 1H), 7.53 (dd, J = 7.8, 7.8 Hz, 
2H), 4.47 (q, J = 7.2, 2H), 1.44 (t, J = 7.2 Hz, 3H). 
 
 
Ethyl 2-(4-methoxyphenyl)-2-oxoacetate (Table 1.12, entry 7, 1.19b)     
The general procedure was employed with ethyl 2-(4-methoxyphenyl)-2-nitroacetate 
(24.7 mg, 0.103 mmol).  The title compound was obtained as a yellow oil (17.7 mg, 
80%). The spectral data were in agreement with reported literature values.71  1H NMR 
(500 MHz, CDCl3) δ 8.01 (d, J = 9.0 Hz, 2H), 6.99 (d, J = 9.0 Hz, 2H), 4.44 (q, J = 7.2 
Hz, 2H), 3.80 (s, 3H), 1.42 (t, J = 7.2 Hz, 3H). 
 
 
 
 
OEtO2C
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Ethyl 2-oxo-2-(p-tolyl)acetate (Table 1.12, entry 3, 1.19c)   
The general procedure was employed with ethyl 2-nitro-2-(p-tolyl)acetate (27.1 mg, 
0.120 mmol).  The title compound was obtained as a yellow oil (15.4 mg, 67%). The 
spectral data were in agreement with reported literature values.71  1H NMR (500 MHz, 
CDCl3) δ 7.92 (d, J = 8.1 Hz, 2H), 7.32 (d, J = 8.1 Hz, 2H), 4.45 (q, J = 7.2, 2H), 2.45 (s, 
3H), 1.43 (t, J = 7.2 Hz, 3H). 
 
 
Ethyl 2-(4-acetylphenyl)-2-oxoacetate (Table 1.12, entry 5, 1.19e) 
The general procedure was employed with ethyl 2-(4-acetylphenyl)-2-nitroacetate (28.0 
mg, 0.110 mmol).  The title compound was obtained as a yellow oil (12.2 mg, 51%).  1H 
NMR (500 MHz, CDCl3) δ 8.13 (d, J = 8.6 Hz, 2H), 8.08 (d, J = 8.6 Hz, 2H), 4.48 (q, J = 
7.1, 2H), 2.67 (s, 3H), 1.45 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ197.4, 
185.6, 163.2, 141.5, 135.8, 130.5, 128.7, 62.82, 27.1, 14.3; IR (film) 2920, 2966, 1738, 
1684, 1197, 1081, 1012 cm–1; HRMS-CI (m/z): [M + H]+ calcd for C12H13O4, 221.0814; 
found, 221.0814. 
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Ethyl 2-oxo-2-(4-(trifluoromethyl)phenyl)acetate (Table 1.12, entry 2, 1.19f)   
The general procedure was employed with 2-nitro-2-(4-(trifluoromethyl)phenyl)acetate 
(30.0 mg, 0.108 mmol).   The title compound was obtained as a yellow oil (22.9 mg, 
86%). 1H NMR (500 MHz, CDCl3) δ 8.17 (d, J = 8.3 Hz, 2H), 7.79 (d, J = 8.3 Hz, 2H), 
4.48 (q, J = 7.1, 2H), 1.45 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 185.1, 
162.9, 136.0 (q, J = 33 Hz), 135.4, 130.6, 126.0 (q, J = 3.6 Hz), 123.5 (q, J = 273.1 Hz), 
62.9, 14.2; IR (film) 2989, 2943, 1738, 1699, 1174, 1128, 1066, 1012 cm–1; HRMS-ESI 
(m/z): [M + H]+ calcd for C11H10F3O3, 247.0582; found, 247.0575. 
 
 
Ethyl 2-(naphthalen-2-yl)-2-oxoacetate (Table 1.12, entry 4, 1.19i) 
The general procedure was employed with ethyl 2-(naphthalen-2-yl)-2-nitroacetate (21.3 
mg, 0.084 mmol).  The title compound was obtained as a yellow oil (14.0 mg, 74%). The 
spectral data were in agreement with reported literature values.71  1H NMR (500 MHz, 
CDCl3) δ 8.56 (s, 1H), 7.70-7.57 (m, 2H), 8.10-7.89 (m, 4H), 4.53 (q, J = 7.2 Hz, 2H), 
1.48 (t, J = 7.2 Hz, 3H). 
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Ethyl 2-(6-methoxynaphthalen-2-yl)-2-oxoacetate (Table 1.12, entry 8, 1.19j)     
The general procedure was employed with ethyl 2-(6-methoxynaphthalen-2-yl)-2-
nitroacetate (30.0 mg, 0.100 mmol).   The title compound was obtained as a yellow oil 
(18.0 mg, 70%). The spectral data were in agreement with reported literature values. 72  
1H NMR (500 MHz, CDCl3) δ 8.48 (s, 1H), 8.03 (dd, J =8.8 Hz, 1H), 7.87 (d, J = 8.8 Hz, 
1H), 7.81 (d, J = 8.8 Hz, 1H), 7.23 (d, J = 8.8 Hz, 1H), 4.48 (q, J = 7.1 Hz, 2H), 7.17 (s, 
1H), 4.51 (q, J = 7.2 Hz, 2H), 3.97 (s, 3H), 1.47 (t, J = 7.1 Hz, 3H). 
 
 
Ethyl 2-(1-methyl-1H-indol-5-yl)-2-oxoacetate (Table 1.12, entry 6, 1.19k)     
The general procedure was employed with ethyl 2-(1-methyl-1H-indol-5-yl)-2-
nitroacetate (29.8 mg, 0.110 mmol).  A phosphate buffer (pH = 7) was used instead of aq 
HCl.  The title compound was obtained as a yellow oil (16.8 mg, 66%). 1H NMR (500 
MHz, CDCl3) δ 8.32 (d, J = 1.6 Hz, 1H), 7.92 (dd, J = 1.6, 8.7 Hz, 1H), 7.39 (d, J = 8.7 
Hz, 1H), 7.15 (d, J = 3.2 Hz, 1H), 6.64 (d, J = 3.2 Hz, 1H), 4.49 (q, J = 7.1, 2H), 3.84 (s, 
3H), 1.45 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 186.9, 165.2, 140.2, 131.1, 
128.2, 126.1, 124.6, 123.0, 109.9, 103.8, 62.1, 33.3, 14.3; IR (film) 2935, 1730, 1668, 
1607, 1097, 1020 cm–1; HRMS-ESI (m/z): [M + Na]+ calcd for C13H13NO3Na, 254.0793; 
found, 254.0793. 
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Ethyl 2-(3-methoxyphenyl)-2-oxoacetate (Table 1.12, entry 9, 1.19q)     
The general procedure was employed with ethyl 2-(3-methoxyphenyl)-2-nitroacetate 
(52.0 mg, 0.220 mmol).  The title compound was obtained as a light red oil (26.8 mg, 
59%).  1H NMR (500 MHz, CDCl3) δ 7.55 (ddd, J = 1.5, 1.5, 8.0 Hz, 1H), 7.51 (dd, J = 
1.5, 2.5 Hz, 1H), 7.39 (dd, J = 8.0, 8.0 Hz, 1H), 7.19 (ddd, J = 1.5, 2.5, 8.0 Hz, 1H), 4.42 
(q, J = 7.1 Hz, 2H), 3.81 (s, 3H), 1.40 (t, J = 7.2 Hz, 3H); 13C NMR (125 MHz, CDCl3) 
δ186.5, 164.0, 160.1, 133.9, 130.1, 123.3, 122.0, 113.5, 62.5, 55.7, 14.3; IR (film) 2982, 
2839, 1736, 1687, 1192, 1095, 1022, 878, 751, 680 cm–1; HRMS-ESI (m/z): [M + Na]+ 
calcd for C11H12O4Na, 231.0633; found, 231.0651. 
 
Formation of α-Amino Esters.   
To a flask was added nitroarylacetate as a solution in glacial AcOH (1 mL).  To this 
solution was added purified zinc dust (4 x 6 equiv in 30 min intervals).  The 
heterogeneous mixture was vigorously stirred for 16 h at rt.  At this point, the reaction 
was quenched with saturated aq K2CO3, extracted with EtOAc (3 x 2 mL), dried with 
NaSO4, and concentrated in vacuo to yield a crude residue.  The residue was 
chromatographed (100% EtOAc) to afford the desired product. 
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Ethyl 2-amino-2-phenylacetate (Table 1.14, entry 1, 1.22a)     
The general procedure was employed with ethyl 2-nitro-2-phenylacetate (30.0 mg, 0.140 
mmol).  The title compound was obtained as a yellow oil (18.0 mg, 85%). The spectral 
data were in agreement with reported literature values. 73  1H NMR (360 MHz, CDCl3) δ 
7.42-7.28 (m, 5H), 4.60 (s, 1H) 4.25-4.09 (m, 2H), 2.04 (bs, 2H), 1.21 (t, J = 7.1 Hz, 3H). 
 
 
Ethyl 2-amino-2-(4-methoxyphenyl)acetate (Table 1.14, entry 2, 1.22b) 
The general procedure was employed with ethyl 2-(4-methoxyphenyl)-2-nitroacetate 
(30.0 mg, 0.125 mmol). The title compound was obtained as a yellow oil (19.2 mg, 85%). 
The spectral data were in agreement with reported literature values.74  1H NMR (500 
MHz, CDCl3) δ 7.31 (d, J = 8.7 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 4.55 (s, 1H) 4.22-4.11 
(m, 2H), 3.81 (s, 3H), 2.04 (bs, 2H), 1.21 (t, J = 7.1 Hz, 3H). 
 
 
Ethyl 2-amino-2-(p-tolyl)acetate (Table 1.14, entry 3, 1.22c) 
The general procedure was employed with ethyl 2-nitro-2-(p-tolyl)acetate (23.6 mg, 
0.110 mmol).  The title compound was obtained as a yellow oil (15.2 mg, 71%).  1H 
NH2EtO2C
OMe
EtO2C NH2
EtO2C NH2
Me
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NMR (500 MHz, CDCl3) δ 7.31 (d, J = 8.0 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 4.57 (s, 
1H) 4.24-4.10 (m, 2H), 2.38 (s, 3H), 2.03 (bs, 2H), 1.25 (t, J = 7.1 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) δ 174.0, 138.0, 137.2, 129.6, 126.8, 61.5, 58.6, 21.2, 14.2; IR (film) 
3383, 3313, 2981, 2927, 2866, 1730, 1097, 1020 cm–1; HRMS-ESI (m/z): [M + H]+ calcd 
for C11H16NO2, 194.1181; found, 194.1178. 
 
 
Ethyl 2-amino-2-(benzofuran-5-yl)acetate (Table 1.14, entry 4, 1.22g) 
The general procedure was employed with ethyl 2-(benzofuran-5-yl)-2-nitroacetate (22.9 
mg, 0.092 mmol).  The title compound was obtained as a yellow oily solid (12.7 mg, 
63%).  1H NMR (500 MHz, CDCl3) δ 7.63 (d, J = 2.1 Hz, 1H), 7.62 (d, J = 1.3 Hz, 1H), 
7.48 (d, J = 8.5 Hz, 1H), 7.32 (dd, J = 1.7, 8.5 Hz, 1H), 6.76 (dd, J = 1.3, 2.1 Hz, 1H), 
4.71 (s, 1H), 4.23-4.11 (m, 2H), 2.31 (bs, 2H), 1.21 (t, J = 7.1 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 174.1, 154.5, 145.6, 135.0, 127.7, 123.1, 119.4, 111.5, 106.6, 61.3, 58.7, 
14.0 ; IR (film) 3383, 3313, 2981, 2927, 1730, 1112, 1027 cm–1; HRMS-ESI (m/z): [M – 
NH2]+ calcd for C12H11O3, 203.0708; found, 203.0718. 
 
 
Ethyl 2-amino-2-(naphthalen-2-yl)acetate (Table 1.14, entry 5, 1.22i) 
The general procedure was employed with ethyl 2-(naphthalen-2-yl)-2-nitroacetate (35.1 
mg, 0.135 mmol).  The title compound was obtained as a yellow oil (21.0 mg, 68%).  1H 
  
  
62 
NMR (500 MHz, CDCl3) δ 7.85-7.83 (m, 4H), 7.52-7.48 (m, 3H) , 4.78 (s, 1H), 4.24-4.13 
(m, 2H), 2.11 (bs, 2H), 1.21 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 174.1, 
137.9, 133.5, 133.2, 128.7, 128.1, 127.8, 126.5, 126.3, 125.9, 124.8, 61.6, 59.1, 14.3; IR 
(film) 3375. 3313, 3059, 2981, 2927, 1730, 1097, 1020 cm–1; HRMS-ESI (m/z): [M + H]+ 
calcd for C14H16NO2, 230.1181; found, 230.1185. 
 
 
Ethyl 2-amino-2-(4-chlorophenyl)acetate (Table 1.14, entry 6, 1.22l) 
The general procedure was employed with ethyl 2-(4-chlorophenyl)-2-nitroacetate (56.0 
mg, 0.230 mmol).  The title compound was obtained as a yellow oil (32.2 mg, 65%).  1H 
NMR (500 MHz, CDCl3) δ 7.37-7.31 (m, 4H), 5.30 (s, 1H), 4.58-4.10 (m, 2H), 2.04 (bs, 
2H), 1.21 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 173.7, 139.0, 134.0, 129.0, 
128.4, 61.6, 58.3, 14.2; IR (film) 3383, 2981, 1736, 1178, 1092, 1015, 831, 764 cm–1; 
HRMS-ESI (m/z): [M + H]+ calcd for C10H13ClNO2, 214.0635; found, 214.0634. 
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2.  DEVELOPMENT OF ANION-BINDING CATALYSTS. 
2.1.  Introduction 
2.1.1.  Past Kozlowski Group Work 
Hydrogen bonding plays a critical role in the arrangement of molecules.  This 
function has consequences on the characteristics of every day compounds such as water, 
DNA, and proteins by determining the secondary structure and properties of these 
substances.  In many cases this secondary structure influences tertiary and quaternary 
assemblies.1  Aside from playing an important role in the properties of a substance, 
hydrogen bonds are also very useful in catalyzing biological processes by transition state 
stabilization.  A few common processes catalyzed this way include amide hydrolysis by a 
serine protease and the [3,3]-sigmatropic rearrangement of chorismate to prephenate in 
the biological synthesis of aromatic amino acids (Scheme 2.1).  An additional example 
involves a pyruvate elimination in the (1R, 6R)-2-succinyl-6-hydroxy-2,4-
cyclohexadiene-1-carboxylate synthase to produce menaquinone (vitamin K2) in 
Escherichia coli (Scheme 2.2).  Consequently, the popularity of hydrogen-bonding 
catalysis in chemistry originates from nature.2 
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Scheme 2.1  Nature’s use of hydrogen bonds. 
 
 
Scheme 2.2  Menaquinone biosynthetic pathway of Escherichia coli. 
 
 
Despite the fact that hydrogen-bonding catalysts are not as easily tunable as Lewis 
acids and their interactions with substrates are not as well defined, they are a useful form 
of catalysis for the chemical community.  They are typically less moisture sensitive and 
toxic.  Even though the first hydrogen-bonding catalyzed reaction in the lab was in 1942 
(Scheme 2.3), it was not until recently this concept emerged as a useful tool for of 
catalysis.3  
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Scheme 2.3  Wasserman’s hydrogen-bonding catalyzed reaction in 1942. 
 
The goal of this project is not necessarily to discover new reactions or methodologies 
but rather to gain a deeper understanding of the important parameters of non-covalent 
interactions in catalysis.  The Kozlowski group’s approach to hydrogen-bonding catalysts 
involves the rationale design of organic compounds that would optimize the geometry 
(i.e. bonding angles).  This technique may be crucial to efficient catalysis, since small 
molecules do not possess the geometrical flexibility of proteins.  The first reaction 
pursued by Kozlowski and coworkers was the Claisen rearrangement.   
The Claisen rearrangement is a [3,3]-sigmatropic shift of an allylic vinyl ether via a 
concerted transition state TS A (Scheme 2.4).  If certain vinylic or allylic substituents are 
present, it will rearrange through dipolar transition state TS B.  In extreme cases, the 
dipolar transition state may lead to an undesirable [1,3]-rearranged product rather than 
the desired product.   
Scheme 2.4  Claisen rearrangement mechanism. 
 
Even though the Claisen rearrangement has been known for about a century, catalytic, 
asymmetric variants are still relatively rare.4  One key example is work done by Jacobsen 
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and coworkers, where rearrangement of a bidentate substrate is affected a by 
guanadinium catalyst (Scheme 2.).5 
Scheme 2.5  Jacobsen’s Claisen reaction catalyzed by a guanadinium catalyst. 
 
Kozlowski and coworkers developed a dual hydrogen bonding catalyst for the Claisen 
rearrangement of a monodentate substrate (Scheme 2.6).  Optimized hydrogen bonding 
angles to an sp3-hybridized oxygen were identified via modeling studies.  A CAVEAT 
(Computer-Assisted Vector Evaluation and Target Design) database-mining program was 
used to find suitable scaffolds (Figure 2.1).   
Scheme 2.6  Claisen rearrangement mechanism with dual-hydrogen bond donor. 
 
 
Figure 2.1  Scaffolds identified via CAVEAT database-mining program. 
Past research has focused on the first two scaffolds (Figure 2.1, A and B), and from 
this work, a 95-fold rate increase over the uncatalyzed rearrangement, with small but 
significant enantioinduction, was observed using a novel bisamidinium catalyst (Scheme 
2.7).  Modification of the phenyl substituents on this catalyst by graduate student Young 
Eun Lee led to no increase in enantioselectivity.   
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Scheme 2.7  Kozlowski’s Claisen rearrangement catalyzed by a bisamidinium catalyst. 
 
At this point, focus in the group turned toward the third and final scaffold (Figure 
2.1, C).  This scaffold is more attractive than the bisamidinium one, because amino acids 
can be used as stereodirecting groups.  Dr. Ryan Walvoord, a former graduate student in 
the group, initially found the anthracenyl scaffold was best achieved by synthesis of an 
acridone (Scheme 2.8). 6   He modified a route by Dixon 7  to generate a 4,5-
diaminoacridone en route to 4,5-diacylacridone.  Unfortunately, when this 4,5-
diacylacridone was tested for catalytic activity in the Claisen rearrangement, none was 
observed. It was determined that efforts would need to focus on increasing the acidity of 
the amide hydrogens to increase reactivity.   
Scheme 2.8  Dr. Walvoord’s route to 4,5-diaminoacridone. 
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2.1.2.  Anion-Binding Chemistry in the Literature 
Focus eventually turned toward binding to a counteranion rather than a substrate 
directly.  This type of ion-pairing chemistry has emerged as a useful form of catalysis and 
relies on electrostatic interactions.8,9  There are two methods of anion-pairing catalysis 
that have been utilized in the literature (Table 2.1).  The first is anion-binding catalysis 
and this type of chemistry is explored in this chapter (Table 2.1A).10  The second is chiral 
anion directed catalysis and it is distinct in that the chiral center is attached to the anion 
rather than bound non-covalently (Table 2.1B).11  These types of chemistry are still in 
their early stages of development in the organic laboratory, and research in this field is 
important for its advancement.  
Table 2.1  Two types of ion-pairing chemistry involving anions. 
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Jacobsen and Seidel have been the leading pioneers in the field of organocatalysis 
involving anion-binding catalysis (Table 2.1A).12,13  The work in this thesis was inspired 
by Jacobsen’s Pictet-Spengler-type reaction of hydroxylactams (Table 2.2).  Here 
Jacobsen was able to effect indole addition into N-acyliminium ions in good yield (97%) 
and good enantiomeric excess (97%) using a thiourea catalyst (TBME = tert-butyl methyl 
ether).13a  A variety of experiments were carried out to support this mechanism.  Not only 
was a pronounced anion affect on enantioselectivity observed (Table 2.2, entry 3–8), but 
a rate enhancement was detected when tertiary alcohols are utilized (Table 2.2, entry 1–
2).  Jacobsen extended this chemistry to an intermolecular reaction13b and an 
intramolecular version with pyrroles.13c  The exceptional anion-binding properties of 
thioureas have been known for quite some time.14  Because of this feature, they are the 
primary functional group found in organocatalysts used for counteranion binding.  Thus, 
the potential to find different and better anion-binding catalysts exists.15   
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Table 2.2  Jacobsen's Pictet-Spengler-type reaction and mechanistic studies. 
 
We hypothesized known anion receptors would make good anion-binding catalysts.  
We were pleased to find acridones and similar anthracenyl scaffolds were well known in 
the literature for their ability to bind to anions (Scheme 2.9 and Scheme 2.10).15  
Xanthene-derived compounds have been used in traditional hydrogen-bonding catalysis 
to promote addition of 2-acetylcyclopentanone into α, β-unsaturated nitroalkenes 
(Scheme 2.11).16  
Scheme 2.9  Crystal structure of an acridone bound to a chloride anion in the literature. 
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Scheme 2.10  Xanthene dithioureas and their affinity for different anions. 
 
Scheme 2.11  Xanthene compounds in traditional hydrogen-bonding catalysis. 
   
2.2.  Results and Discussion 
2.2.1.  Derivatization of Acridone Scaffold, Formation of Acridine or 
Thioacridone, and Analysis of a New Reaction 
This thesis starts with attempts to activate the initial acridone scaffold synthesized by 
Dr. Walvoord (Scheme 2.8).  If a more active form could be achieved, rate acceleration 
in the Claisen rearrangement would be observed.  First, ditosyl acridone 2.2 was 
synthesized (Scheme 2.12), which has two stable tautomeric states.  Then, using methods 
developed by Phuong Huynh for testing hydrogen bonding capability,17 it was determined 
catalyst 2.2 possesses activity between N,N-bis[3,5-bis(trifluoromethyl)]phenyl thiourea 
and N,N-bisphenyl thiourea, overall less activity than the previously developed 
bisamidinium (Scheme 2.7), which would be necessary for rate enhancement.  Efforts to 
make diacyl derivative 2.4 led to an unstable product and disulfonyl acridone 2.5 gave 
multiple unidentified byproducts (Scheme 2.12). 
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Scheme 2.12  Derivatization of 4,5-diaminoacridone. 
 
 
 
Protonation of the diacyl acridone 2.6 would also increase its ability to hydrogen 
bond.  However, efforts to access acridone salt 2.7 and then perform an anion exchange 
were unsuccessful (Scheme 2.13).  Later, this result was determined to be due to an 
unfavorable protonation-equilibrium (pKa –0.3).18 
Scheme 2.13  Attempted activation of 4,5-diacylacridone by protonation. 
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previously optimized iron reduction (Scheme 2.8) did not generate the desired 
diaminoacridine 2.13.  Hydrogen in the presence of Pd/C was used to access 
diaminoacridine 2.13, albeit in low yield (35%).  Acylation of 2.13 afforded 4,5-
diacylacridine 2.14, which was slightly unstable to air producing 4,5-diacylacridone 2.6 
(refer back to Scheme 2.13 for structure) in some cases.  4,5-Diacylacridine 2.14 did not 
undergo protonation to afford acridine salt 2.15.  This was surprising given its higher 
basicity (pKa 3.1).18  
Scheme 2.14  Increasing basicity of catalyst scaffold by forming an acridine. 
 
 
Thioamides are more acidic than amides, and because of this characteristic, they can 
make better hydrogen-bond donors.19  Additionally, they have a lower a tendency to self-
aggregate.20  A metal co-catalyst can also be used to bind to sulfur if further activation is 
necessary.  These features suggest thioamides may be more suitable catalysts than their 
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corresponding amides.  Therefore, formation of a thioacridone 2.16 was undertaken via a 
chloropyridine intermediate (Scheme 2.15).  Unfortunately, at this stage, the previously 
established Fe0/AcOH reduction conditions (Scheme 2.8) were unsuccessful at producing 
a 4,5-diaminothioacridone.  Trace amount of monoaminothioacridone 2.17 was obtained 
via reduction with sodium dithionate.  Attempts to acylate monoaminothioacridone 2.17 
led to acylation on sulfur.  Given the low yields and chemoselectivity problems, this route 
was abandoned.  Attempts to form the thioacridone from 4,5-diaminoacridone 2.1 or 
diacylacridone 2.6 using Lawesson’s reagent or via chloropyridine formation were 
unsuccessful.  
Scheme 2.15  Attempted thioacridone synthesis. 
 
  
Since a more acidic acridone scaffold could not be obtained, focus was turned 
towards the catalysis of reactions with lower activation barriers than a Claisen 
rearrangement.  One interesting target that graduate student Ryan Walvoord identified 
was a dearomatization/spirocyclization (Table 2.3). 21   There is no background or 
thermally induced reaction.  Only mercury, zinc, and boron Lewis acids have been used 
to promote this reaction.  Unfortunately, exposure of 2.18 to a variety of hydrogen-
bonding catalysts to produce 2.19, gave only one successful catalyst, the bisamidinium 
catalyst from Scheme 2.7 (Table 2.3, entry 3).  No enantioselectivity was observed.  
Attempts to dearomatize the corresponding benzyl vinyl ketone with this bisamidium 
N
HNO2 NO2
O
t-Bu
1.  POCl3, TEA,
    TBAC, MeCN, rt,   
    4 h
2.  thiourea, EtOH,    
     80 ºC, 30 min
58%
(over 2 steps)
N
HNO2 NO2
S
t-Bu
Na2S2O4, 
NaOH (aq)
CH2Cl2, rt, 16 h N
HNH2 NO2
S
t-Bu
2.9 2.16 2.17
trace by LRMS
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catalyst were unsuccessful indicating that the allenyl moiety is significant in this 
transformation. 
Table 2.3  The study of a dearomatization/spirocyclization reaction using hydrogen-
bonding catalysis. 
 
 
2.2.2.  Formation of Xanthene Scaffold to Replace the Acridone Scaffold 
A reanalysis of the acridone-derived scaffold revealed several drawbacks.  Access to 
diaminoacridone 2.1 requires 7 steps and is obtained in an overall 55% yield (Scheme 
2.16).  Furthermore, acridone derivatives are difficult to isolate due to equilibrium 
between vinylogous amide 2.2 and hydroxy pyridine 2.3.   
Scheme 2.16  A summary of Dr. Walvoord’s previous route to 4,5-diaminoacridone. 
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0
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To circumvent these issues, diaminoxanthene 2.27 was identified as a surrogate and a 
route to this material was optimized (Table 2.4).  4,5-Diaminoxanthene 2.27 was 
accessed in fewer steps and a high overall yield (75%, Scheme 2.17).  Additionally, 
compound 2.27 can be mono-protected to compound 2.28 (Scheme 2.17).  This reactivity 
enables unsymmetrical catalysts to be made. 
Table 2.4  Optimization of the synthesis of a 4,5-diaminoxanthene.
 
 
Scheme 2.17  Summary of route to a 4,5-diaminoxanthene. 
 
2.2.3.  Development of a Library of Different Chiral Xanthene Compounds 
With compounds 2.27 and 2.28 in hand, a library of catalysts were made that could be 
screened for reactivity and enantioinduction.  Before this undertaking, peptide bond 
O
1. Lithiation
2. Amination O
N3 N3
Reduction
O
NH2 NH2
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1
2
3
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n-BuLi (5 equiv)
rt, 15 min;  D2O
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none none
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none none
83% mono-deuterated
xanthene
100% mono-deuterated
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4
5
n-BuLi (5 equiv)
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DIAD, THF, 
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H2 (1 atm),
EtOAc
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2.5 h, rt
LAH, THF, rt
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0
34
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2.5 h, –78 ºC
NaBH4, THF
MeOH, 65 ºC
51
n-BuLi (5 equiv)
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NaBH4, THF
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n-BuLi (5 equiv)
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6
7
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O
1.  n-BuLi 
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O
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MeOH
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NH2 NH2
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NHBoc NH2
enables 
unsymmetrical 
catalyst formation
65%2.25 2.26 2.27 2.28
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formation was optimized (Table 2.5).  It was determined that HATU and HOAt provided 
the best yield and purity. 
Table 2.5  Optimization of amino acid coupling conditions. 
 
 
Using these conditions it was straightforward to make a variety of catalysts (Scheme 
2.18 and Scheme 2.19).   Three different classes of catalysts were synthesized and 
include C2-symmetrical catalysts 2.29, bifunctional catalysts 2.31, and unsymmetrical 
catalysts 2.34–2.36.  First, C2-symmetrical catalysts were generated (Scheme 2.18).  Not 
only is synthesis of these catalysts more straightforward but C2-symmetrical catalysts are 
beneficial because of the fewer possible number of diastereomeric transition states 
available. 22   Synthesis of bifunctional compounds 2.30 was then achieved.  
Multifunctional catalysts have been found useful in many systems.9a  Both urea (2.37 and 
2.35) and thiourea (2.34 and 2.36) unsymmetrical catalysts were made (Scheme 2.19).  
Although urea compounds are less acidic and therefore weaker hydrogen-bond donors, 
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O
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N
N N
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0
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23
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they have been found to give a greater amount of enantioinduction in certain systems.16  
Both amides (2.29, 2.36, and 2.37) and sulfonyl amides (2.34 and 2.35) were formed.  A 
greater variety of amides are accessible using commercially available amino acids 2.30, 
but sulfonyl amides were hypothesized to be better hydrogen-bond donors (again due to 
their increased acidity).  
Scheme 2.18  Synthesis of C2-symmetrical and bifunctional catalysts. 
 
Scheme 2.19  Synthesis of unsymmetrical catalysts. 
 
 
Purification and characterization of the N-Boc xanthene compounds 2.29 and 2.37 is 
difficult due to the various structural isomers available by amide tautomerization.  It was 
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discovered these catalysts could be isolated as their hydrochloride salts instead (Scheme 
2.20).  This step enables their purification by filtration and gives an accessible free 
amine, which could be utilized in enamine catalysis. 
Scheme 2.20  Isolation of xanthene compounds via deprotection and hydrochloride salt 
formation. 
 
Attempts to synthesize a pyrrole catalyst similar to the one used in Table 2.2 utilizing 
the Paul-Knorr pyrrole synthesis were unsuccessful.  Instead a pyrrole was incorporated 
into xanthene scaffold 2.32 using 2.30i, which was synthesized from commercially 
available pyrrole 2.40 (Scheme 2.21). 
Scheme 2.21  Synthesis of xanthene compound with pyrrole moiety. 
 
A survey of the literature showed dibromo xanthene 2.43 could be accessed from 
commercially available 2.42 (Scheme 2.22).  An attempt to make a chiral bisaniline 
catalyst via cross coupling gave 2.44b (3% yield, unoptimized).  Starting material 2.43 
and monocoupled compound were the two major components isolated from this reaction.  
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Scheme 2.22  A second route to access chiral, non-racemic xanthene catalysts. 
 
Since the xanthene scaffold is known in the literature, formation a novel acridan 
scaffold using a similar synthesis was attempted (Scheme 2.23).  Unfortunately syntheses 
of 9,9-disubstituted acridan analogues 2.47 and 2.49 from commercially available 2.45 
were low yielding.  Furthermore, attempts to form a dilithiated species from 2.47 or 2.49 
that would enable 2.48 or 2.50 to be accessed were unsuccessful. 
Scheme 2.23  Attempts to access a novel diaminoacridan catalyst scaffold. 
 
 
2.2.4.  Determination of Catalysts that are Effective at Promoting the Pictet-
Spengler-Type Reaction of Hydroxylactams 
With a variety of catalysts in hand, it was decided to evaluate their catalytic activity 
using Jacobsen’s Pictet-Spengler-type reaction (Table 2.2).  This reaction should have a 
much lower activation barrier than the Claisen and dearomatization/spirocyclization 
reactions previously studied.  Specifically, reduced reaction temperatures are necessary to 
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suppress the background thermal reaction.  Three sets of experiments were performed 
(Table 2.6, TBME = tert-butyl methyl ether).  In entry 1–5, bissulfonamide 2.55 is more 
active than bisamide 2.29b.  It was disappointing that bisamide 2.29b does not promote 
the reaction at all.  Unsymmetrical catalysts with urea (2.37c) and thiourea (2.36g) 
moieties perform better than bissulfonamide 2.55 but surprisingly similar to each other. 
Literature supports that N-alkyl, N-aryl thioureas and ureas have a very similar affinity 
for a chloride anion (Keq = 22 and 21 in DMSO respectively) indicating the activity of 
these catalysts is a function of their affinity for a chloride anion rather than their pKa (13 
and 19 respectively).23   In entry 6–8, xanthene 2.53 was compared to acridone 2.56.  It 
was determined the additional NH available for hydrogen bonding in acridone 2.56 does 
not increase the rate of reaction relative to xanthene 2.53.  We hypothesize that 2.56 
undergoes silylation, making it inferior as a scaffold (Scheme 2.24).  The final set of 
experiments (entry 9–12) proves the efficiency of bisthiourea 2.53 and unsymmetrical 
monothiourea 2.36g over simple thiourea 2.54.  These experiments suggest that four and 
three hydrogen bonds, respectively, are responsible for catalysis when using 2.53 and 
2.36g respectively.  Since this reaction is known in the literature (Table 2.2), these 
substrates were not tested for enantiomeric excess.  
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Table 2.6  Catalyst evaluation in the known Pictet-Spengler-type reaction. 
 
 
 
Scheme 2.24  Hypothesized silylation of acridone 2.56. 
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7
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2.37c
2.36g
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0
0
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2.56
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2.2.5.  Catalysis of the Cyclization of Furans into N-Acyliminium Ions 
Given the good activity of the xanthene-based catalysts, we wanted to expand this 
Pictet-Spengler-type reaction to more challenging substrates.  We decided to investigate 
the cyclization of 2 and 3-substituted furans (2.61 and 2.66, Scheme 2.25 and Scheme 
2.26, respectively) into N-acyliminium ions.  There are no reported enantioselective 
methods for this transformation. 
The cyclization of 3-substituted furans is slower (Table 2.7, entry 3, 11% conversion 
after 1 h at –42 ºC) than the corresponding indole (46% conversion after 1.5 h at –55 ºC).  
This difference is the result of furans being less nucleophilic.  Thus, the reaction time was 
increased from 1 to 7 h.  Unsymmetrical sulfonamide thiourea 2.34 performs better than 
amide urea 2.37c (entry 4 and 5, 60% vs. 42% conversion) and this result is proposed to 
be a consequence of sulfonamides being more acidic than amides (pKa 16 vs. 23 in 
DMSO, respectively).24   tert-Leucine-derived catalyst 2.36h showed small but significant 
levels of enantioinduction (entry 6, 70% conversion and 17% ee).  Surprisingly, histidine-
derived 2.36f does not promote the reaction.  Neither bisamides 2.29b and 2.29e (entry 9 
and 10) nor bifunctional catalyst 2.31b promote the cyclization.   
Scheme 2.25  Synthesis of 3-substitututed furans. 
 
O
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O
O
H
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Table 2.7  Cyclization of 3-substitututed furans onto N-acyliminium ions using xanthene 
catalysts. 
 
 
We were uncertain if furan 2.66 would undergo cyclization given the decreased 
stability of the positive charge in its non-aromatic intermediate (relative to furan 2.61).   
However, we were pleased to see cyclization does occur with addition of catalyst.  Warm 
temperatures (0 ºC) and increased reaction times (17 h) are necessary (Table 2.8).  
Surprisingly, bisamide 2.29b (Table 2.6, entry 6) performs well for this reaction (60% 
conversion) despite its failure to promote the previous two reactions (0% conversion).  
Bissulfonamide 2.68 does not perform as well as 2.29b (entry 2 and 6, 22% vs. 60% 
conversion).  This observation suggests π-stacking with 2.29b promotes reactivity of this 
substrate.  Unfortunately, no significant enantioselectivity was observed. 
Scheme 2.26  Synthesis of 2-substitututed furans. 
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1
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Table 2.8  Cyclization of 2-substitututed furans into N-acyliminium ions using xanthene 
catalysts. 
 
 
Additional screening was done around 3-substitututed furans in attempts to optimize 
the best yielding catalyst in Table 2.7 (entry 6).  Yields and enantiomeric excess were 
measured using several solvents and varied temperatures (Table 2.9).  Ethereal solvents 
give good conversion and small but significant amounts of enantiomeric excess, whereas 
more polar solvents 25  such as CH2Cl2 tend to give good conversion and no 
enantioinduction (Table 2.9, entry 1–5).  Aromatic solvents decrease the conversion and 
enantioselectivity, presumably due to decreased solubility of the catalysts (entry 2 and 4).  
Additional experiments around ethereal solvents (entry 6–9, CPME = cyclopentyl methyl 
ether) support that polar solvents decrease enantioselectivity, possibly due to increased 
reaction rates (entry 6 vs. 7, THF vs. CPME, 14% vs. 24% ee).  Also, it was determined 
higher reaction concentrations (0.1 M versus 0.01 M) increase the rate of reactions, 
subsequently lowering enantioselectivity (entry 9 vs. 5, 6% vs. 22% ee).  In an attempt to 
increase the enantioselectivity, the temperature was lowered to –78 ºC.  However, this 
change inhibited reaction progression (entry 11–13, <5% conversion).  Decreased 
O
TMSCl, 
cat (30 mol %)
TBME, 
0 ºC, time O
N
2.66 2.67
N
HO
O O
O
NH HN SO2O2SO O
2.68
O
N
O
O
N
O
entry         catalyst       time (h)                        conversiona (%)
1
2
3
4
5
none
2.68
2.36g
2.34
2.37c
22
61b
60b
57b
< 5
a Determined by 1H NMR relative to an IS 
b Significant enantioselectivity was not observed
6 2.29b 60b
17
17
17
17
17
17
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solubility of the catalyst at these temperatures is most likely the cause for the low 
conversions (reaction mixtures appeared cloudy as opposed to clear).  Under the 
hypothesis that more polar linear ethereal solvents may increase enantioselectivity (entry 
1 vs. 5, TBME vs. ether, 16% vs. 22% ee), diglyme was tested.  However, this solvent 
provided no benefit (entry 10, <5% ee).  An intermediate temperature was also attempted 
(–60 ºC).  In CPME, little to no catalyzed reaction was observed (entry 14, about 12% 
conversion) and there was not sufficient product to determine accurately the enantiomeric 
excess.  The reactions in CPME were still cloudy indicating potential catalyst 
precipitation.  In ether, the reaction did progress, but no increase in enantioselectivity was 
observed at lower temperatures (entry 5 vs. entry 15, 22% vs. 20% ee).  From these 
results the optimal reaction conditions were determined to be CPME, at –42 ºC for 7 h. 
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Table 2.9  Additional screening for the cyclization of 3-substitututed furans. 
 
2.2.6.  Using the Xanthene Compounds as Brønsted Acid Catalysts 
Another interesting reaction is the asymmetric addition of a Brønsted acid to an 
alkene.  This idea came from the initial finding that trifluoroacetic acid is sufficiently 
reactive to add irreversibly across an olefin while acetic acid is not (Scheme 2.6).  The 
hypothesis was that the xanthene catalysts could be used as chiral Brønsted acid catalysts 
(Scheme 2.28). 
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7
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0, 0
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5, N/A
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5
5
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7
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19, N/A
31, N/A
26
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8
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9
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78, 20
97, 6
7
26
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<
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Scheme 2.27  Initial findings of Brønsted acid addition to an unactivated olefin. 
 
This process has potential to create an atom-economical, asymmetric addition of a 
Brønsted acid across an olefin.  An organocatalytic method of this kind is unknown in the 
literature.  Since acetate products 2.70 and 2.72 are not chiral, a target olefin would have 
to be carefully chosen.  Interestingly, the solubility of solid acids in toluene (i.e. 
HCO2CCl3) is increased in the presence of these anion-binding compounds.  In these 
instances, reactivity may be enhanced by catalyst interaction with the substrate and by 
increased reagent solubility.  However, the tendency of trichloroacetic acid to form a 
carbene makes it an unsuitable reagent. 
Scheme 2.28  Non-covalently bound chiral Brønsted acid. 
 
We decided to start with an acidic amide surrogate reaction that has been promoted 
by a chiral phosphoric acid, Toste’s intramolecular hydroamination of a diene.26   Rate 
deceleration was detected in the hydroamination of 2.77 to form 2.78 (Scheme 2.29).  
This “negative catalysis” is documented in the literature. 27  When histidine derived 2.36f 
and bifunctional compound 2.31b were used as additives no reaction occurred.  Even 
with some additive-reagent interaction (entry 2–4), no enantioselectivity was observed.  
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Scheme 2.29  Hydroamination of a diene with xanthene compounds. 
 
 
2.2.7.  Determination of the Anion-Binding Constants of the Xanthene Catalysts 
We became interested in the binding constants for these xanthene compounds, 
because their reactivity was determined to be a function of their affinity for a chloride 
anion rather than pKa.  Since they had performed better than a simple thiourea in 
Jacobsen’s Pictet-Spengler type reaction (Table 2.2), we wanted to confirm this 
increased catalytic activity was due to their stronger affinity for a chloride anion.  Studies 
on similar compounds have been performed (Scheme 2.10).  Although 2.29b was found 
to have the lowest equilibrium constant for chloride binding (Keq = 56), it is still 
favorable in less polar solvents such as pyridine (Scheme 2.30).  The average value of the 
entropic cost for such a biomolecular reaction is –22.5 calK/mol.28  Therefore, at room 
temperature (298 K) the enthalpy of this process is –4.32 kcal/mol.  If we divide this 
value by two, then one NH•••Cl– interaction has a disassociation energy of 2.32 kcal/mol 
in pyridine and is therefore a weak hydrogen bond.2  The equilibrium constant of this 
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reaction was too low to be measured in DMSO.  Figure 2.2 shows the change in 
chemical shift of the NH protons in 1H NMR with increasing equivalents of chloride 
anion.  Since only one peak is observed, this system is undergoing fast exchange between 
2.29b and complex 2.29•ClN4n-Bu4; an average of the bound NH protons and unbound 
NH protons is observed rather than two distinct peaks.  The immediate change in 
chemical shift after addition of chloride anion (t = 1 h) indicates equilibrium has been 
reached before data collection (t = 1–24 h).  
Scheme 2.30  Summary of affinity of 2.29b for chloride anions. 
 
 
Figure 2.2  1H NMR chemical shift of NH in 2.29b with increasing equivalents of 
chloride anion. 
Plotting the change in the chemical shift against the concentration of 
tetrabutylammonium chloride (TBAC) gives a well-behaved binding curve (Figure 2.3). 
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Figure 2.3  1H NMR binding curve of 2.29b with chloride anion. 
Using equations 1.1 and 1.2 we can derive an isotherm for 1:1 binding (equation 1.3), 
where one molecule of the xanthene compound is forming a complex with only one 
chloride anion. 29   In equation 1.1, K11 is the equilibrium constant of 1:1 complex 
formation, where activities (a) have been expressed in terms of concentration (c) and the 
standard state concentration has been omitted to simplify the equilibrium expression.30  In 
equation 1.2, F11 is the fraction of bound substrate.  Equation 1.3 shows that F11 is 
dependent on [L] and not the ratio between substrate and ligand.  The fraction of bound 
substrate can also be represented by chemical shifts (equation 1.2), where Δδ11 is the 
chemical shift difference between unbound compound 2.29b and the theoretical shift of 
completely bound complex 2.29•ClN4n-Bu4.  The measured change in chemical shift is 
represented by Δδobs.  Lt and St represent the total ligand and substrate concentration in 
the system respectively (see equation 1.4 and 1.5 respectively).  Equation 1.2 and 1.3 
allow us to derive a relationship between chemical shift and K11 (equation 1.6).  If the 
condition Lt >> St is not met, than an iterative calculation must be performed.  If equation 
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1.5 is inserted into 1.6 and equation 1.2 substituted into the numerator, equation 1.7 is 
obtained.  An initial plot of Lt/Δδobs against (Lt + St) gives an estimate of Δδ11.  Then a 
plot is made of Lt/Δδobs against (Lt + St – [SL]) and iteration is carried out until the plot 
converges on one value for Δδ11.  At this point K11 can be determined from the y-
intercept.  See Appendix C for the raw data corresponding to equilibrium constants 
measured in this chapter.  
 
K11 = aSL/(aSaL), activity (a) = γ(c/c )  
standard state concentration (c ) =1 M  activity coefficient (γ) → 1 as  c → 0 
K11 = [SL]/[S][L]      (1.1) 
F11 =  [SL]/St = Δδobs /Δδ11     (1.2) 
F11 = K11[L]/(1 + K11)      (1.3) 
St = [S] + [SL]       (1.4) 
Lt = [L] + [SL]      (1.5) 
Δδobs = Δδ11K11[L]/(1+ K11[L])    (1.6) 
Lt/Δδobs = (Lt+St–[SL])/Δδ11 + 1/(K11 Δδ11)   (1.7) 
Next analysis was performed on 2.36h and 2.37c since they were predicted to be the 
next strongest anion-binders (Scheme 2.31).  In line with other literature reports,23 these 
two catalysts have very similar binding constants, Keq = 127 vs. 159 for 2.36h and 2.37c 
respectively (ΔG = –3.00 and –2.87 kcal/mol, ΔH = –9.70 and –9.57 kcal/mol) in DMSO.  
This similarity is supported by our experimentally-determined reactivity (Table 2.6, entry 
3 and 4).  The steric hindrance of the tert-leucine may decrease the affinity compound 
2.36h has for the anion. 
S   +   L
K11
SL
ο
ο
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Scheme 2.31  Summary of affinity of 2.37c and 2.36h for chloride anions. 
 
Finally, analysis was performed on 2.53 (Scheme 2.32).  As predicted, this catalyst 
has the highest affinity for a chloride anion of the compounds studied (Keq = 1517, ΔG = 
–4.34 kcal/mol, ΔH = –11.05 kcal/mol, –5.53 kcal/mol per one thiourea) in DMSO.  If 
we perform a similar analysis of a simple thiourea from the literature23 (Keq = 22, ΔG = –
1.83 kcal/mol, ΔH = –8.53 kcal/mol) we may conclude the anion pocket geometry of 2.53 
is not optimal for chlorides since weaker NH•••Cl– interactions are calculated.  This 
discrepancy may also indicate a greater entropic penalty is present when 2.53 binds to an 
anion than when a simple thiourea does.  A summary of these binding constants 
compared to other neutral, organic, anion binders can be found in Table 2.10.31 
Scheme 2.32  Summary of affinity of 2.53 for chloride anions. 
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Table 2.10  Summary of binding constants. 
 
 
2.2.8.  Experimentally Testing a Computational Model 
In the furan cyclization, formation of the N-acyliminium ion is likely the rate-
determining step based on precedent.13a  With previous studies having established facile 
promotion of the cyclization of furans into N-acyliminium ions with the xanthene-derived 
catalyst, we aimed to gain deeper insight into the enantiodetermining step.  Kailasham 
Rama, a master’s degree student, who was assisted by Dr. Osvaldo Gutierrez, a postdoc, 
carried out transition-state computations (refer to Appendix D for details).  All transition 
states are referenced to iminium ion intermediate 2.91 and catalyst when relevant.  All 
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calculations use diethyl ether as the solvent and a conductor-like polarizable continuum 
model (CPCM) for solvation 
Scheme 2.33  Initial reaction coordinate of uncatalyzed pathway [M062X/6-31G(d,p)], in 
diethyl ether using a CPCM model for solvation. 
 
Preliminary calculations on an uncatalyzed pathway suggested 
deprotonation/rearomatization to be the enantio-determining step.  However, when 
catalyst is included, attack of the furan onto the N-acyliminium ion becomes the enantio-
determining step.32  With achiral catalyst, deprotonation by the chloride ion is favorable 
over using water or the catalyst itself, i.e. the sulfur (Scheme 2.34).  Kailash also 
determined attack to form the 6-membered ring was favorable over attack to form a spiro 
compound (5-membered ring), Scheme 2.35.  This 6-membered ring forms a chair-like 
transition state (Scheme 2.36 for full reaction profile). 
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Scheme 2.34  Deprotonation with chloride, achiral catalyst or water [B3LYP/6-31G(d)], 
in diethyl ether using a CPCM model for solvation. 
 
Scheme 2.35  Six- vs. five-membered ring formation with achiral catalyst [B3LYP/6-
31G(d)], in diethyl ether using a CPCM model for solvation. 
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Scheme 2.36  Initial reaction coordinate with chiral, non-racemic catalyst [B3LYP/6-
31G(d)], in diethyl ether using a CPCM model for solvation. 
 
 
With a chiral catalyst DFT computations (B3LYP/6-31G(d)) predicted small energy 
difference in the two diastereomeric transition states (ΔΔH‡ = 1.73 and ΔΔG‡ = 0.56 
kcal/mol) (Table 2.11 and Figure 2.4).  This free energy difference is small but provides 
a rationale for the low level of enantioinduction observed.  In this case, (S)-2.62 is 
predicted to be the favored enantiomer of the product.  With a Gibbs free energy 
difference of 0.56 kcal/mol and a reaction temperature of –42 ºC (rounded up to –50 ºC) 
an enantiomeric ratio of 76:24 (51% ee) is predicted.  Although higher than the observed 
enantioselectivity, this value is within the error of the calculations.33  At –50 ºC, an 
energy difference of 1.8 kcal/mol and 3.4 kcal/mol would be necessary for 97 and 99% ee 
respectively.  Decreasing the temperature (–78 ºC) with this energy difference only 
provides a slight increase in enantiomeric excess (57%).   
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Table 2.11  Initial diastereomeric transition state energy differences, in diethyl ether 
using a CPCM model for solvation. 
 
 
Figure 2.4  3D structure of initial Me carbamate (R)-2.36m in diastereomeric TS 1‡  
[B3LYP/6-31G(d)]. 
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At this point, optimization was performed on the full catalyst structure (Table 2.12).  
The catalysts used in Table 2.11 have a methyl carbamate in place of the N-Boc 
carbamate of 2.36h.  This change resulted in a decrease in the energy difference between 
the two transition states (Table 2.12, entry 1–3 and Figure 2.5).  A key C–H•••O 
interaction in the lower (R)-2.36m + (R,S)-TS 1‡ transition state forces the thiourea aryl 
moiety out-of-plane relative to the thiourea (Figure 2.6), presumably a difficult 
proposition.34  We may be able to capitalize on this interaction by increasing the acidity 
of the corresponding Ar–H.  To test this hypothesis, cyano groups were used in place of 
the trifluoromethyl groups on the thiourea moiety (Table 2.12, entry 1 vs. 4 and entry 3 
vs. 5).  In both cases, this modification increases the energy difference between the two 
transition states.  The twisted nature of the thiourea aryl moiety does not change in the 
low-energy transitions states of the structures in Table 2.12.   
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Table 2.12  Diastereomeric transition states of modified catalyst scaffolds. 
 
 
Figure 2.5  3D structure of (R)-2.36h in diastereomeric TS 1‡ [B3LYP/6-31G(d)]. 
 
O
N
O
(R)-cat + Int-2.91
Energy
Reaction Progression
ΔΔG/H
O
N
H H
O
(R)(S)
(R)-cat +(S,R)-TS 1
ΔG/H
ΔΔG ΔΔH
B3LYP/6-31G(d), optimized (kcal/mol)
1.  2.36m 
2. 2.36n  
3. 2.36h 
  
4. 2.96m   
5. 2.96h
0.56
0.37
0.01
0.77
0.67
1.73
1.75
1.47
2.00
1.63
O
NH HNS O
NH N
H
O
O
2.36m   R1= CF3, R2 = Me
2.36n    R1= CF3, R2 = Bn
2.36h    R1= CF3, R2 = t-Bu
2.96m   R1= CN, R2 = Me
2.96h    R1= CN, R2 = t-Bu
R1
R1
R1
(R)-catalyst
••••
Cl
••••
••••
B3LYP/6-311+G(d,p) 
single point (kcal/mol)
MO62X/6-311+G(d,p)
single point (kcal/mol)
ΔΔH
6.   2.36m 
7.   2.36n  
8.   2.36h 
  
9.   2.96m   
10.  2.96h
0.89
1.07
1.18
0.60
0.92
ΔΔH
11.  2.36m 
12.  2.36n  
13.  2.36h 
  
14.  2.96m   
15.  2.96h
0.59
0.87
0.49
0.94
0.67
(R)-cat +(R,S)-TS 1
O
N
H H
O
(S)(R)
(R)
(R)
(S)
(R)
(S)
(R)
(R)-cat + (S,R)-TS 1(R)-cat + (R,S)-TS 1
  
  
108 
   
Figure 2.6  C–H•••O interaction between (R)-2.36m and lower energy TS 1‡ [B3LYP/6-
31G(d)]. 
To experimentally validate these trends, catalysts 2.36m and 2.36n were synthesized 
and tested (Table 2.13).  Unfortunately, catalyst 2.36m and 2.36n provided no benefit 
over the original catalyst (entry 2 and 3 vs. 4, 16% and 6% vs. 25% ee).  The reaction 
with catalyst 2.36n had significant byproducts suggesting the carboxybenzyl group was 
not stable under the reaction conditions.  At this time, a base additive was tested to 
determine if the one equivalent of acid produced during the reaction was poisoning the 
catalyst or increasing the background reaction (entry 5, 24% ee).  This additive did not 
improve enantioselectivity.  To ascertain that enantioinduction was not limited by 
turnover, 100 mol % of catalyst was also utilized but had no benefit on enantioselectivity 
(entry 6, 20% ee).   
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Table 2.13  First attempt to validate the computational model:  testing 2.36m and 2.36n 
in the furan cyclization reaction. 
 
The fact that experimental results do not support the trends from our initial 
calculations suggest we are missing lower energy transition states or not using a level of 
theory that accurately accommodates the variables in the system.  Single point energy 
values were undertaken using two higher levels of theory.  The B3LYP/6-311+G(d,p) 
level of theory has a larger basis set relative to B3LYP/6-31G(d), polarization on 
hydrogen atoms, and a diffuse function for heavy atoms.35  Diffuse functions allow the 
electrons to occupy distances farther away from the nucleus and therefore may be critical 
when anions and hydrogen bonds are involved.  The M062X/6-311+G(d,p) level of 
theory uses a different functional to describe the electron density of the system and 
typically performs better when dispersion interactions are important.36,37 
Overall, energies calculated using B3LYP/6-311+G(d,p) (Table 2.12, entry 6–8) 
correlate better than those from M062X/6-311+G(d,p) (entry 11–13).  These results are 
consistent with B3LYP treating systems that do not have large dispersion interactions 
better. 
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Replacement of the trifluoromethyl groups by cyano groups it predicted to be 
disadvantageous to the enantioselectivity rather than beneficial [B3LYP/6-311+G(d,p)].  
This phenomenon may be rationalized if the out-of-plane aryl group (Figure 2.6) is 
destabilizing rather than stabilizing and therefore raising the energy of the lowest energy 
transition state.  If this hypothesis is correct we would want to synthesize and test the 
unsubstituted aryl ring to decrease the extent of the C–H•••O interaction.  Synthesis of 
this catalyst series is currently underway (Scheme 2.37).  Synthesis of an adamantyl-
derived amino acid to increase the steric bulk at the chiral center of the catalyst is also 
ongoing.  Additionally, determination of the absolute stereochemistry of the major 
enantiomer is in progress to help validate the computational model. 
Scheme 2.37  New catalyst series to further validate computational model. 
 
2.3.  Conclusions 
This portion of the thesis discusses the effect of non-covalent interactions on reaction 
catalysis.  Its goal is to study the important parameters of non-covalent interactions in 
enzyme catalysis.    
At first hydrogen-bonding interactions to a substrate were examined.  Derivatives of 
an acridone scaffold were synthesized on the hypothesis that increasing the acidity of this 
scaffold would provide a catalyst with stronger hydrogen-bonding capability.  While a 
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bistosyl acridone was successfully made, attempts to synthesize a diamino thioacridone 
were unsuccessful.  Additionally protonation of an acridone and acridine scaffold was 
ineffective.  A new spirocyclization/dearomatization reaction was studied, but it was 
determined the activation barrier to this reaction was too high.  Only a previously 
designed bisamidinium scaffold was effective at promoting this reaction.  
At this point, focus was turned toward exploiting the hydrogen bonding 
characteristics in anion-binding catalysts.  If we can design an effective anion-binder we 
may be able to catalyze a variety of reactions utilizing only one catalyst.  A library of 
anion-binding compounds has been developed based on a xanthene scaffold.  An efficient 
route to this scaffold was designed and used to make over 20 potential chiral, non-
racemic catalysts.  These catalysts are unique from the thiourea hydrogen-bonding 
catalysts currently in the literature, because they are more effective in promoting Pictet-
Spengler-type reactions of hydroxylactams.  This set of potent anion-binders has potential 
to pave the way for a new reaction development focused on counteranion binding.  With 
this information, two different reactions were investigated for rate enhancement and 
enantioinduction.  These reactions include the addition of a Brønsted acid to an alkene 
and the cyclization of furans into N-acyliminium ions.  In both reactions, interaction of 
the catalyst with the substrate is supported by the experimental results.  Future efforts are 
aimed toward validating a computational model of the cyclization of furans onto N-
acyliminium ions with the goal of achieving higher enantioinduction. 
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2.4.  Experimental  
General Methods.  Unless otherwise noted, all non-aqueous reactions were carried 
out under an atmosphere of dry argon in dry glassware and all solvents and reagents were 
HPLC grade and used without further purification.  When necessary, solvents and 
reagents were dried prior to use.  Moisture sensitive reagents were added via syringe.  
Flash column chromatography was performed on EM Reagents Silica Gel 60 (230-400).  
Analytical thin layer chromatography (TLC) was performed on EM Reagents 0.25 mm 
silica-gel 254-F plates.  Visualization was accomplished with UV light and/or KMnO4 
stain.  
1H NMR and 13C spectra were recorded on a Bruker AM-500 (500 MHz) 
spectrometer.  Chemical shifts are reported from the solvent resonance peak (CDCl3 7.27 
ppm).  Data are reported as follows:  chemical shift, multiplicity (s = singlet, d = doublet, 
t = triplet, q = quartet, bs = broad singlet, m = multiplet), coupling constants, and number 
of protons.  Mass spectra were obtained on a high resonance VG autospec with an 
ionization mode of either CI or ES.  IR spectra were taken on a Perkin-Elmer 1600 series 
or JASCO FT/IR-480 spectrometer.  Melting points were obtained on a Thomas 
Scientific Unimelt apparatus and are uncorrected. All yields reported refer to isolated 
yields unless otherwise indicated, and the purity of the product was determined by 1H 
NMR analysis.  Compounds described in the literature were characterized by comparison 
of their spectra to reported data.  New compounds were also characterized by high 
resolution mass. 
The following compounds were made following literature protocols:  2.30j,38 2.51,13a 
2.43,39 2.54,40 2.61,41 2.66,13c and 2.77.26,42 
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N,N'-(2-(tert-Butyl)-9-oxo-9,10-dihydroacridine-4,5-diyl)bis(4methylbenzenesulfon 
amide) (2.3)  
To a solution of 4,5-diaminoacridone 2.1 (66.7 mg, 0.24 mmol) in CH2Cl2  (1.2 mL) was 
added pyridine (43.0 µL, 0.24 mmol).  The reaction mixture was cooled to 0 °C before 
the addition of p-TsCl (101 mg, 0.53 mmol).  The mixture was stirred overnight at rt 
before being diluted with CH2Cl2 (1 mL) and quenched with saturated NH4Cl (aq).  The 
layers were separated and the aqueous layer was extracted with CH2Cl2 (3 x 1 mL), dried 
with Na2SO4, and concentrated.  The residue was chromatographed (2:98 MeOH:CH2Cl2) 
to give the desired product (100 mg, 70%) as a yellow solid.  1H NMR (500 MHz, 
CDCl3) δ 9.95 (s, 1H), 8.29 (d, J = 7.6 Hz, 1H), 8.23 (d, J = 2.1 Hz, 1H), 7.85 (s, 1H), 
7.77 (s, 1H), 7.72 (d, J = 8.3 Hz, 1H), 7.70 (d, J = 8.3 Hz, 2H), 7.21 (d, J = 8.3 Hz, 2H), 
7.18 (d, J = 8.3 Hz, 2H), 7.07 (d, J = 2.1 Hz, 2H), 6.98 (t, J = 7.9 Hz, 2H), 2.34 (s, 3H), 
2.32 (s, 3H), 1.13 (s, 9H). 
 
  
2-(tert-Butyl)-4,5-dinitro-9,10-dihydroacridine (2.11) 
To a solution of 4,5-dinitroacridone 2.9 (226 mg, 0.661 mmol) in THF  (15 mL) was 
added borane (3.3 mL, 3.3 mmol, 1M solution in THF) at 0 °C.  The mixture was stirred 
at 70 °C for 2 h before being quenched with water (5 mL) at 0 °C.  The reaction mixture 
N
H
O
t-Bu
HNNH TsTs
N
H
t-Bu
NO2NO2
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was extracted with CH2Cl2 (3 x 5 mL), dried with Na2SO4, and concentrated.  The crude 
residue was chromatographed (100% CH2Cl2) to give the desired product (149 mg, 69%) 
as a yellowish orange solid.  1H NMR (500 MHz, CDCl3) δ 12.4 (s, 1H), 8.12 (d, J = 1.5 
Hz, 2H), 7.45 (s, 1H), 7.40 (d, J = 7.1 Hz, 1H), 6.99 (t, J = 8.2 Hz, 1H), 4.27 (s, 2H), 1.56 
(s, 9H); 13C NMR (125 MHz, CDCl3) 145.2, 135.6, 134.8, 134.1, 134.0, 132.9, 132.6, 
124.9, 123.7, 123.2, 121.2, 121.1, 34.6, 31.9, 31.2 δ.  
 
  
2-(tert-Butyl)-4,5-dinitroacridine (2.12) 
To solution of 4,5-dinitroacridan 2.11 (149 mg, 0.455 mmol) in CH2Cl2  (23 mL) was 
added MnO2 (248 mg, 5.70 mmol) at 0 °C.  The mixture was stirred at 45 °C for 5 h.  The 
reaction mixture was filtered over Celite, washed with CH2Cl2 (5 mL), and concentrated.  
The residue was chromatographed (30:70 EtOAc:hexanes) to give the desired product 
(96.1 mg, 62%) as a yellow solid.  1H NMR (500 MHz, CDCl3) δ 8.93  (s, 1H), 8.32 (d, J 
= 1.9 Hz, 1H), 8.21 (d, J = 7.9 Hz, 1H), 8.14 (d, J = 7.9, 1H), 8.12 (d, J = 1.9, 1H), 7.62 
(dd, J = 7.9, 7.9 Hz, 1H), 1.50 (s, 9H). 
 
  
2-(tert-Butyl)acridine-4,5-diamine (2.13)  
To a solution of 4,5-dinitroacridine 2.12 (30.0 mg, 0.0920 mmol) in EtOAc  (0.5 mL) was 
added Pd/C (7.5 mg, 0.007 mmol, 10% wt Pd).  The reaction flask was flushed with H2 
before being placed under H2 (1 atm) for 3 h at rt.  The reaction mixture was filtered over 
N
t-Bu
NO2NO2
N
t-Bu
NH2NH2
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celite, washed with EtOAc (2 mL), and concentrated.  The crude residue was 
chromatographed (20:80 EtOAc:hexanes) to give the desired product (8.5 mg, 35%) as a 
yellow solid.  1H NMR (500 MHz, CDCl3) δ 8.56 (s, 1H), 7.35–7.30 (m, 2H), 7.38 (d, J = 
1.9 Hz, 1H), 7.07 (d, J = 1.8 Hz, 1H), 6.92 (dd, J = 6.5, 6.5, 1H), 5.08 (bs, 4H), 1.43 (s, 
9H); IR (film) 3460, 3352, 3059, 2958, 2873, 1599 cm–1. 
 
  
N,N'-(2-(tert-Butyl)acridine-4,5-diyl)diacetamide (2.14) 
To solution of 4,5-diaminoacridine 2.13 (8.6 mg, 0.032 mmol) in CH2Cl2  (0.6 mL) was 
added acetic anhydride (6 µL, 0.65 mmol) followed by DMAP (4.7 mg, 0.038 mmol).  
The reaction flask was stirred for 2 h at rt before being quenched with sat NaHCO3 (aq), 
extracted with CH2Cl2 (3 x 2 mL), dried over NaSO4, and concentrated.  The residue was 
chromatographed (50:50 EtOAc:hexanes) to give the desired product (6.1 mg, 55%) as a 
yellow solid.  1H NMR (500 MHz, CDCl3) δ 9.58 (s, 1H), 9.51 (s, 1H), 9.03 (s, 1H), 8.79 
(d, J = 7.4 Hz, 1H), 8.71 (s, 1H), 7.69 (d, J = 7.4 Hz, 1H), 7.61 (s, 1H), 7.53 (dd, J = 7.4, 
7.4 Hz, 1H), 2.44 (s, 6H), 1.48 (s, 9H). 
 
 
2-(tert-Butyl)-4,5-dinitroacridine-9(10H)-thione (2.16)  
4,5-Dinitroacridone 2.9 (30 mg, 0.09 mmol) and tetrabutylammonium chloride (50 mg, 
0.18 mmol) were placed in a Schlenk flask and dried in vacuo for 1 h.  Addition of 
MeCN (0.5 mL) afforded a heterogeneous reaction mixture.  Addition of Et3N (0.1 mL, 
N
t-Bu
NHAcNHAc
N
H
t-Bu
NO2NO2
S
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0.675 mmol) and POCl3 (21 µL, 0.25 mL) gave a homogeneous brownish orange reaction 
mixture that was stirred for 4 h at rt before being concentrated in vacuo (1 h).  At this 
point, thiourea (41.1 mg, 0.54 mmol) was added followed by EtOH (0.5 mL). The 
mixture was stirred at 80 °C for 35 min, at which point a reddish brown ppt had formed.  
The mixture was diluted with water, extracted with CH2Cl2 (3 x 2 mL), dried over 
NaSO4, and concentrated.  The resulting crude mixture was purified by chromatography 
(100% CH2Cl2) to give the desired product (17.3 mg, 54%) as a red solid.  1H NMR (500 
MHz, CDCl3) δ 13.85 (bs, 1H), 9.32 (d, J = 2.4 Hz, 1H), 9.26 (dd, J = 8.1, 1.5 Hz, 1H), 
8.90 (d, J = 2.4 Hz, 1H), 8.82 (dd, J = 8.1, 1.5 Hz, 1H), 7.44 (dd, J = 8.1, 8.1 Hz, 1H), 
1.48 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 201.3, 147.1, 139.5, 136.14, 136.06, 135.9, 
132.1, 131.9, 130.9, 130.1, 128.8, 122.7, 121.9, 35.4, 31.2; IR (film) 3229, 2966, 2927, 
1529, 1500, 1290 cm–1. 
 
  
9,9-Dimethyl-9H-xanthene-4,5-diamine (2.27) 
To a stirring solution of xanthene 2.25 (0.77 g, 3.65 mmol) in freshly distilled THF (10 
mL) was added n-BuLi (2.23M, 8.03 mmol) at –78 ºC.  The mixture went from colorless 
to red, at which point it was allowed to warm to rt and stirred for 1 h.  The mixture was 
now an orange-red.  After being cooled to –78 ºC, a white precipitate formed.  Tosyl 
azide (1.73 g, 8.77 mmol) was added as a solution in THF (5 mL).  The mixture was 
stirred for 4 h at –78 ºC.  At this point, the mixture was added to a solution of Na4P2O7 
(7.3 mmol) in water (~50 mL).  Ether (~25 mL) was added and this biphasic solution was 
O
NH2 NH2
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allowed to sit overnight.  The next day, the layers were separated and the water layers 
was extracted with Et2O (2 x 25 mL).  The organic layers were combined and washed 
once with brine (~25 mL) before being dried with MgSO4 and concentrated.   
To the remaining red solid was added THF (10 mL) followed by NaBH4 (203 mg, 
5.37 mmol).  The mixture was heated to reflux for 2 h.  Over this period, MeOH (1 mL) 
was slowly added.  After cooling to rt, the mixture was diluted with EtOAc and slowly 
acidified with 1 M HCl.  The organic layer was discarded and the remaining aqueous 
layer was basified with saturated Na2CO3 (aq) and extracted with EtOAc (3 x 25 mL).  
The combined organics were dried over NaSO4, and concentrated to give 
spectroscopically pure 2.27 (665 mg, 75%) as an off-white solid.  This product can be 
chromatographed (5:95 MeOH:CH2Cl2) to increase its mass purity. The spectral data 
were in agreement with reported literature values. 43  1H NMR (500 MHz, CDCl3) δ 6.91 
(dd, J = 7.8, 7.8 Hz, 2H), 6.85 (dd, J = 1.5, 7.8 Hz, 2H), 6.67 (dd, J = 1.5, 7.8 Hz, 2H), 
3.75 (bs, 4H), 1.62 (s, 6H). 
 
General Procedure 2.1 for (thio)urea formation.   
To a stirring solution of 2.28 (1 equiv) in CH2Cl2 (0.2 M) was added 3,5-
trifluoromethyl phenyl isocyanate or isothiocyanate (2 equiv).  The mixture was stirred 
for 18 h at rt.  At this point the reaction was diluted with ethyl acetate and washed with 1 
M HCl and brine.  The organic layer was dried over Na2SO4 and concentrated. The crude 
residue was chromatographed (10:90 to 25:75 EtOAc:hexanes) to give the desired 
product.   
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tert-Butyl (5-(3-(3,5-bis(trifluoromethyl)phenyl)thioureido)-9,9-dimethyl-9H-
xanthen-4-yl)carbamate (2.32)  
General Procedure 2.1 was applied to 2.28 (1.10 g, 3.23 mmol).  The title compound 
was obtained as a tan solid (1.28 mg, 65%).  Full characterization was performed on the 
final catalyst. 
 
 
 tert-Butyl (5-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)-9,9-dimethyl-9H-xanthen-4-
yl)carbamate  (2.33) 
General Procedure 2.1 was applied to 2.28 (1.67 mg, 4.90 mmol).  The title compound 
was obtained as a tan solid (0.916 mg, 38%).  Full characterization was performed on the 
final catalyst. 
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tert-Butyl (5-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)-9,9-dimethyl-9H-xanthen-4-
yl)carbamate  (2.53) 
General Procedure 2.1 was applied to 2.27 (300. mg, 1.25 mmol) using 3,5-
trifluoromethyl phenyl isothiocyanate (4 equiv).  The title compound was obtained as a 
white solid (0.821 mg, 84%). mp 102–114 °C; 1H NMR (500 MHz, Acetone-d6) δ 9.67 
(s, 2H), 9.27 (s, 2H), 8.26 (s, 4H), 7.77 (d, J = 7.9 Hz, 2H), 7.70 (s, 2H), 7.51 (d, J = 7.9 
Hz, 2H), 7.22 (dd, J = 7.9, 7.9 Hz, 2H), 1.68 (s, 6H); 13C NMR (125 MHz, Acetone-d6) δ 
180.7, 143.9, 141.4, 131.6, 130.9 (q, J = 33.6 Hz), 126.1, 125.8, 124.8, 124.1, 123.5, 
123.4 (q, J = 272.0 Hz), 117.7, 34.7, 31.5; IR (film) 3221, 2978, 1707, 1623, 1539, 1434 
cm1; HRMS-ESI (m/z): [M + H]+ calcd for C33H23F12N4OS2, 783.1122; found, 783.1123. 
 
   
1,1'-(2-(tert-Butyl)-9-oxo-9,10-dihydroacridine-4,5-diyl)bis(3-(3,5-
bis(trifluoromethyl)phenyl)thiourea) (2.56) 
To a solution of 4,5-diaminoacridone 2.17 (55.0 mg, 0.20 mmol) in DMF  (11 mL) was 
added 3,5-trifluoromethyl phenyl isothiocyanate (0.36 mL, 1.95 mmol).  The mixture was 
stirred overnight at rt before being diluted with EtOAc (10 mL) and quenched with water.  
O
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The layers were separated and the aqueous layer was extracted with EtOAc (2 x 5 mL), 
dried with Na2SO4, and concentrated.  The residue was chromatographed (3:97 
MeOH:CH2Cl2) to give the desired product (48 mg, 30%) as a yellow solid.  mp 167–170 
°C; 1H NMR (500 MHz, DMF-d7) δ 10.68 (s, 1H), 10.36 (s, 1H), 10.35 (s, 1H), 9.54 (s, 
1H),  8.43 (s, 2H), 8.42 (s, 2H), 8.33-8.32 (m, 2H), 8.03-8.01 (m, 2H), 7.88 (d, J = 7.6 
Hz, 1H), 7.80 (s, 2H), 7.38 (dd, J = 7.6, 7.6 Hz, 1H), 1.41 (s, 9H);  13C NMR (125 MHz, 
DMF-d7) δ 183.5, 183.4, 178.2, 145.6, 143.20, 143.17, 138.0, 136.0, 134.0, 132.4, 131.6 
(q, J = 33.2 Hz), 131.6 (q, J = 33.2 Hz), 128.1, 128.0, 126.4, 124.9, 124.8, 124.6 (q, J = 
272.4 Hz), 124.6 (q, J = 272.4 Hz), 123.1, 122.6, 122.3, 121.5, 118.4, 118.4, 35.6, 31.8; 
IR (film) 2927, 1594, 1593, 1456, 1277, 1173, 1132 cm–1; HRMS-ESI (m/z): [M + H]+ 
calcd for C35H26F12N5OS2, 824.1387; found, 824.1398. 
 
General Procedure 2.2 Amino Acid Coupling Procedure. 
To 2.32, 2.33, 2.27 (1 equiv, 1 equiv, and 0.5 equiv respectively) was added 
CF3CO2H (0.5 M).  This mixture was stirred for 1 h at rt and EtOAc and saturated 
Na2CO3 (aq) was added.  The aqueous layer was washed with with EtOAc (2 x), and the 
organic layers were dried with NaSO4 and concentrated to give spectroscopically pure 
material, which was used in the next step without further purification. 
To a stirring solution of the N-protected amino acid (2 equiv) in DMF (0.10 M) was 
added HATU (2 equiv), HOAt (0.6 equiv), and Et3N (2 equiv) at 0 ºC.  This mixture was 
stirred for 10 min before the addition of free aniline from above (1 equiv, 1 equiv, and 0.5 
equiv respectively) as a solution in DMF (0.10 M).  The mixture was stirred overnight at 
rt.  Then the mixture was diluted with EtOAc and washed with saturate citric acid (aq), 
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saturated NaHCO3 (aq), and brine.  The organic layer was dried with NaSO4 and 
concentrated.  The crude residue was chromatographed (5:90 to 30:70 EtOAc:hexanes) to 
give the desired product.   
General Procedure 2.3 Amino Acid Coupling Procedure. 
Alternatively, the unprotected diamine 2.27 could be mono-coupled to amino acids.  
To a stirring solution of the N-protected amino acid (1.2 equiv) in DMF (0.10 M) was 
added HATU (1 equiv), HOAt (0.3 equiv), and Et3N (1–2 equiv) at 0 ºC.  This mixture 
was stirred for 10 min before the addition diamine 2.27 (2 equiv) as a solution in CH2Cl2 
(0.10 M).  The mixture was stirred overnight at rt.  Then the mixture was diluted with 
EtOAc and washed with saturate citric acid (aq), saturated NaHCO3 (aq), and brine.  The 
organic layer was dried with NaSO4 and concentrated to give a crude oil.  The residue 
was chromatographed (10:90 to 30:70 EtOAc:hexanes) to give the desired product.  
Recovery of starting material (diamine 2.27) is possible by elution with a more polar 
solvent (50:50 to 75:100 EtOAc:hexanes).  For hindered couplings that proceed slowly 
this procedure works much better than General Procedure 2.2.  Diamino xanthene 2.27 
is less sterically hindered so the rate of the reaction increases.  Additionally, the slow 
hydrolysis of the thiourea is no longer a concern. 
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tert-Butyl (S)-(1-((5-amino-9,9-dimethyl-9H-xanthen-4-yl)amino)-3,3-dimethyl-1-
oxobutan-2-yl)carbamate (2.97h) 
General Procedure 2.3 was applied to 2.27 (50.0 mg, 0.21 mmol).  The title compound 
was obtained as an oily solid (50.0 mg, 85%).  1H NMR (500 MHz, acetone-d6) δ 9.07 
(bs, 1H), 8.13 (d, J = 7.8 Hz, 1H), 7.26 (dd, J = 7.8 Hz, 1H), 7.06 (dd, J = 7.8, 7.8 Hz, 
1H), 6.86 (dd, J = 7.9, 7.9 Hz, 1H), 6.76 (d, J = 7.9 Hz, 1H), 6.67 (d, J = 7.9 Hz, 1H), 
6.17 (d, J = 9.5 Hz, 1H), 4.94 (bs, 2H), 4.36 (d, J = 9.5 Hz, 1H), 1.62 (s, 3H), 1.59 (s, 
3H), 1.42 (s, 9H), 1.12 (s, 9H); 13C NMR (125 MHz, Acetone-d6) δ 169.7, 156.0, 140.5, 
137.5, 136.4, 130.5, 130.0, 126.0, 123.6, 122.4, 121.1, 119.6, 113.4, 113.1, 78.8, 62.3, 
34.1, 34.0, 32.2, 30.8, 27.7, 26.2 [note: Me-groups on xanthene backbone lose their 
symmetry in 1H and 13C NMR]; IR (film) 3056, 2362, 2342, 1682, 1534, 1482, 1427  
cm–1. 
 
 
Methyl (S)-(1-((5-amino-9,9-dimethyl-9H-xanthen-4-yl)amino)-3,3-dimethyl-1-
oxobutan-2-yl)carbamate (2.97m) 
General Procedure 2.3 was applied to 2.27 (50 mg, 0.21 mmol).  The title compound 
was obtained as an oily solid (50 mg, 85%).  1H NMR (500 MHz, acetone-d6) δ 9.07 (bs, 
O
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BocHN t-Bu
O
NH NH2O
MeO2CHN t-Bu
  
  
123 
1H), 8.07 (d, J = 7.8 Hz, 1H), 7.27 (d, J = 7.8 Hz, 1H), 7.07 (dd, J = 7.8, 7.8 Hz, 1H), 
6.85 (dd, J = 7.8, 7.8 Hz, 1H), 6.75 (dd, J = 7.9, 1.4 Hz, 1H), 6.66 (dd, J = 7.9, 1.4 Hz, 
1H), 6.41 (d, J = 9.3 Hz, 1H), 4.92 (bs, 2H), 4.32 (d, J = 9.5 Hz, 1H), 3.64 (s, 3H), 1.61 
(s, 3H ), 1.56 (s, 3H), 1.12 (s, 9H); 13C NMR (125 MHz, acetone-d6) δ 169.5, 157.2, 
140.8, 137.4, 136.4, 130.5, 129.9, 125.8, 123.6, 122.4, 121.4, 120.1, 113.5, 113.0, 63.2, 
51.6, 34.1, 34.0, 31.9, 31.1, 26.2. 
 
  
Di-tert-butyl ((2S,2'S)-((9,9-dimethyl-9H-xanthene-4,5-diyl)bis(azanediyl))bis(1-
oxopropane-1,2-diyl))dicarbamate (2.29a) 
General Procedure 2.2 was applied to 2.27 (496 mg, 2.06 mmol).  The title compound 
was obtained as a white solid (672 mg, 56%).  mp 184–185; °C 1H NMR (500 MHz, 
CDCl3) δ 9.39 (bs, 2H), 8.05 (d, J = 7.4 Hz, 2H), 7.17 (d, J = 7.4 Hz, 2H), 7.10 (dd, J = 
7.4, 7.4 Hz, 2H), 5.25 (bs, 2H), 4.86 (m, 2H), 1.58 (s, 6H), 1.45 (d, J = 7.5 Hz, 6H), 1.38 
(s, 18H); 13C NMR (125 MHz, CDCl3) δ 171.9, 156.1, 140.6, 130.6, 126.1, 123.4, 121.0, 
120.3, 80.4, 50.2, 34.6, 31.6, 28.5, 17.3. 
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Di-tert-butyl ((2S,2'S)-((9,9-dimethyl-9H-xanthene-4,5-diyl)bis(azanediyl))bis(1-oxo-
3-phenylpropane-1,2-diyl))dicarbamate (2.29b) 
General Procedure 2.2 was applied to 2.27 (329 mg, 1.34 mmol).  The title compound 
was obtained as a white solid (708 mg, 70%).  mp 100–106 °C; 1H NMR (500 MHz, 
acetone-d6) δ 9.52 (bs, 2H), 8.11 (d, J = 7.2 Hz, 2H), 7.34-7.29 (m, 6H), 7.21-7.20 (m, 
6H), 7.13 (t, J = 8.0 Hz, 2H), 6.67 (d, J = 7.9 Hz, 2H), 5.16 (m, 2H), 3.26-3.08 (m, 4H), 
1.61 (s, 6H), 1.23 (s, 18H); 13C NMR (125 MHz, acetone-d6) δ 170.6, 156.5, 140.0, 
137.6, 130.4, 129.1, 128.2, 126.5, 126.1, 123.1, 120.6, 119.6, 79.3, 55.5, 36.3, 34.3, 30.8, 
27.6.  IR (film) 3315, 2972, 1684, 1542, 1420 cm–1; HRMS-ESI (m/z): [M + H]+ calcd for 
C43H51N4O7, 735.3758; found, 735.3769. 
 
  
 Di-tert-butyl ((2S,2'S)-((9,9-dimethyl-9H-xanthene-4,5-diyl)bis(azanediyl))bis(3-
methyl-1-oxobutane-1,2-diyl))dicarbamate (2.29c) 
General Procedure 2.2 was applied to 2.27 (100 mg, 0.42 mmol).  The title compound 
was obtained as a white solid (93.0 mg, 35%).  mp 200–202 °C; 1H NMR (500 MHz, 
CDCl3) δ 9.06 (bs, 2H), 7.93 (d, J = 7.8 Hz, 2H), 7.18 (d, J = 7.8 Hz, 2H), 7.09 (dd, J = 
7.8, 7.8 Hz, 2H), 5.31 (bs, 2H), 4.43 (m, 2H), 2.18 (m, 2H), 1.58 (s, 6H), 1.37 (s, 18H), 
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1.10 (d, J = 6.7 Hz, 6H), 1.07 (d, J = 6.7 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 171.3, 
156.4, 140.7, 130.4, 125.6, 123.1, 121.3, 120.8, 80.0, 60.7, 34.5, 31.6, 30.0, 28.3, 19.5, 
18.2; IR (film) 3328, 2971, 1676, 1545, 1422 cm–1.  
 
  
tert-Butyl (S)-2-(3-((5-(3-(3,5-bis(trifluoromethyl)phenyl)thioureido)-9,9-dimethyl-
9H-xanthen-4-yl)amino)-2-((tert-butoxycarbonyl)amino)-3-oxopropyl)-1H-
imidazole-1-carboxylate N,N'-(2-(tert-butyl)-9-oxo-9,10-dihydroacridine-4,5-
diyl)bis(4-methylbenzenesulfonamide) (2.36f)   
General Procedure 2.2 was applied to 2.32 (618 mg, 1.01mmol).  The title compound 
was obtained as a tan solid (264 mg, 31%). mp 104–110 ºC; 1H NMR (500 MHz, 
acetone-d6) δ 10.53 (s, 1H), 9.46 (s, 1H), 9.24 (s, 1H), 8.38 (s, 2H), 8.07–8.05 (m, 2H), 
7.93 (s, 1H), 7.77 (s, 1H), 7.46 (d, J = 7.5 Hz, 1H), 7.32–7.29 (m, 2H), 7.19 (dd, J = 8.0, 
8.0 Hz, 1H), 7.12 (dd, J = 8.0, 8.0 Hz, 1H), 6.77 (s, 1H), 4.91 (s, 1H), 3.25–3.01 (m, 2H), 
1.62 (s, 3H), 1.60 (s, 3H), 1.58 (s, 9H), 1.29 (s, 9H); HRMS-ESI (m/z): [M + H]+ calcd 
for C40H43F6N6O6S, 849.2869; found, 849.2870. 
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 tert-Butyl ((2S,3S)-1-((5-(3-(3,5-bis(trifluoromethyl)phenyl)thioureido)-9,9-
dimethyl-9H-xanthen-4-yl)amino)-3-methyl-1-oxopentan-2-yl)carbamate (2.36g)  
General Procedure 2.2 was applied to 2.32 (618 mg, 1.01 mmol).  The title compound 
was obtained as a tan solid (313 mg, 40%).  mp 98–110 °C; 1H NMR (500 MHz, acetone-
d6) δ 10.17 (s, 1H), 9.22 (s, 2H), 8.44 (s, 2H), 8.07 (d, J = 7.5 Hz, 1H),  7.98 (d, J = 7.5 
Hz, 1H), 7.76 (s, 1H), 7.44 (d, J = 7.5 Hz, 1H), 7.33 (d, J = 7.5 Hz, 1H), 7.19 (dd, J = 7.5, 
7.5 Hz, 1H), 7.15 (dd, J = 7.5, 7.5 Hz, 1H), 6.92 (bs, 1H), 4.50 (m, 1H), 1.69 (m, 4H), 
1.60 (s, 3H), 1.36 (s, 9H), 1.27-1.18 (m, 2H), 0.98 (d, J = 6.7 Hz, 3H), 0.90 (t, J = 7.3 Hz, 
3H); 13C NMR (125 MHz, acetone-d6) δ 181.3, 171.2, 158.2, 143.7, 142.8, 141.0, 132.0 
(q, J = 32.6 Hz), 131.6, 131.3, 127.1, 127.1, 125.9, 124.4 (q, J = 272.1 Hz), 124.3, 123.9, 
123.9, 123.7, 122.1, 121.1, 118.1, 80.9, 60.3, 36.3, 35.3, 33.4, 31.2, 28.7, 25.8, 15.9, 10.9 
[note: Me groups on xanthene backbone lose their symmetry in 1H and 13C NMR]; IR 
(film) 3351, 2970, 2932, 2878, 1676, 1626, 1540, 1472, 1278 cm–1; HRMS-ESI (m/z): [M 
– H]– calcd for C35H37F6N4O4S, 723.2440; found, 723.2441. 
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tert-Butyl (S)-(1-((5-(3-(3,5-bis(trifluoromethyl)phenyl)thioureido)-9,9-dimethyl-9H-
xanthen-4-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (2.36h)  
Following the general procedure, the title compound was obtained as a white solid (137 
mg, 76%). mp 110–117 ºC; 1H NMR (500 MHz, acetone-d6) δ 10.15 (bs, 1H), 9.16 (bs, 
1H), 9.12 (bs, 1H), 8.45 (s, 2H), 7.96 (d, J = 7.9 Hz, 1H), 7.85 (d, J = 7.9 Hz, 1H), 7.73 
(s, 1H), 7.42 (d, J = 7.9 Hz 1H), 7.30 (d, J = 7.9 Hz, 1H), 7.16–7.11 (m, 2H), 6.55 (d, J = 
9.3 Hz, 1H), 4.62 (d, J = 9.3 Hz, 1H), 1.67 (s, 3H), 1.55 (s, 3H), 1.33 (s, 9H), 1.10 (s, 
9H); 13C NMR (125 MHz, acetone-d6) δ 180.2, 169.6, 157.1, 143.0, 141.7, 140.2, 130.91, 
130.87 (q, J = 33.1 Hz), 130.3, 126.0, 125.8, 125.3, 123.42, 123.39 (q, J = 271.0 Hz), 
123.1, 122.9, 121.2, 120.7, 117.0, 79.6, 62.9, 34.3, 33.6, 32.6, 29.7, 29.3, 27.6, 25.6 
[note: Me groups on xanthene backbone lose their symmetry in 1H and 13C NMR];  IR 
(film) 3248, 2973, 1684, 1625, 1532, 1506, 1472 cm–1; HRMS-ESI (m/z): [M + H]+ calcd 
for C35H39F6N4O4S, 725.2596; found, 725.2592. 
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(S)-N-(5-(3-(3,5-Bis(trifluoromethyl)phenyl)thioureido)-9,9-dimethyl-9H-xanthen-4-
yl)-3-phenyl-2-pivalamidopropanamide (2.36i)  
General Procedure 2.2 was applied to 2.32 (263 mg, 0.43 mmol).  The title compound 
was obtained as a tan solid (43 mg, 13%).  1H NMR (500 MHz, CDCl3) δ 10.11 (s, 1H), 
9.17 (s, 1H), 8.95 (s, 1H), 8.23(m, 2H), 8.09 (s, 2H), 7.64 (s, 1H), 7.30–7.09 (m, 9H), 
6.54 (d, J = 7.9 Hz, 1H), 4.90 (dt, J = 7.9, 7.9 Hz, 1H), 3.43 (dd, J = 7.9, 14.4 Hz, 1H), 
3.43 (dd, J = 7.9, 14.4 Hz, 1H), 1.64 (s, 3H), 1.63 (s, 3H), 1.06 (s, 9H); IR (film) 3335, 
2970, 1691, 1615, 1541, 1425 cm1; HRMS-ESI (m/z): [M + H]+ calcd for 
C38H37F6N4O3S, 743.2491; found, 743.2501. 
 
  
(S)-N-(1-((5-(3-(3,5-Bis(trifluoromethyl)phenyl)thioureido)-9,9-dimethyl-9H-
xanthen-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-1H-pyrrole-2-carboxamide (2.36j) 
General Procedure 2.2 was applied to 2.32 (202 mg, 0.33 mmol).  The title compound 
was obtained as a tan solid (64 mg, 26%).  mp 136–140 °C; 1H NMR (500 MHz, CDCl3) 
δ 9.88 (d, J = 7.5 Hz, 1H), 9.54 (d, J = 7.5 Hz, 1 H), 9.38 (d, J = 7.5 Hz, 1H), 9.22 (d, J = 
7.5 Hz, 1H), 8.16–8.09 (m, 2H), 8.03 (s, 2H), 7.64 (dd, J = 7.8, 59.6 Hz, 1H), 7.59 (s, 
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1H), 7.29–7.15 (m, 8H), 7.10 (td, J = 8.0, 3.1 Hz, 1H), 6.89–6.82 (m, 2H), 6.23–6.19 (m, 
1H), 5.06–5.00 (m, 1H), 3.44–3.37 (m, 1H), 3.21–3.13 (m, 1H), 1.63 (s, 3H), 1.59 (s, 
3H); IR (film) 3283, 2959, 1677, 1551, 1432 cm–1. 
 
 
Methyl (S)-(1-((5-(3-(3,5-bis(trifluoromethyl)phenyl)thioureido)-9,9-dimethyl-9H-
xanthen-4-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (2.36m)   
General Procedure 2.1 was applied to 2.97m (107 mg, 0.21 mmol).  The title compound 
was obtained as a gummy solid (74 mg, 52%). 1H NMR (500 MHz, acetone-d6) δ 10.10 
(bs, 1H), 9.15 (bs, 2H), 8.43 (s, 2H), 7.95 (d, J = 7.9 Hz, 1H), 7.78 (d, J = 7.9 Hz, 1H), 
7.73 (s, 1H), 7.44 (d, J = 7.9 Hz 1H), 7.31 (d, J = 7.9 Hz, 1H), 7.17–7.10 (m, 2H), 6.75 
(d, J = 9.3 Hz, 1H), 4.59 (d, J = 9.3 Hz, 1H), 3.62 (s, 3H), 1.67 (s, 3H), 1.56 (s, 3H), 1.10 
(s, 9H); 13C NMR (125 MHz, acetone-d6) δ 180.6, 169.4, 158.2, 143.3, 141.8, 140.2, 
130.9, 130.8 (q, J = 33.8 Hz), 130.3, 126.0, 125.72, 125.67, 123.6, 123.4 (q, J = 270.5 
Hz), 123.3, 123.1, 122.7, 121.3, 120.8, 117.1 63.5, 51.9, 34.2, 33.7, 32.5, 30.0, 25.8 
[note: Me-groups on xanthene backbone lose their symmetry in 1H and 13C NMR]; IR 
(film) 3250, 2970, 1690, 1690, 1540, 1450, 1420 cm–1;  HRMS-ESI (m/z): [M + H]+ 
calcd for C32H33F6N4O4S, 683.2127; found, 683.2122. 
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Benzyl (S)-(1-((5-(3-(3,5-bis(trifluoromethyl)phenyl)thioureido)-9,9-dimethyl-9H-
xanthen-4-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (2.36n) 
General Procedure 2.2 was applied to 2.32 (76 mg, 0.13 mmol).  The title compound 
was obtained as a gummy white solid (66 mg, 67%). 1H NMR (500 MHz, DMF-d7) δ 
10.45 (bs, 1H), 10.19 (bs, 1H), 9.52 (bs, 1H), 8.50 (s, 2H), 8.05 (d, J = 7.8 Hz, 1H), 7.85 
(s, 1H), 7.79 (d, J = 7.8 Hz 1H), 7.50 (d, J = 7.8 Hz 2H), 7.39–7.27 (m, 6H), 7.21 (dd, J = 
7.8, 7.8 Hz, 1H), 7.17 (dd, J = 7.8, 7.8 Hz, 1H), 5.12 (d, J = 13.0 Hz 1H), 5.06 (d, J = 
13.0 Hz 1H), 4.47 (d, J = 9.0 Hz, 1H), 1.68 (s, 3H) 1.65 (s, 3H), 1.07 (s, 9H); 13C NMR 
(125 MHz, DMF-d7) δ 180.8, 170.0, 157.2, 143.2, 142.3, 140.2, 137.3, 131.0, 130.7 (q, J 
= 32.5 Hz), 130.4, 128.4, 127.8, 127.7, 126.5, 126.1, 125.3, 123.8, 123.7 (q, J = 270.0 
Hz), 123.5, 123.2, 123.0, 121.5, 120.5, 117.1, 66.2, 63.8, 34.4, 34.1, 32.2, 31.4, 26.2 
[note: Me-groups on xanthene backbone lose their symmetry in 1H and 13C NMR];  IR 
(film) 3413, 2973, 1685, 1637, 1540, 1472 cm–1; HRMS-ESI (m/z): [M + H]+ calcd for 
C38H37F6N4O4S, 759.2440; found, 759.2436. 
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 tert-Butyl (S)-(1-((5-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)-9,9-dimethyl-9H-
xanthen-4-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate (2.37c) 
General Procedure 2.2 was applied to 2.33 (554 mg, 0.93 mmol).  The title compound 
was obtained as a tan solid (472 mg, 73%). mp 210–214 °C; 1H NMR (500 MHz, 
acetone-d6) δ 9.24 (bs, 1H), 9.22 (bs, 1H), 8.21 (s, 1H), 8.17 (s, 2H), 8.11 (d, J = 7.5 Hz, 
1H), 8.04 (d, J = 7.5 Hz, 1H), 7.61 (bs, 1H), 7.32 (dd, J = 7.9, 1.4 Hz, 1H), 7.25 (dd, J = 
7.9, 1.4 Hz, 1H), 7.16–7.14 (m, 3H), 4.46 (dd, J = 9.4, 9.4 Hz, 1H), 2.34–2.29 (m, 1H), 
1.67 (s, 3H), 1.60 (s, 3H), 1.14 (s, 9H), 1.12 (d, J = 6.7 Hz, 3H), 1.05 (d, J = 6.7 Hz, 3H); 
13C NMR (125 MHz, acetone-d6) δ 169.8, 158.1, 152.2, 142.2, 140.2, 139.3, 131.8 (q, J = 
33.0 Hz), 130.5, 130.1, 126.8, 126.1, 123.6 (q, J = 272.0 Hz), 123.4, 123.2, 121.4, 120.3, 
119.9, 118.7, 117.5, 114.6 (septet, J = 3.8 Hz), 80.5, 34.3, 31.9, 30.8, 27.7, 19.0, 18.2; IR 
(film) 3321, 3119, 2975, 1668, 1627, 1555, 1420 cm–1; HRMS-ESI (m/z): [M + Na]+ 
calcd for C34H36F6N4O5Na, 717.2488; found, 717.2475. 
 
General Procedure 2.4 for Morpholine Formation  
To a 20-mL borosilicate glass scintillation vial was added 2.29 (1 equiv) and CH2Cl2 
(0.5 M).  TFA (0.5 M) was added and the reaction mixture was stirred at rt for 4 h.  At 
this point, the mixture was diluted with EtOAc and saturated Na2CO3 (aq) was added.  
The layers were separated and the aqueous layer was extracted with EtOAc (x 2).  The 
O
NH HN
N
OO
BocHN H
CF3
CF3
  
  
132 
organic layers were combined, dried with Na2SO4, and concentrated.  To this residue was 
added MeCN (0.2 M), Na2CO3 (4 equiv), and bis(2-bromoethyl) ether (4 equiv).  The 
reaction mixture was stirred at 80 ºC for 48 h at which point it was concentrated to give 
an oil. The residue was chromatographed (5:95 to 10:90 MeOH:CH2Cl2) to give the 
desired product. 
 
  
(2S,2'S)-N,N'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(2-morpholinopropanamide) 
(2.31a) 
General Procedure 2.4 was applied to 2.29a (76.6 mg, 0.17 mmol).  The title compound 
was obtained as a yellow oil (8.0 mg, 9%).  1H NMR (500 MHz, acetone-d6) δ 9.21 (bs, 
2H), 7.87 (m, 2H), 7.33 (d, J = 7.8 Hz, 2H), 7.15 (dd, J = 7.8, 7.8 Hz, 2H), 3.68 (m, 8H), 
3.41 (q, J = 6.7 Hz, 2H), 2.70–2.58 (m, 8H), 1.63 (s, 6H), 1.34 (d, J = 7.5 Hz, 6H). 
 
General Procedure 2.5 for Sulfonamide Formation 
To a stirring solution of xanthene amine (1 equiv), pyridine (1.2 equiv), and CH2Cl2 
(0.2 M) was added sulfonyl chloride (1.1 equiv) at 0 ºC.  The reaction mixture was stirred 
overnight at rt.  At this point, saturated NH4Cl (aq) was added, and the reaction mixture 
was extracted with EtOAc (x 3).  The organic layers were dried with NaSO4 and 
concentrated. The crude residue was chromatographed (25:75 EtOAc:hexanes) to give 
the desired product.   
 
O
NH HNO
N Me
O
NMe
O O
  
  
133 
 
N-(5-(3-(3,5-Bis(trifluoromethyl)phenyl)thioureido)-9,9-dimethyl-9H-xanthen-4-yl)-
1-((1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonamide (2.34)   
General Procedure 2.5 was applied to 2.32 (526 mg, 0.86 mmol).  The title compound 
was obtained as a white solid (328 mg, 53%). mp 101–111 ºC; 1H NMR (500 MHz, 
acetone-d6) δ 9.72 (bs, 1H), 9.46 (bs, 1H), 8.36 (s, 2H), 8.24 (s, 1H), 7.76 (s, 1H), 7.69 
(dd, J = 8.0, 1.2 Hz, 1H), 7.50 (dd, J = 8.0, 8.0 Hz, 2H), 7.42 (dd, J = 1.2, 8.0 Hz, 1H), 
7.21-7.15 (m, 2H), 4.01 (d, J = 15.0 Hz, 1H), 3.18 (d, J = 15.0 Hz, 1H), 2.42–2.27 (m, 
2H), 2.05–2.02 (m, 2H), 1.98-1.93 (m, 1H), 1.86-1.82 (m, 1H), 1.68 (s, 3H), 1.64 (s, 3H), 
1.39–1.34 (m, 1H), 0.98 (s, 3H), 0.76 (s, 3H); 13C NMR (125 MHz, acetone-d6) δ 214.6, 
181.2, 143.7, 142.0, 141.7, 131.3, 131.1, 130.9 (q, J = 33.6 Hz), 126.1, 125.4, 125.1, 
124.2, 124.1, 123.7, 123.4, 123.1 (q, J = 272.1 Hz), 122.8, 122.4, 117.5, 58.4, 49.2, 47.8, 
42.8, 42.1, 34.5, 31.6, 30.9, 26.5, 25.4, 19.1, 19.0 [note: Me groups on xanthene 
backbone lose their symmetry in 1H and 13C NMR]; IR (film) 3324, 2967, 1738, 1543, 
1473, 1383, 1278, 1178, 1135 cm–1; HRMS-ESI (m/z): [M + H]+ calcd for 
C34H34F6N3O4S2, 726.1895; found, 726.1898.  
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N,N'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(4-methylbenzenesulfonamide) (2.55)  
General Procedure 2.5 was applied to 2.27 (0.5 equiv, 38.7 mg, 0.16 mmol).  The title 
compound was obtained as an orange solid (46.5 mg, 53%). mp 165–172 ºC; 1H NMR 
(500 MHz, acetone-d6) δ 8.81 (bs, 2H), 7.70 (d, J = 8.3 Hz, 4H), 7.31 (dd, J = 8.0, 1.4 
Hz, 2H), 7.27-7.25 (m, 6H), 7.04 (dd, J = 8.0, 8.0 Hz, 2H), 2.29 (s, 6H), 1.46 (s, 6H);  13C 
NMR (125 MHz, acetone-d6) δ 143.6, 142.5, 138.3, 131.6, 130.5, 128.1, 126.0, 124.3, 
123.4, 122.1, 35.1, 32.2, 21.4; IR (film) 3260, 2964, 2924, 1480, 1331, 1163 cm–1; 
HRMS-ESI (m/z): [M + H]+ calcd for C29H29N2O5S2, 549.1518; found, 549.1515. 
 
  
1-((1R,4S)-7,7-Dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)-N-(5-((((1S,4R)-7,7-
dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methyl)sulfonamido)-9,9-dimethyl-9H-
xanthen-4-yl)methanesulfonamide (2.68)  
General Procedure 2.5 was applied to 2.27 (0.5 equiv, 233 mg, 0.97 mmol).  The title 
compound was obtained as a white solid (114 mg, 18%).  1H NMR (500 MHz, CDCl3) δ 
8.86 (bs, 2H), 7.59 (dd, J = 8.0, 1.4 Hz, 2H), 7.23 (dd, J = 8.0, 1.4 Hz, 2H), 7.12 (dd, J = 
8.0, 8.0 Hz, 2H), 3.65 (d, J = 15.2 Hz, 2H), 3.13 (d, J = 15.1 Hz, 2H), 2.52–2.45 (m, 2H), 
2.35–2.25 (m, 2H), 2.15–2.10 (m, 2H), 2.08–2.00 (m, 4H), 1.67 (s, 6H), 1.55–1.45 (s, 
4H), 1.04 (s, 6H), 0.89 (s, 6H). 
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General Procedure 2.6 for Hydrochloride Salt Formation  
To a solution of 2.29 (1 equiv) in ether (0.07 M) was added HCl (10 equiv, 2.0 M 
solution in ether).  The mixture was stirred for 3 h at rt at which point a solid precipitated.  
This solid was collected by filtration and washed with hexanes to give the desired 
product. 
 
   
(2S,2'S)-1,1'-((9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(azanediyl))bis(1-oxo-3-
phenylpropan-2-aminium) chloride (2.38b)  
General Procedure 2.6 was applied to 2.29b (50.0 mg, 0.068 mmol).  The title 
compound was obtained as a yellow solid (28.0 mg, 68%).  1H NMR (500 MHz, 
Acetone-d6) δ 7.67–7.05 (m, ~18H), 5.50 (bs, 2H), 3.69–3.30 (m, 10H), 1.58 (bs, 6H).  
 
  
 (S)-1-((5-(3-(3,5-Bis(trifluoromethyl)phenyl)ureido)-9,9-dimethyl-9H-xanthen-4-
yl)amino)-3-methyl-1-oxobutan-2-aminium chloride (2.39c)   
General Procedure 2.6 was applied to 2.37c (50.0 mg, 0.072 mmol).  The title 
compound was obtained as a yellow solid (15.5 mg, 34%).  1H NMR (500 MHz, 
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Acetone-d6) δ 11.48 (bs, 1H), 10.99 (bs, 1H), 9.85 (bs, 1H), 8.30 (s, 2H), 8.13(dd, J = 
8.0, 1.3 Hz, 1H), 8.09 (bs, 3H), 7.88 (dd, J = 8.0, 1.3 Hz, 1H), 7.55 (s, 1H), 7.38 (dd, J = 
7.9, 1.4 Hz, 1H), 7.20 (dd, J = 7.9, 1.4 Hz, 1H), 7.14–7.10 (m, 2H), 5.47 (bs, 1H), 2.68–
2.61 (m, 1H), 1.68 (s, 3H), 1.63 (s, 3H), 1.21 (d, J = 7.0 Hz, 3H), 1.12 (d, J = 7.0 Hz, 
3H). 
 
 
Di-tert-butyl 2,2'-((2,7-di-tert-butyl-9,9-dimethyl-9H-xanthene-4,5-
diyl)bis(azanediyl))(2S,2'S)-bis(3-phenylpropanoate) (2.44b)44   
To a Schlenk flask was added 2.43  (50 mg, 0.104), Pd2dba3 • CHCl3 (2.4 mg, 0.0026 
mmol), BINAP (5.0 mg, 0.0078 mmol), and NaOt-Bu (28 mg, 0.29 mmol).  Next, toluene 
(0.5 M, 0.21 mL) was added.  The mixture was stirred for 10 min before the addition of 
L-phenylalanine tert-Butyl ester (48 mg, 0.25 mmol).  The mixture was stirred at 80 ºC 
for 18 h at which point the reaction was filtered, washed with ether, and concentrated to 
give a residue. The residue was chromatographed (5:95 EtOAc:hexanes) to give the 
desired product as a yellow oil (2 mg, 3%).  The mono-coupled product was also isolated 
(25 mg, 38%).  1H NMR (500 MHz, acetone-d6) δ 7.37–7.20 (m, 14H), 6.83 (bs, 1H), 
6.81 (bs, 1H), 6.58 (bs, 1H), 6.52 (bs, 1H), 4.26–4.24 (m, 2H), 3.12–3.28 (m, 4H), 1.33–
1.23 (m, 40H). 
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General Procedure 2.7 for catalyzed Pictet-Spengler typed reactions and cyclization 
of furans into N-acyl iminium ions  
To a microwave vial was added catalyst (0.3 or 0.6 equiv) and substrate (1 equiv) as 
solution in CH2Cl2.  The solutions were concentrated and dried in vacuo for 18 h (~ 5 
torr) and backfilled with Ar.  Afterwards, the reaction mixtures were equipped with stir 
bars, solvent (0.01 M) was added, and each mixture was sonicated for 1 min.  The 
mixtures were cooled to the desired temperature.  A solution of TMSCl (2 equiv, 0.41 M 
in reaction solvent) was pre-cooled to the same temperature as the reaction mixtures.  
After 10 min of cooling, TMSCl was added to each reaction mixture. The solutions were 
then stirred for the desired amount of time.   
At this point, Et3N (5 equiv) was pre-cooled to the same temperature as the reactions.  
After 10 min of cooling, the reaction mixtures were quenched with Et3N.  They were then 
removed from the cold bath opened to the atmosphere and added into CH2Cl2 containing 
an internal standard (BHT, 0.5 equiv) and saturated NaHCO3 (aq).  The layers were 
separated and the aq layer was extracted with CH2Cl2 (x 2).  The combined organics were 
dried with MgSO4, filtered, and concentrated to give a residue.  The residue was analyzed 
by 1H NMR.  Note:  Microwave vials were washed with a KOH/i-PrOH solution, rinsed 
with water and acetone, then dried at 80 ºC overnight.  Stir bars were washed sequentially 
with aqua regia, NaHCO3, water, and acetone, then dried at 80 ºC overnight.  If 
necessary, CDCl3 was passed through a column of basic alumina to remove trace acid 
impurities. 
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4,8,9,9a-Tetrahydrofuro[3,2-g]indolizin-7(5H)-one (2.62)  
General Procedure 2.7 was applied to 2.61 without catalyst at rt for 1 h to obtain a 
racemic standard.  The title compound was obtained after preparative plate 
chromatography (50:50 EtOAc:hexanes).  CSP HPLC (Chiralpak IA, 1.0 mL/min, 90:10 
hexanes:i-PrOH, λ = 220 nm):  tR(S or R) = 10.1 min, tR(S or R) = 11.9 min.  1H NMR 
(500 MHz, CDCl3) δ 7.33 (d, J = 1.8, 1H), 6.26 (d, J = 1.8, 1H), 4.75 (t, J = 6.9, 1H), 
4.40 (dd, J = 13.2, 6.9, 1H), 2.91–2.88 (m, 1H), 2.71–2.43 (m, 5H), 1.97–1.89 (m, 1H). 
 
  
4,8,9,9a-Tetrahydrofuro[2,3-g]indolizin-7(5H)-one (2.67) 
Racemic 2.66 was created following a literature protocol.45  The title compound was 
obtained after preparative plate chromatography (50:50 EtOAc:hexanes).  SFC 
(Chiralpak OD-H, 0.5 mL/min, 7.5% i-PrOH modifier, λ = 220 nm):  tR(S or R) = 6.51 
min, tR(S or R) = 6.91 min.  1H NMR (500 MHz, CDCl3) δ 7.33 (d, J = 1.8, 1H), 6.24 (d, 
J = 1.8, 1H), 4.63 (m, 1H), 4.49 (dd, J = 13.2, 6.9, 1H), 3.02–2.96 (m, 1H), 2.85–2.41 (m, 
5H), 1.82–1.75 (m, 1H). 
 
General Procedure 2.8 for the Hydroamination of Dienes 
A solution of additive (0.50 equiv) in CH2Cl2 (50. mg/mL) was concentrated in vacuo 
for 30 min (~ 5 torr) in a 1-dram vial.  Afterwards, the vial was equipped with a stir bar.  
Then, 2.77 (1 equiv) was added as a solution in toluene (50 mg/mL).  Lastly, CF3CO2H 
O
N
O
H
O
N
O
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(0.50 equiv, 6.4 µL/mL toluene) was added.  The vials were capped with telfon tape 
reinforcing the seal and then stirred for 2 to 3 days.  At this point, EtOAc, BHT (0.5 
equiv, 36 mg/mL EtOAc) and saturated NaHCO3 (aq) were added.  The layers were 
separated and the aq layer was extracted with EtOAc (x 2).  The combined organics were 
dried with MgSO4, filtered, and concentrated.  The residue was analyzed by 1H NMR. 
 
  
4,4-Dimethyl-2-(2-methylprop-1-en-1-yl)-1-tosylpyrrolidine (2.78)  
The general procedure was applied to 2.77 and no additive was added to obtain racemic 
2.78.  The title compound was obtained after preparative plate chromatography (10:90 
EtOAc:hexanes).  CSP HPLC (Chiralpak IA, 1.0 mL/min, 95:5 hexanes:i-PrOH, λ = 254 
nm):  tR(S or R) = 11.7 min, tR(S or R) = 13.9 min.1H NMR (500 MHz, CDCl3) δ 7.67 (d, 
J = 8.1, 2H), 7.28 (d, J = 8.1, 2H), 5.02 (d, J = 8.1, 1H), 4.37 (dt, J = 8.1, 8.1, 1H), 3.24 
(d, J = 9.9, 1H), 3.12 (d, J = 9.9, 1H), 2.43 (s, 3H), 1.77 (dd, J = 12.8, 7.4, 1H) 1.69 (s, 
3H), 1.64 (s, 3H), 1.43 (dd, J = 12.8, 7.4, 1H), 1.06, (s, 3H), 0.82 (s, 3H). 
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3.  A TETRACHLORINATED BISBENZO[A]PHENAZINE AS A NEW 
MATERIAL 
3.1.  Introduction 
Phenazines are redox-active compounds containing an anthracenyl ring system with a 
pyrazine core (Figure 3.1).1  Phenazines have been found in natural products with 
cytotoxic and antibiotic activity (Figure 3.2).  Phenazines,4 and the related pyrazine 
heterocycles also have been developed as dyes,5 heavy metal detectors,6 semiconductors,7 
fluorescent probes, organic-light emitting diodes (OLEDs),8,9 and sensors (Figure 3.2).10  
Additionally, benzo[a]phenazines have been found to be acidochromic and have 
interesting photophysical properties.11,12   
 
Figure 3.1  Three different phenazine structures and associated nomenclature. 
 
 
Figure 3.2  Two examples of pyrazines in the literature. 
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There are a variety of ways in the literature to make phenazines (Scheme 3.1).  
However, the condensation reaction between a phenylenediamine and a quinone provides 
direct access to a phenazine in a single step.   
Scheme 3.1  Summary of routes to phenazines. 
 
Past Kozlowski group research, performed by Dr. Erin Podlesny focused on 
formation of axial chiral BINOL-based phenazine derivatives from the corresponding 
binaphtho-ortho-quinone (Scheme 3.2).13,14  Several axial chiral bisbenzo[a]phenazines 
can be accessed in 7 steps and 13–19% overall yield.  This sequence commences with an 
enantioselective vanadium catalyzed naphthol coupling reaction, previously described in 
the literature by Sasai and Gong.15  Trituration of the resultant binaphthol provided 99% 
ee material.  After selective oxidation to the binaphtho-ortho-quinones,13 the desired 
phenylenediamine was condensed to form the corresponding phenazine.  These exact 
axially chiral compounds have not been reported. Carbon-based homologs, 16   
bisphenazine-based helicenes,17 biaryl derivatives,18 and an axial chiral bisacridine,19 are 
closely related structures found in the literature.  The racemates were accessed by 
utilizing achiral vanadium catalyst VO(acac)2 in the naphthol-coupling step.  The in-in-
regiochemistry was verified from a crystal structure.13  
R
ON
2
N
N
H2N
X
NO2
H2N X
NO2
H2N
X
N
O
N
O HO
+ +
+ +
NO2
O
O
+
H2N
H2N
H+
strong
base
strong or 
weak acid
1.  Pd coupling
2.  [H]
3.  Pd coupling
1.  Cu coupling
2.  strong base
1. –H2O
2. [H]
  
  
146 
One of the bisbenzo[a]phenazines synthesized, the tetrachlorinated compound, was 
mechanochromic and solvatochromic.  These properties mean the compound changed 
color during mechanical stress or upon exposure to various alkane solvents. 20  More 
importantly, these color changes were reversible.  Dr. Podlesny tested the other 
derivatives for this behavior and determined the chloro groups, free phenols, 
regiochemistry and dimeric structure were all critical to these properties.  Additionally, 
1H NMR analysis revealed the phenazine remained in tact during mechanical stress.  It 
also suggested the solvatochromic behavior was from the phenazine forming a complex 
with the linear alkane utilized.  
Scheme 3.2  Synthetic route to in-in-bisbenzo[a]phenazines. 
 
These properties immediately became of interest to the Kozlowski group because of 
the novel materials properties.  Functional materials have applications the medical, 
optoelectronical and energy fields.21  These materials undergo a change in color, shape, 
or size in response to external stimuli.  Two everyday examples of such compounds are 
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leuco dyes and liquid crystals.  Leuco dyes are found in mugs that turn blue in the freezer 
and become colorless when you warm them to ambient temperature (Scheme 3.3).  Aside 
from being found in LCD-TV displays, thermochromic liquid crystals are in plastic strip 
thermometers that change colors to indicate whether or not someone has a fever (Figure 
3.3).   
Scheme 3.3  Leuco dyes as functional materials. 
 
 
 
Figure 3.3  One example of the structure of a liquid-crystalline material. 
The functional properties of this tetrachlorinated bisbenzo[a]phenazine could be 
utilized by dispersing it into polymers to make a binary material.  Its mechanochromic 
behavior may enable an optical response to external stress and could be useful in 
determining the compromised structural integrity of plastics. 22  It might also have utility 
in metal-free rewritable media.  One example of rewritable security ink is a copper 
metallocycle with different UV-active thermodynamic and kinetic polymorphs. 23  One 
form is accessible by thermal printing and erased by prolonged heating.  
To gain additional insight into the properties of this tetrachlorinated 
bisbenzo[a]phenazine Dr. Podlesny grew a crystal structure of its complex with n-
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hexane. 24   The yellow-orange crystals revealed four symmetry independent forms of 
bisphenazine (A, B, C, D) in the asymmetric unit with a network of intermolecular 
hydrogen bonds.  Each phenazine pairs with another (A and B or C and D) to encage one 
linear molecule of hexane (Figure 3.4A).  This encapsulation explains the function of 
hexanes in initiating crystallization.  Each of these dimeric units, A/B and C/D, forms 
separate layers in the space-filling diagram (Figure 3.4B).  The network of 
intermolecular O-H···Cl and O-H···N hydrogen bonds secures each layer (Figure 3.4C).  
The arrangement of O-H···Cl bonds (d = 2.70–2.88 Å; θ = 130.5–140.0°) happens 
between two symmetrically equal molecules, meaning A is hydrogen bonded to other 
molecules of A, B to B, etc.  However, the O-H···N hydrogen bonding (d = 2.03–2.37 Å; 
θ = 112.9–159.3°) takes place between two symmetrically nonequivalent molecules in the 
same layer, such that A/B or C/D pair in O-H···N non-covalent bonding. 
The weak intermolecular O-H···Cl-C interactions in this structure are uncommon. 
Only 5% of compounds containing both O-H and Cl-C groups have these intermolecular 
interactions, as determined by a literature search in the CSD (Cambridge Structural 
Database).25   Free chloride ions or those bound to metals are typically better acceptors 
than chlorines attached to carbon.26  These hydrogen bonds are weak as established by 
the long bond distances involved (>2.2 Å).25,27  
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Figure 3.4  Crystal structure of 3.2•hexane.  A) Asymmetric unit of the crystal structure 
of 3.2.  B) A/B and C/D layers in crystal structure of 3.2.  C) Network of intermolecular 
O-H···Cl and O-H···N hydrogen bonds for the A/B molecule layer. 
  
At this point Dr. Danielle Reifsnyder’s analysis of the powder X-ray diffraction 
patterns28 of this tetrachlorinated bisbenzo[a]phenazine revealed the red-orange solid 
obtained initially after rotary evaporation from a solution in methanol was amorphous 
while the yellow-orange solid obtained after exposure to n-hexane was crystalline.29,30,31  
Since other solvents also produced a similar color change as n-hexane, this analysis posed 
a new set of questions surrounding how longer linear alkane chains activate a similar 
solid state self-assembly. 
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This chapter aims to reproduce the synthesis and properties found by Dr. Podlesny 
and Dr. Reifsnyder.  It will expand upon these properties by quantifying the degree of 
color change observed when the tetrachlorinated phenazine is exposed to various solvents 
and comparing all of these solid-state structures via PXRD.  It will discuss how longer 
linear alkane chains are able incorporate into the crystal lattice of Figure 3.4A and the 
transitions associated with the disruption of this lattice using Modulated Differential 
Scanning Calorimetry (MDSC). 
3.2.  Results and Discussion 
3.2.1.  Synthesis of in-in-Bisbenzo[a]phenazine 
Initially Dr. Podlesny’s original synthesis was reproduced (Scheme 3.4).  The third 
step, MOM-deprotection, was optimized, and this change increased my overall yield of a 
three-step sequence from 16% to 38% (Table 3.1). 
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Scheme 3.4  Summary to in-in-bisbenzo[a]phenazine 3.2. 
 
Table 3.1  Optimization of MOM-deprotection. 
 
 
The color changes Dr. Podlesny observed were recreated.  When solid 
tetrachlorinated 3.2 is exposed to n-hexane it becomes a yellow solid (Y-O, Figure 
3.5C).  At this point it was also determined that exposure of 3.2 to perfluoroalkanes turns 
the solid more red (R-O, Figure 3.5A).  The mechanochromism of form Y-O was 
confirmed.  A color change is observed from yellow-orange to red-orange when the 
sample is sheared between glass slides (R-O, Figure 3.6B).  A similar R-O solid is 
obtained by concentration of 3.2 from a homogeneous solution in methanol.  This 
mechanochromism is reversible; if the sheared solid (or R-O form attained from MeOH) 
is re-exposed to alkane solvent or vapor it reverts back to the Y-O form (Figure 3.6C).  
OHHO
3.1
N
N
Cl
Cl N
N
Cl
ClOH
HO
7 steps
14%
overall
yield 3.2
OMeMOMO
OMeMOMO
3.3
OMeHO
OMeHO
3.4
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relative to an IS (0.023 mmol scale)
1.  HCl, THF, 6 h 0 ºC
2.  TsOH•H2O, CH2Cl2:MeOH (1:1), 
      24 h, 40 ºC
3. CF3CO2H, CH2Cl2, 24 h, rt
45 (messy)
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0 (48% SM)
1.   IBX
Cl
Cl
NH2
NH2
AcOH
N
N
N
N
OMe
MeOCl
Cl
Cl
Cl
3.2
Yield (%) of 3.2 (over three 
steps, 1 mmol scale)
0.023 mmol
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38
2.
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Apparently, shearing destroys the crystalline form and returns it an amorphous form, 
which is accompanied by a color change from yellow-orange to red-orange.   
 
Figure 3.5  Solvatochromism of 3.2.  A) A negative response is obtained when R-O is 
exposed to perfluoroalkanes (solid becomes more red).  B) R-O produced by 
concentration of 3.2 from MeOH.  C) A positive response occurs when R-O is exposed to 
linear alkanes (solid becomes more yellow).24 
 
Figure 3.6  Reproduction of mechanochromic properties of 3.2.  A) Solid before shearing 
(Y-O form). B) Production of R-O form by shearing. C) Reversal of R-O solid to the Y-
O solid by suspension in n-hexane. 24 
 
3.2.2.  Quantification of Color Change 
Quantification of the degree of color change was necessary for this property to be 
useful.  Attempts to measure color changes of 3.2 in ethyl acetate and THF were 
unsuccessful; a red-orange homogeneous solution was obtained regardless of the linear 
alkane added.  This color change was only observed in precipitates making it unfeasible 
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to use solution UV-Vis spectroscopy.  Diffuse reflectance UV-Vis spectroscopy was 
attempted (Table 3.2 and Figure 3.7).  In these measurements a Kubelka-Munk function 
was used to convert the reflectance data into absorption data (equation 3.1),32 and a 
higher wavelength indicates a more red solid appears.  However, the solids could not be 
ground into fine homogeneous powders needed for reproducible measurements due to the 
mechanohromism of the material.  Aside from reproducibility, we were concerned that 
the small difference in end points (Table 3.2, 7 nm after an average of three trials) was 
not sufficient to distinguish accurately between various red to yellow colored solids. 
f(R) = (1–R)2/(2R)     (3.1) 
 
 
Figure 3.7  Superimposed diffuse reflectance UV-Vis spectra (one trial). 
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Table 3.2  Diffuse reflectance UV-Vis spectroscopy (average of three trials).  
Solvent Wavelength (nm) 
cyclohexane 459 
hexanes 458 
pentane 457 
1-hexyne 457 
nonane 457 
dodecane 456 
decane 456 
3-hexyne 455 
1-butyne 453 
 
Photo-image processing was found to be more reproducible.  It requires measuring a 
digital image-based (DIB) response from the RGB-histogram in AdobePhotoshop 
(Scheme 3.5). 33,34,35  The y-axis represents the number of pixels and the x-axis represents 
the tonal range (0-255) of the specific color under analysis. 36  The units for the tonal 
range are arbitrary.  The mean green light intensity (Figure 3.8) of the images was 
studied since red combined with green produces yellow.  Samples that gave photos with 
stronger green light intensity correspond to those that appear more yellow.   
Scheme 3.5  Concept of photo-image processing. 
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Figure 3.8  RGB histogram in AdobePhotoshop focused on the green channel. 
Since photo-image processing is a recently established technique in the literature, 
much time was dedicated to optimizing this method of analysis.  Indeed, initial attempts 
at photo-image processing were unsuccessful due to variations in images caused by 
ambient light (Figure 3.9 and Table 3.3).  For example, three pictures of one 3.2•n-
nonane sample gave a green light intensity from 130.90 to 143.15 (Table 3.3, entry 5).   
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Figure 3.9  Two representative pictures of initial sample analysis.  Left: 3.2•n-nonane, 
photo taken after dark, 5 pm.  Right: 3.2•n-nonane, photo taken at 1 pm. 
Table 3.3  Summary of initial photo-image processing results.  Three pictures were taken 
of one sample.  
 
Complex Trial 1 (1 pm) Trial 2 (5 pm) Trial 3 (5 pm) 
1. 3.2•n-hexanes 120.90 124.99 123.01 
2. 3.2•1-hexyne 121.25 132.01 127.87 
3. 3.2•3-hexyne 122.10 123.31 124.65 
4. 3.2•2-butyne 101.82 120.58 124.20 
5. 3.2•n-nonane 135.02 143.15 130.90 
6. 3.2•n-pentane 117.85 125.40 121.35 
7. 3.2•n-decane 143.05 134.36 132.64 
 
Ariel Klinghoffer, a high school student undertaking research at Penn, participated in 
resolving the reproducibility issues.  To start, a light-tight box was built with controlled 
fluorescent lighting and had a well-defined camera position (Figure 3.10).  We still 
observed slight differences in images and their green light intensity (Table 3.4, entry 1, 
77 vs. 71 for 3.2 in cyclohexane).  A camera with a higher resolution (Nikon D3100) 
afforded some benefit (Table 3.4, entry 3 vs. entry 6).  We hypothesized the glare from 
liquid in the homogenous samples was responsible for the variations we were still 
observing (Table 3.4, entry 4-6).  
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Figure 3.10 Computer generated schematic of photo-image processing box.   
Table 3.4  Summary of intermediate photo-image processing results.  Two pictures were 
taken of one sample.  
 
Complex Trial 1 Trial 2 Camera 
1. 3.2 in cyclohexane 77.05 70.65 
Nikon CoolPix L4 Digital Camera 2. 3.2•n-hexane 83.34 83.39 
3. 3.2•n-decane  
4. 3.2•n-dodecane 
90.43 
96.28 
97.91 
94.35 
4. 3.2 in cyclohexane 26.01 28.30 
Nikon D3100 5. 3.2•n-hexane 56.79 55.55 
6. 3.2•n-decane 59.79 58.96 
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Figure 3.11  Representative pictures of intermediate sample analysis in light-tight box, 
3.2•n-dodecane. 
   
Analysis on the filtered and dried solid removed this point of variation (Figure 3.12).  
With a good method established, a thorough analysis could was performed (Table 3.5).  
The method was found to give excellent reproducibility between photos of the same 
sample (Table 3.5, entry 13, round 1).  
 
   
Figure 3.12  Representative pictures of final sample analysis in light tight box. Filtered, 
dried solids on glass slide.  Left: 3.2•n-hexane.  Right: 3.2•n-octance. 
Table 3.6 summarizes selected results from Table 3.5.  A variety of solvents 
produced a similar color change to that initially observed for n-hexane.  Starting from the 
R-O form, color changes from red-orange to yellow are considered a positive response.  
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Conversely, conversion of the red-orange solid to a red solid is regarded as a negative 
response.  
 
Table 3.5  Colorimetric Response of 3.2 to Various Solvents (all rounds). 
 
 
 
 
 
 
 
a Three different pictures of the same sample were analyzed to determine reproducibility 
of the photograph and analysis. 
The original R-O material color appears at a mean green light intensity of 77 (Table 
3.6, entry 4).  A negative response is obtained with perfluorinated alkanes (entry 1 and 2, 
41 and 49), while a positive response is produced when linear alkanes are used (entry 12–
Entry Reagent 
Mean green light intensity  
Average Round 1 Round 2 Round 3 
1 perfluorohexane, R 41  47 34 
2 perfluorooctane 49 47  51 
3 cyclohexane 53  53 53 
4 methanol, R-O 77 77 76  
5 2-butyne 91 91 91  
6 2-methylpentane 105  102 107 
7 carbon disulfide 107  105 109 
8 cis-2-hexene 107 106 107  
9 cis-3-hexene 109 110 107  
10 trans-2-hexene 110 103 118 108 
11 deutero-octane 111 105 119 108 
12 1-hexene 118 123 123 109 
13 n-hexane, Y-O 118 
121a 
 115 121a 
121a 
14 tridecane, Y 118  121 114 
15 n-octane 120 119  120 
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14).  Intriguingly, a strong positive response is not obtained with branched alkanes (entry 
6 versus 12).  This result, along with the fact that cyclohexane gives a negative response 
(entry 3), further demonstrates the unique function of linear alkanes.  Solids, such as 
tetracosane (C24H50), must be dissolved in cyclohexane before yielding a similar positive 
response (not shown).  Gaseous molecules (butane) afford no response.  High pressures 
may be necessary before interaction of these molecules with 3.2 can be obtained.   
Table 3.6  Summary of photo-image processing results.24  
 
a Numbers are an average of two trials. 
 
3.2.3.  Explanation and Expansion of Solvatochromic Properties using PXRD 
As previously mentioned, since other solvents also produced a similar color change as 
n-hexane, we became interested in their solid-state structure.  To further investigate these 
structures quickly a variety of powder X-ray diffraction patterns were collected.  The 
XRPD spectra reveal a similar crystalline polymorph of 3.2 is obtained regardless of the 
linear alkane (n-pentane to n-octane, n-dodecane, n-tridecane, n-pentadecane) used to 
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initiate crystallization.  This observation suggests the atoms in the solid state of all these 
complexes have a very similar spatial arrangement relative to each.    Representative 
spectra can be seen in Figure 3.13.  The formation of a crystalline material is not 
observed by PXRD when 3.2 is subjected to cyclohexane or perfluorohexane.  For all raw 
data and spectra associated with the complexes analyzed refer to Appendix E.  
 
Figure 3.13  X-ray powder diffraction of the Y-O forms 3.2•n-hexane (red) and 3.2•n-
pentadecane (black). 
3.2.4.  Single Crystal X-Ray Diffraction Analysis 
Although the crystal structure in Figure 3.4 answered our initial inquiry as to why 
linear alkanes were so important, it posed a new set of questions.  Since the pores of 3.2 
are not aligned between the different layers, it was unclear whether an alkane longer than 
the cavity would be able to thread through the misalignment or whether portion of the 
alkane chain would not be caged.  To further understand how longer alkanes can cause 
similar PXRD patterns, multiple attempts were made to grow suitable crystals for single 
3.2•n-hexane 
3.2•n-pentadecane 
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crystal X-ray diffraction analysis (Table 3.7).  This task proved to be quite difficult.  The 
disorder associated with longer alkane chains typically afforded unsuitable crystals.  
 
Table 3.7  Summary of conditions tried for growing crystals of 3.2.  
Technique Solvent + 3.2 
Solvent in outer vial OR 
Solvent layered on top  
slow vapor-diffusion 
THF n-pentane (in freezer) 
(x 4 at various concentrations) n-heptane  
 
n-octane 
(x 2 vials) n-nonane  
(x 2) n-decane 
(x 2) n-undecane  
 
n-dodecane 
ethyl acetate n-pentane-decane 
pyridine n-pentane-nonane 
i-propanol n-pentane-dodecane 
MeCN n-pentane-dodecane 
THF, n-pentane-dodecane  
(2 drops) cyclopentane 
mesitylene, n-octane  
(2 drops) n-octane 
DMSO n-octane 
slow liquid diffusion THF n-pentane-dodecane 
slow evaporation 
(fully tightened vial 
cap) 
benzene, CDCl3, n-pentane-
tridecane a (2 drops) none trifluorotoluene, n-pentane-
decane (1:1) 
CH2Cl2, naphthalene, n-tridecane 
(2 drops) 
n-tridecane benzene, n-tridecane (2 drops)  
(x 3 at various concentrations)b 
mesitylene, n-tridecane (2 drops) 
CH2Cl2, naphthalene, n-octane 
(2 drops) n-octane 
benzene, n-octane (2 drops) 
a The n-tridecane vial gave crystals with too much disorder to be solved. 
b Gave a crystal with disorder but was able to be solved. 
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However, a 3.2•n-tridecane complex was obtained that was suitable for single crystal 
X-ray analysis (refer to Appendix F for crystal structure details).   Benzene appears 
critical to the success of this crystal; along with n-tridecane it incorporates itself into the 
crystal lattice.  This crystal still had a lot of disorder associated with it; however, Dr. Pat 
Carroll, Penn’s X-Ray crystallographer, was able to model the majority.  This structure 
was found to differ from that of 3.2•n-hexane by the presence of only two symmetry 
independent molecules (A and B) in the unit cell of the crystal.  As before, these 
molecules pair together (Figure 3.14A) and now four of them have the ability to encage 
one linear tridecane.  The different hydrogen-bonding network shifts the molecular pores 
into alignment to accommodate the longer alkane chain (Figure 3.14A and B) thereby 
creating a more symmetrical unit cell.  The structure still possesses a network of 
intermolecular Cl···H-O hydrogen bonds (2.80–2.83 Å; θ = 145.2–151.2°), which occur 
between symmetrically equivalent molecules.  In contrast to the 3.2•n-hexane complex, 
O-H···O-H hydrogen bonds (d = 2.07–2.10 Å; θ = 167.2–168.6°) are observed between 
symmetrically nonequivalent molecules within the same layer.  That is, A/B and A’/B’ 
share O-H···O-H interactions.   
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Figure 3.14  Crystal structure of 3.2•tridecane. A) Phenazine molecules caging one 
tridecane.  B) Two A/B layers in crystal structure.  C) Network of intermolecular O-
H···Cl and O-H···O-H hydrogen bonding for the A/B molecular layer. 
3.2.5.  Progress Towards Quantification of the Energy Associated with a 
Crystalline to Amorphous Phase Change 
A sample of 3.2•n-hexane does not change appearance when put under high vacuum 
(5 torr) over night (15 h) and hexane is still observed by 1H NMR spectroscopy.  This 
observation indicates a strong attraction between the alkane and the bisphenazine.  A 
color change is only observed if heat is used (>150 ºC).  At this point, the sample 
gradually becomes the color of the R-O form and 1H NMR reveals a loss of hexane 
(Scheme 3.6).   
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Scheme 3.6  3.2•n-hexane before and after DSC. 
 
To study the energetics of binding of the alkane to the bisphenazine cavity, modulated 
differential scanning calorimetry (MDSC) was utilized.37   This method separates the 
reversible and irreversible transitions by using two heating rates, a modulated and an 
average one.  This non-linear heating and cooling rate allows us to separate the data into 
thermodynamic and kinetic transitions (equation 3.2).  Heat flow (dQ/dt) detected when 
heat rate, dT/dt, is zero can only be caused by a kinetic transition, f(T,t).38  With MDSC, 
the vaporization of the alkane and overlapping glass transition of 3.2 could be removed 
from the transition of interest.  Hermetically sealed aluminum pans were utilized to 
prevent mass loss during the transition.    
Modulated differential scanning calorimetry (MDSC) of this nonreversible transitions 
of the bisphenazine-hexane adduct reveals no transition until the onset of the primary one 
at 190 °C (Figure 3.15).  This result indicates the C-H···π interactions between the arene 
faces of the pores of 3.2 and n-hexane are highly stabilizing given the much lower boiling 
point of n-hexane (68 °C).  From the MDSC, the energy associated with this transition is 
~58 kcal/mol unit cell, which may be representative of the hydrogen bonds present in the 
unit cell (4 weak H-bonds = 0.5–4 kcal/mol each, 4 moderate H-bonds = 4–15 kcal/mol 
along) along with any attractive Van der Waals interactions.  Unfortunately, this energy 
3.2•n-hexane 3.2 
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is slightly overestimated due to the combustion of n-hexane at the transition temperature, 
which occurred even under a nitrogen atmosphere. 
dQ/dt = Cp(dT/dt) + f(T,t)     (3.2) 
 
 
Figure 3.15  DSC of transition associated with 3.2•n-hexane. 
In an attempt to quantify the exact stabilizing energy for one -CH2- unit, MDSC was 
performed on multiple complexes (Table 3.8).  The unprocessed DSC curves can be 
found in Appendix G.  The shape of these curves was highly dependent on the texture of 
the powdered sample.  The observation of more than one transition in many cases could 
be from the temperature gradient within the sample or from multiple processes occurring 
(decomplexation and destruction of the crystal lattice).  Unfortunately, a large amount of 
solid (10–15 mg) is needed to increase sensitivity (detection of a transition).  This 
improvement is accompanied by a decrease in resolution (from temperature gradients 
within the sample). 
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Table 3.8  Summary of DSC results of various complexes.  
3.2 • alkane Temperature (ºC) 
n-pentane 190 
n-hexane 212 
n-heptane 231 
n-nonane 208 
n-dodecane 237 
n-tridecane 190 
n-tetradecane 177 
 
Additional problems arose with pan deformation caused by vaporization and/or 
combustion of the linear alkane at the transition temperature, 190–237 ºC (Table 3.9).39  
This hypothesis was supported by black soot found in the pan in spite of the fact that 1H 
NMR revealed 3.2 was intact.  Additional MDSC experiments on linear alkanes in the 
absence of bisphenazine suggested that oxidation could be suppressed under nitrogen 
(refer to Appendix G for more detail).  MDSC experiments were undertaken of 3.2•n-
alkane under nitrogen.  However, pan deformation was still observed.  Presumably, it was 
occurring only from the expansion of the alkane vapor.  However, black soot was still 
observed (although lesser amounts) indicating combustion of the alkane was still 
occurring.    A pinhole experiment was attempted to alleviate the pressure built up during 
this transition.  The difference in energy of this transition to the previous sealed pan 
transition (74 vs. 52 J/g) indicates the mass lost from the pinhole or the pan deformation 
of the sealed pan is significant.   
With no way to prevent combustion/vaporization and no way to account for the mass 
lost or pan deformation, quantifying the exact energy associated with decomplexation of 
the linear alkanes from 3.2 was not possible at this stage.  The transitions of 3.2 
complexes with longer alkanes, such as 3.2•n-pentadecane could not be measured 
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because the transition occurred later (≥250 ºC), which overlapped with the decomposition 
temperature of 3.2 (250 ºC).  
Table 3.9  Properties of n-alkanes.  
n-alkane boiling point (° C) autoignition temp (° C) 
pentane 34 260 
hexane 68 225 
heptane 98 225 
octane 125 220 
nonane 151 205 
decane 174 210 
undecane 196 205 
dodecane 214 205 
tridecane 235 202 
tetradecane 253 235 
pentadecane 268 N/A 
3.3.  Conclusions 
In summary, photo-image processing was used to quantify the degree of color change 
of a tetrachlorinated bisbenzo[a]phenazine when exposed to different solvents.  The 
facile disruption of the crystal lattice during mechanical stress, as determined by PXRD, 
provides an explanation of the mechanochromism of this compound.  The PXRD patterns 
of a variety of 3.2•n-alkane complexes indicate a very similar crystalline polymorph 
forms despite the size of alkane chain used to initiate its assembly.   Single crystal X-ray 
analysis of two complexes, 3.2•n-hexane and 3.2•n-tridecane suggests these axial chiral 
molecules create dimeric box-like cages that enclose alkane molecules.  The crystalline 
form is held together by hydrogen bonds including weak O-H···Cl-C interactions.  As 
implied by MDSC analysis, the attractive interactions of the alkane with the arene faces 
of the phenazine appear highly stabilizing.  The reversible mechanochromic properties of 
this compound could be valuable in the design functional materials. 
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3.4.  Experimental  
General Methods.  Reactions were carried out under an atmosphere of dry argon in 
dry glassware and all solvents were distilled prior to use.  Moisture sensitive reagents 
were added via syringe.  Flash column chromatography was performed on EM Reagents 
Silica Gel 60 (230-400).  Analytical thin layer chromatography (TLC) was performed on 
EM Reagents 0.25 mm silica-gel 254-F plates.  Visualization was accomplished with UV 
light.  
1H NMR and 13C spectra were recorded on a Bruker AM-500 (500 MHz) 
spectrometer.  The purity of the product was determined by 1H NMR analysis.  
Compounds described in the literature were characterized by comparison of their spectra 
to reported data.   
 
(S)-2,2'-dimethoxy-[1,1'-binaphthalene]-7,7'-diol (3.4) 
To a solution of 3.3 (10 mg, 0.023 mmol) in CH2Cl2/MeOH  (0.6 mL) was added 
TsOH•H2O (0.88 mg, 0.0046 mmol).  The reaction mixture was stirred at 40 °C for 24 h 
before being diluted with EtOAc (1 mL) containing butylated hydroxytoluene (BHT) as 
an internal standard (1 equiv) and quenched with saturated NaHCO3 (aq).  The layers 
were separated and the aqueous layer was extracted with EtOAC (2 x 1 mL), dried with 
Na2SO4, and concentrated.  1H NMR of the crude reaction mixture was taken (100% 
OMe
OMe
HO
HO
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conversion relative to 3.3, 51% conversion relative to an internal standard, BHT).  The 
spectral data were in agreement with reported literature values.14   
 
Figure 3.16  Crude 1H NMR spectrum of compound 3.4 with BHT, EtOAc and CH2Cl2 
(500 MHz, CDCl3). 
 
Procedure for Preparation of DSC Samples: 
Differential scanning calorimetry (DSC) was performed using a TA instruments Q 
2000 calorimeter equipped with a liquid nitrogen cooling accessory.40 , 41 , 42  Tzero 
aluminum pans were used with Tzero hermetic sealable lids.  Pans were sealed under N2 
when necessary.  Modulate DSC was modulated at ± 0.318 ºC every 60 s with a ramp of 
2.00 ºC/min and a nitrogen flow rate of 25 mL/min.  One to two full cycles were 
measured (one cycle is comprised of heating to the desired temperature and cooling back 
down to the initial temperature). 
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To generate powders for DSC analysis, orange amorphous powder of 3.2 (~40 mg) 
was mixed with respective alkane (1–2 mL) to create a heterogeneous solution.  These 
solutions were sonicated for 1 min and allowed to equilibrate for 18 h.  At this point, the 
solid was removed by filtration.  Excess alkane (≥ 10 carbons) was rinsed away with 
cyclohexane.  1H NMR analysis of 3.2•n-hexane reveals that this rinsing does not alter 
the ratio of 3.2 to alkane.  Powders were dried under high vacuum (5 torr) for 1 h. 
 
Procedure for Preparation of Photo-Image Processing Samples: 
Photo-Image Processing (PIP) was performed using a Nikon CoolPix L4 Digital 
Camera.  Pictures were taken in a light-tight box equipped with a GE Fluorescent 6-Inch 
Battery Operated Closet Light 51000, which was mounted 37.0 cm above the sample.  
The camera was placed 28.5 cm above the sample.  No zoom or flash was used.    
To generate powders for analysis, orange amorphous powder of 3.2 (~40 mg) was 
mixed with alkane (1–2 mL) to create a heterogeneous solution.  These solutions were 
sonicated for 1 min and allowed to equilibrate for 18 h.  At this point, the solid was 
removed by filtration.  Excess alkane was rinsed away with cyclohexane if necessary.  
Powders were then dried under high vacuum for 1 h.   
At this point, powders were placed on a glass slide and flattened.  A picture was taken 
and analyzed using Adobe Photoshop.  An elliptical portion of the powder (912 pixels) 
was highlighted.  The mean green light intensity provided the greatest difference between 
end points and therefore was used to determine the degree of color change within these 
limits. 
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Procedure for Preparation of PXRD Samples: 
Powder XRD patterns were taken on a Rigaku Smartlab high-resolution 
diffractometer using a 2.2 kW sealed tube generator.  The X-ray source was unfiltered 
Cu-Kα radiation with a wavelength of λ=1.54056 Å.  The detector was a 1" Si point 
detector, and intensities were measured in counts per second (cps).  For transmission 
measurements, 2θ scan, all powders were mounted using 1.0 mm glass capillaries.  All 
spectra present have the background removed (except Figure H3.1).   
To prepare powders for PXRD, orange amorphous powder of 3.2 (~40 mg) was 
allowed to stand in a homogeneous solution of alkane (1–2 mL) for 18 h.  At this point, 
the solid was removed by filtration.  Excess alkane was rinsed away with cyclohexane if 
needed.  Powders were then dried under high vacuum for 1 h.   
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Appendix A:  Chapter 1 Spectroscopic Data 
 
Figure A1.1  1H NMR spectrum of compound 1.5b (500 MHz, CDCl3). 
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Figure A1.2  13C NMR spectrum of compound 1.5b (125 MHz, CDCl3). 
 
 
Figure A1.3  IR spectrum of compound 1.5b. 
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Figure A1.4  1H NMR spectrum of compound 1.5c (500 MHz, CDCl3). 
 
Figure A1.5  13C NMR spectrum of compound 1.5c (125 MHz, CDCl3). 
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Figure A1.6  IR spectrum of compound 1.5c. 
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Figure A1.7  1H NMR spectrum of compound 1.5d (500 MHz, CDCl3). 
  
Figure A1.8  13C NMR spectrum of compound 1.5d (125 MHz, CDCl3). 
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Figure A1.9  IR spectrum of compound 1.5d. 
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Figure A1.10  1H NMR spectrum of compound 1.5e (500 MHz, CDCl3). 
 
Figure A1.11  13C NMR spectrum of compound 1.5e (125 MHz, CDCl3). 
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Figure A1.12  IR spectrum of compound 1.5e. 
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Figure A1.13  1H NMR spectrum of compound 1.5f (500 MHz, CDCl3). 
 
Figure A1.14  13C NMR spectrum of compound 1.15f (125 MHz, CDCl3). 
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Figure A1.15  IR spectrum of compound 1.5f. 
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Figure A1.16  1H NMR spectrum of compound 1.5g (500 MHz, CDCl3). 
 
Figure A1.17  13C NMR spectrum of compound 1.5g (125 MHz, CDCl3). 
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Figure A1.18  IR spectrum of compound 1.5g. 
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Figure A1.19  1H NMR spectrum of compound 1.5h (500 MHz, CDCl3). 
 
Figure A1.20  13C NMR spectrum of compound 1.5h (125 MHz, CDCl3). 
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Figure A1.21  IR spectrum of compound 1.5h. 
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Figure A1.22  1H NMR spectrum of compound 1.5i (500 MHz, CDCl3). 
 
Figure A1.23  13C NMR spectrum of compound 1.5i (125 MHz, CDCl3). 
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Figure A1.24  IR spectrum of compound 1.5i. 
 
 
 
 
 
 
1.5i 
  
  
192 
 
Figure A1.25  1H NMR spectrum of compound 1.5j (500 MHz, CDCl3). 
 
Figure A1.26  13C NMR spectrum of compound 1.5j (125 MHz, CDCl3). 
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Figure A1.27  IR spectrum of compound 1.5j. 
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Figure A1.28  1H NMR spectrum of compound 1.5k (500 MHz, CDCl3). 
 
Figure A1.29  13C NMR spectrum of compound 1.5k (125 MHz, CDCl3). 
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Figure A1.30  IR spectrum of compound 1.5k. 
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Figure A1.31  1H NMR spectrum of compound 1.5l (500 MHz, CDCl3). 
 
Figure A1.32  13C NMR spectrum of compound 1.5l (125 MHz, CDCl3). 
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Figure A1.33  IR spectrum of compound 1.5l. 
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Figure A1.34  1H NMR spectrum of compound 1.5p (500 MHz, CDCl3). 
 
Figure A1.35  13C NMR spectrum of compound 1.5p (125 MHz, CDCl3). 
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Figure A1.36  IR spectrum of compound 1.5p. 
 
1.5p 
  
  
200 
 
Figure A1.37  1H NMR spectrum of compound 1.5r (500 MHz, CDCl3). 
 
Figure A1.38  13C NMR spectrum of compound 1.5r (125 MHz, CDCl3). 
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Figure A1.39  1H NMR spectrum of compound 1.9a (500 MHz, CDCl3). 
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Figure A1.40  1H NMR spectrum of compound 1.9b (500 MHz, CDCl3). 
 
Figure A1.41  1H NMR spectrum of compound 1.9c (500 MHz, CDCl3). 
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Figure A1.42  1H NMR spectrum of compound 1.9d (500 MHz, CDCl3). 
  
Figure A1.43  1H NMR spectrum of compound 1.9e (500 MHz, CDCl3). 
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Figure A1.44  13C NMR spectrum of compound 1.9e (125 MHz, CDCl3). 
 
 
Figure A1.45  IR spectrum of compound 1.9e. 
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Figure A1.46  1H NMR spectrum of compound 1.9f (500 MHz, CDCl3). 
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Figure A1.47  1H NMR spectrum of compound 1.9i (500 MHz, CDCl3). 
 
 
Figure A1.48  13C NMR spectrum of compound 1.9i (125 MHz, CDCl3). 
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Figure A1.49  IR spectrum of compound 1.9i. 
  
Figure A1.50  1H NMR spectrum of compound 1.9j (500 MHz, CDCl3). 
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Figure A1.51  13C NMR spectrum of compound 1.9j (125 MHz, CDCl3). 
 
Figure A1.52  IR spectrum of compound 1.9j. 
 
NO2
OMe
1.9j 
  
  
209 
 
 
Figure A1.53  1H NMR spectrum of compound 1.9k (500 MHz, CDCl3). 
 
 
Figure A1.54  13C NMR spectrum of compound 1.9k (125 MHz, CDCl3). 
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Figure A1.55  IR spectrum of compound 1.9k. 
 
 
Figure A1.56  1H NMR spectrum of compound 1.19a (500 MHz, CDCl3). 
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Figure A1.57  1H NMR spectrum of compound 1.19b (500 MHz, CDCl3). 
 
 
Figure A1.58  1H NMR spectrum of compound 1.19c (500 MHz, CDCl3). 
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Figure A1.59  1H NMR spectrum of compound 1.19e (500 MHz, CDCl3). 
 
 
Figure A1.60  13C NMR spectrum of compound 1.19e (125 MHz, CDCl3). 
 
MeO
OEtO2C
1.19e 
  
  
213 
 
Figure A1.61  IR spectrum of compound 1.19e. 
 
  
Figure A1.62  1H NMR spectrum of compound 1.19f (500 MHz, CDCl3). 
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Figure A1.63  13C NMR spectrum of compound 1.19f (125 MHz, CDCl3). 
 
 
Figure A1.64  IR spectrum of compound 1.19f. 
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Figure A1.65  1H NMR spectrum of compound 1.19i (500 MHz, CDCl3). 
 
Figure A1.66  1H NMR spectrum of compound 1.19j (500 MHz, CDCl3). 
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Figure A1.67  1H NMR spectrum of compound 1.19k (500 MHz, CDCl3). 
 
 
Figure A1.68  13C NMR spectrum of compound 1.19k (125 MHz, CDCl3). 
O
N
Me
EtO2C
1.19k 
  
  
217 
 
 
Figure A1.69  IR spectrum of compound 1.19k. 
 
  
Figure A1.70  1H NMR spectrum of compound 1.19q (500 MHz, CDCl3). 
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Figure A1.71  13C NMR spectrum of compound 1.19q (125 MHz, CDCl3). 
 
 
Figure A1.72  IR spectrum of compound 1.19q. 
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Figure A1.73  1H NMR spectrum of compound 1.22a (500 MHz, CDCl3). 
 
 
 
Figure A1.74  1H NMR spectrum of compound 1.22b (500 MHz, CDCl3). 
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Figure A1.75  1H NMR spectrum of compound 1.22c (500 MHz, CDCl3). 
 
 
Figure A1.76  13C NMR spectrum of compound 1.22c (125 MHz, CDCl3). 
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Figure A1.77  IR spectrum of compound 1.22c. 
 
Figure A1.78  1H NMR spectrum of compound 1.22g (500 MHz, CDCl3). 
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Figure A1.79  13C NMR spectrum of compound 1.22g (125 MHz, CDCl3). 
 
 
 
Figure A1.80  IR spectrum of compound 1.22g. 
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Figure A1.81  1H NMR spectrum of compound 1.22i (500 MHz, CDCl3). 
 
 
 
Figure A1.82  13C NMR spectrum of compound 1.22i (125 MHz, CDCl3). 
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Figure A1.83  IR spectrum of compound 1.22i. 
 
 
Figure A1.84  1H NMR spectrum of compound 1.22l (500 MHz, CDCl3). 
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Figure A1.85  13C NMR spectrum of compound 1.22l (125 MHz, CDCl3). 
 
 
Figure A1.86  IR spectrum of compound 1.22l. 
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Appendix B:  Chapter 2 Spectroscopic Data 
 
Figure B2.1  1H NMR spectrum of compound 2.3 (500 MHz, CDCl3). 
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Figure B2.2  1H NMR spectrum of compound 2.11 (500 MHz, CDCl3). 
  
Figure B2.3  13C NMR spectrum of compound 2.11 (125 MHz, CDCl3). 
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Figure B2.4  1H NMR spectrum of compound 2.12 (500 MHz, CDCl3). 
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Figure B2.5  1H NMR spectrum of compound 2.13 (500 MHz, CDCl3). 
 
  
Figure B2.6  IR spectrum of compound 2.13. 
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Figure B2.7  1H NMR spectrum of compound 2.14 (500 MHz, CDCl3). 
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Figure B2.8  1H NMR spectrum of compound 2.16 (500 MHz, CDCl3). 
 
Figure B2.9  13C NMR spectrum of compound 2.16 (125 MHz, CDCl3). 
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Figure B2.10  IR spectrum of compound 2.16. 
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Figure B2.11  1H NMR spectrum of compound 2.27 (500 MHz, CDCl3). 
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Figure B2.12  1H NMR spectrum of compound 2.53 (500 MHz, acetone-d6). 
  
Figure B2.13  13C NMR spectrum of compound 2.53 (125 MHz, acetone-d6). 
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Figure B2.14  IR spectrum of compound 2.53. 
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Figure B2.15  1H NMR spectrum of compound 2.56 (500 MHz, DMF-d6). 
  
Figure B2.16  13C NMR spectrum of compound 2.56 (125 MHz, DMF-d6). 
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Figure B2.17  IR spectrum of compound 2.56. 
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Figure B2.18  1H NMR spectrum of compound 2.97h (500 MHz, acetone-d6). 
 
   
Figure B2.19  13C NMR spectrum of compound 2.97h (125 MHz, acetone-d6). 
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Figure B2.20  IR spectrum of compound 2.97h. 
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Figure B2.21  1H NMR spectrum of compound 2.97m (500 MHz, acetone-d6). 
 
  
Figure B2.22  13C NMR spectrum of compound 2.97m (125 MHz, acetone-d6). 
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Figure B2.23  1H NMR spectrum of compound 2.29a (500 MHz, CDCl3). 
  
Figure B2.24  13C NMR spectrum of compound 2.29a (125 MHz, CDCl3). 
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Figure B2.25  1H NMR spectrum of compound 2.29b (500 MHz, acetone-d6).  
 
Figure B2.26  13C NMR spectrum of compound 2.29b (125 MHz, acetone-d6). 
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Figure B2.27  IR spectrum of compound 2.29b. 
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Figure B2.28  1H NMR spectrum of compound 2.29c (500 MHz, CDCl3). 
 
  
Figure B2.29  13C NMR spectrum of compound 2.29c (125 MHz, CDCl3). 
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Figure B2.30  IR spectrum of compound 2.29c. 
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Figure B2.31  1H NMR spectrum of compound 2.36f (500 MHz, acetone-d6). 
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Figure B2.32  1H NMR spectrum of compound 2.36g (500 MHz, acetone-d6). 
 
 
Figure B2.33  13C NMR spectrum of compound 2.36g (125 MHz, acetone-d6). 
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Figure B2.34  13C NMR spectrum of compound 2.36g (125 MHz, DMF-d7). 
 
Figure B2.35  IR spectrum of compound 2.36g. 
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Figure B2.36  1H NMR spectrum of compound 2.36h (500 MHz, acetone-d6). 
 
  
Figure B2.37  13C NMR spectrum of compound 2.36h (125 MHz, acetone-d6). 
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Figure B2.38  IR spectrum of compound 2.36h. 
 
O
NH HN SO
HNBocHN t-Bu CF3
CF3
2.36h 
  
  
251 
 
Figure B2.39  1H NMR spectrum of compound 2.36i (500 MHz, CDCl3). 
 
Figure B2.40  IR spectrum of compound 2.36i. 
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Figure B2.41  1H NMR spectrum of compound 2.36j (500 MHz, CDCl3). 
 
 
Figure B2.42  IR spectrum of compound 2.36j. 
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Figure B2.43  1H NMR spectrum of compound 2.36m (500 MHz, acetone-d6).  
 
Figure B2.44  13C NMR spectrum of compound 2.36m (125 MHz, acetone-d6). 
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Figure B2.45  IR spectrum of compound 2.36m. 
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Figure B2.46  1H NMR spectrum of compound 2.36n (500 MHz, acetone-d6). 
 
  
Figure B2.47  13C NMR spectrum of compound 2.36n (125 MHz, acetone-d6). 
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Figure B2.48  IR spectrum of compound 2.36n. 
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Figure B2.49  1H NMR spectrum of compound 2.37c (500 MHz, acetone-d6). 
 
 
Figure B2.50  13C NMR spectrum of compound 2.37c (125 MHz, acetone-d6). 
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Figure B2.51  IR spectrum of compound 2.37c. 
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Figure B2.52  1H NMR spectrum of compound 2.31a (500 MHz, acetone-d6). 
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Figure B2.53  1H NMR spectrum of compound 2.34 (500 MHz, acetone-d6). 
 
Figure B2.54  13C NMR spectrum of compound 2.34 (125 MHz, acetone-d6). 
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Figure B2.55  IR spectrum of compound 2.34. 
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Figure B2.56  1H NMR spectrum of compound 2.55 (500 MHz, acetone-d6). 
 
Figure B2.57  13C NMR spectrum of compound 2.55 (125 MHz, acetone-d6). 
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Figure B2.58  IR spectrum of compound 2.55. 
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Figure B2.59  1H NMR spectrum of compound 2.68 (500 MHz, CDCl3). 
 
 
Figure B2.60  1H NMR spectrum of compound 2.38b (500 MHz, acetone-d6). 
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Figure B2.61  1H NMR spectrum of compound 2.39b (500 MHz, acetone-d6). 
 
 
 
 
 
Figure B2.62  1H NMR spectrum of compound 2.44b (500 MHz, CDCl3). 
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Figure B2.63  1H NMR spectrum of compound 2.62 (500 MHz, CDCl3). 
 
 
Figure B2.64  1H NMR spectrum of compound 2.67 (500 MHz, CDCl3). 
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Figure B2.65  1H NMR spectrum of compound 2.78 (500 MHz, CDCl3). 
Ts
N
2.78 
  
  
268 
 
Appendix C:  Chapter 2 Raw Data from Equilibrium Measurements 
Table C2.1  Measurements for bisamide in Scheme 2.30. 
equiv δobs Δδobs Lt Lt/Δδobs St St+Lt [SL] St+Lt-[SL] 
0 10.095 0.0000 0.0000 #DIV/0! 0.0272 0.0272 0.0000 0.0272 
0.25 10.421 0.3260 0.0068 0.0209 0.0272 0.0340 0.0042 0.0298 
0.5 10.637 0.5420 0.0136 0.0251 0.0272 0.0408 0.0070 0.0338 
0.75 10.856 0.7610 0.0204 0.0268 0.0272 0.0476 0.0099 0.0377 
1 10.978 0.8830 0.0272 0.0308 0.0272 0.0544 0.0115 0.0429 
1.5 11.371 1.2760 0.0408 0.0320 0.0272 0.0680 0.0166 0.0514 
2 11.473 1.3780 0.0544 0.0395 0.0272 0.0816 0.0179 0.0637 
3 11.72 1.6250 0.0816 0.0502 0.0272 0.1088 0.0211 0.0877 
4 11.828 1.7330 0.1088 0.0628 0.0272 0.1360 0.0225 0.1135 
5 11.912 1.8170 0.1360 0.0748 0.0272 0.1632 0.0236 0.1396 
∞ 
 
2.0969 
  
0.0272 
 
0.0272 
  
Figure C2.1  Initial plot to estimate Δδobs for compound 2.29b. 
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Figure C2.2  Final plot to determine Keq for 2.29b. 
 
Table C2.2  Measurements for thiourea in Scheme 2.31. 
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Lt	  +	  St	  -­‐	  [SL]	  
equiv δobs2 δobs1 δobs3 Δδobs3 Lt Lt/Δδobs St St+Lt [SL] 
St+Lt-
[SL] 
0 10.37 10.37 9.37 0.000 0 #DIV/0! 0.02758 0.0276 0.0000 0.0276 
0.25 10.5535 10.7375 9.5101 0.1401 0.00688 0.0491 0.02758 0.0345 0.0049 0.0296 
0.5 10.7532 11.0896 9.6671 0.2971 0.01378 0.0464 0.02758 0.0414 0.0103 0.0310 
0.75 10.8261 11.2157 9.7229 0.3529 0.0206 0.0584 0.02758 0.0482 0.0123 0.0359 
1 10.9774 11.4864 9.8413 0.4713 0.0276 0.0586 0.02758 0.0552 0.0164 0.0388 
2 11.2239 11.9201 10.0371 0.6671 0.05516 0.0827 0.02758 0.0827 0.0232 0.0596 
3 11.2587 11.9878 10.0656 0.6956 0.08274 0.1189 0.02758 0.1103 0.0242 0.0861 
4 11.314 12.0857 10.1109 0.7409 0.11032 0.1489 0.02758 0.1379 0.0258 0.1121 
5 11.3046 12.0688 10.1018 0.7318 0.1379 0.1884 0.02758 0.1655 0.0254 0.1400 
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Figure C2.3  Initial plot to estimate Δδobs for 2.36h. 
 
Figure C2.4  Final plot to determine Keq for 2.36h. 
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Table C2.3  Measurements for urea in Scheme 2.31. 
equiv δobs2 δobs1 δobs3 Δδobs3 Lt Lt/Δδobs St St+Lt [SL] 
St+Lt-
[SL] 
0 9.266 9.522 9.008 0.0000 0 #DIV/0! 0.02878 0.0288 0.0000 0.0288 
0.25 9.7069 9.7438 9.2508 0.2428 0.00718 0.0296 0.02878 0.0360 0.0072 0.0287 
0.5 9.8408 10.0843 9.4223 0.4143 0.01439 0.0347 0.02878 0.0432 0.0123 0.0309 
0.75 9.942 10.336 9.551 0.5430 0.02154 0.0397 0.02878 0.0503 0.0161 0.0342 
1 10.035 10.566 9.669 0.6610 0.02878 0.0435 0.02878 0.0576 0.0196 0.0379 
1.5 9.902 10.228 9.498 0.4900 0.04317 0.0881 0.02878 0.0720 0.0146 0.0574 
2 10.18 10.934 9.858 0.8500 0.05756 0.0677 0.02878 0.0863 0.0253 0.0611 
3 10.218 11.041 9.913 0.9050 0.08634 0.0954 0.02878 0.1151 0.0269 0.0882 
4 10.234 11.084 9.934 0.9260 0.11512 0.1243 0.02878 0.1439 0.0275 0.1164 
5 10.24 11.097 9.941 0.9330 0.1439 0.1542 0.02878 0.1727 0.0277 0.1450 
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0.0272 
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Figure C2.5  Initial plot to estimate Δδobs for 2.37c. 
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Figure C2.6  Final plot to determine Keq for 2.37c. 
 
 
Table C2.4  Measurements for bisthiourea in Scheme 2.32. 
equiv δobs1 δobs2 Δδobs2 Lt Lt/Δδobs St St+Lt [SL] 
St+Lt-
[SL] 
0 10.326 9.642 0.0000 0 #DIV/0! 0.02878 0.0288 0.0000 0.0288 
0.25 10.6589 9.8482 0.2062 0.00718 0.0348 0.02878 0.0360 0.0081 0.0279 
0.5 10.8965 9.9925 0.3505 0.01439 0.0411 0.02878 0.0432 0.0138 0.0294 
0.75 11.1025 10.1181 0.4761 0.02154 0.0452 0.02878 0.0503 0.0187 0.0316 
1 11.2735 10.2216 0.5796 0.02878 0.0497 0.02878 0.0576 0.0228 0.0348 
1.5 11.4374 10.3194 0.6774 0.04317 0.0637 0.02878 0.0720 0.0266 0.0453 
2 11.475 10.3406 0.6986 0.05756 0.0824 0.02878 0.0863 0.0275 0.0589 
3 11.5193 10.3629 0.7209 0.08634 0.1198 0.02878 0.1151 0.0283 0.0868 
4 11.5389 10.3711 0.7291 0.11512 0.1579 0.02878 0.1439 0.0287 0.1152 
5 11.543 10.3723 0.7303 0.1439 0.1970 0.02878 0.1727 0.0287 0.1440 
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Figure C2.7  Initial plot to estimate Δδobs for 2.53. 
 
 
Figure C2.8  Final plot to determine Keq for 2.53. 
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Appendix D:  Chapter 2 Raw Data of Computations Performed by Rama 
Kailasham with the Assistance of Dr. Osvaldo Gutierrez 
All calculations were performed using the Gaussian 09 program.  A FineGrid 
(75,302) was employed resulting in about 7000 points per atom.  The level of theory and 
basis set used is specified in each corresponding Scheme or Table.  For Catalyst (R)-
2.36h + Int-2.91, no imaginary frequencies were found.  For Catalyst (R)-2-36h + (R,S)-
TS 1‡  and Catalyst (R)-2.36h + (S,R)-TS 1‡  one imaginary frequency was found.  For 
information on the other transition states please refer to Rama Kailasham’s dropbox file. 
Table D2.1  Catalyst (R)-2.36h + Int-2.91 .txt file from .mol file, B3LYP/6-31G(d), 
optimized.   
Sum of electronic and thermal enthalpies:  -3808.722695 a.u. 
Sum of electronic and themal Free energies:  -3808.888664 a.u. 
KAI-Reactant-Catalyst-t-butyl-CF3-B3LYP-SR 
 
Created by GaussView 5.0.8 
105108  0  0  0  0  0  0  0  0  0    0 
   -0.1723   -0.2230    0.3005 C   0  0  0  0  0  0  0  0  0  0  0  0 
    0.8687    0.1263   -0.5522 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.6779    1.2430   -0.2999 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.4002    2.0066    0.8389 C   0  0  0  0  0  0  0  0  0  0  0  0 
    0.3362    1.6779    1.7071 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.4371    0.5474    1.4301 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.2204    3.4848    0.4235 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.5808    2.8232   -0.7540 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.6934    3.3053   -1.4577 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.9875    2.8195   -2.3828 H   0  0  0  0  0  0  0  0  0  0  0  0 
    5.4367    4.3854   -0.9922 C   0  0  0  0  0  0  0  0  0  0  0  0 
    5.0875    5.0090    0.2028 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.9691    4.5751    0.9167 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.7805   -1.0975    0.0895 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.0573   -0.4784   -1.4337 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.2491    0.2897    2.0958 H   0  0  0  0  0  0  0  0  0  0  0  0 
    6.3023    4.7319   -1.5487 H   0  0  0  0  0  0  0  0  0  0  0  0 
    5.6749    5.8301    0.5924 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.1294    3.1230    1.1844 O   0  0  0  0  0  0  0  0  0  0  0  0 
    3.6146    5.1160    2.1725 N   0  0  0  0  0  0  0  0  0  0  0  0 
    3.3245    4.4258    2.8768 H   0  0  0  0  0  0  0  0  0  0  0  0 
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    3.6362    6.4192    2.5699 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.8037    7.7390    1.5206 S   0  0  0  0  0  0  0  0  0  0  0  0 
    3.4470    6.5327    3.9277 N   0  0  0  0  0  0  0  0  0  0  0  0 
    3.2122    5.6594    4.4145 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.7403    3.4096    4.8039 Cl  0  0  0  0  0  0  0  0  0  0  0  0 
   -1.1707    2.7527    3.3218 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.2092    2.3422    2.7984 O   0  0  0  0  0  0  0  0  0  0  0  0 
    2.8002    1.6140   -1.2724 C   0  0  0  0  0  0  0  0  0  0  0  0 
    0.0799    2.4835    2.8479 N   0  0  0  0  0  0  0  0  0  0  0  0 
    0.8861    2.8765    3.3410 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.7684    0.4107   -1.4229 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.5765    0.6425   -2.1237 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.2438   -0.4702   -1.8056 H   0  0  0  0  0  0  0  0  0  0  0  0 
    4.2161    0.1501   -0.4583 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.1827    1.9567   -2.6543 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.9633    2.2181   -3.3764 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.4950    2.8047   -2.5726 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.6268    1.1031   -3.0561 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.3952    7.6905    4.7256 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.4990    7.7006    5.8032 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.2487    8.7879    4.5370 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.4420    8.8003    6.6608 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.8450    6.8516    5.9650 H   0  0  0  0  0  0  0  0  0  0  0  0 
    4.1686    9.8829    5.3957 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.9684    8.7786    3.7315 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.2668    9.9060    6.4605 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.2128   10.7632    7.1204 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.3534    2.6867    6.6575 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.4519    2.9011    7.4651 O   0  0  0  0  0  0  0  0  0  0  0  0 
   -3.5148    2.0552    6.9749 O   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.3772    3.0488    5.3553 N   0  0  0  0  0  0  0  0  0  0  0  0 
   -3.1335    2.6864    4.7862 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -3.6571    1.6437    8.3401 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -3.5443    2.4940    9.0179 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.9228    0.8743    8.5943 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -4.6651    1.2346    8.4151 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.2613    3.6120    4.6009 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.4711    5.1430    4.2998 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.3505    3.5015    5.1957 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.5071    8.7764    7.8389 C   0  0  0  0  0  0  0  0  0  0  0  0 
    5.0417   11.0833    5.1434 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.1590   10.0196    8.2359 F   0  0  0  0  0  0  0  0  0  0  0  0 
    0.3689    8.1008    7.5803 F   0  0  0  0  0  0  0  0  0  0  0  0 
    2.0788    8.1771    8.9223 F   0  0  0  0  0  0  0  0  0  0  0  0 
    6.2055   10.7493    4.5443 F   0  0  0  0  0  0  0  0  0  0  0  0 
    5.3499   11.7303    6.2913 F   0  0  0  0  0  0  0  0  0  0  0  0 
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    4.4319   11.9870    4.3402 F   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.4873    5.8946    5.6451 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.5628    5.7322    6.2091 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.5918    6.9721    5.4723 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.3254    5.5736    6.2724 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.8001    5.3937    3.5625 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.8354    4.8769    2.5988 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -3.6575    5.0618    4.1585 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.9206    6.4675    3.3777 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.3043    5.6690    3.4435 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.3922    6.7544    3.3214 H   0  0  0  0  0  0  0  0  0  0  0  0 
    0.6623    5.4583    3.9134 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.2933    5.2239    2.4429 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.0581    0.4772    9.5965 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.3996   -0.5617   10.5352 C   0  0  0  0  0  0  0  0  0  0  0  0 
    0.3665   -0.6400   11.4167 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.2961   -1.1673   10.5355 H   0  0  0  0  0  0  0  0  0  0  0  0 
    0.1664   -1.2561   12.2801 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.5952    0.2752   11.1030 O   0  0  0  0  0  0  0  0  0  0  0  0 
    2.0408    4.8000    8.9403 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.1387    4.2691   11.0263 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.2161    4.2696   11.2301 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.6400    4.2174   12.0019 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.2093    3.3280    9.1089 N   0  0  0  0  0  0  0  0  0  0  0  0 
    1.4905    5.2518    7.9836 O   0  0  0  0  0  0  0  0  0  0  0  0 
    2.6694    5.4426   10.1549 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.9293    6.0826   10.6415 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.4869    6.0896    9.8248 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.7870    3.0608   10.2317 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.9776    2.0391   10.5394 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.1615    0.9461    9.9958 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.8251    1.7016    9.6015 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.8754    0.9314    8.4132 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.5800    0.3816    7.5106 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.9332    0.6835    8.5672 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.7250    2.4083    8.0581 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.2842    2.6620    7.1484 H   0  0  0  0  0  0  0  0  0  0  0  0 
    0.6822    2.6838    7.8695 H   0  0  0  0  0  0  0  0  0  0  0  0 
  1  2  4  0  0  0  0 
  1  6  4  0  0  0  0 
  1 14  1  0  0  0  0 
  2  3  4  0  0  0  0 
  2 15  1  0  0  0  0 
  3  4  4  0  0  0  0 
  3 29  1  0  0  0  0 
  4  5  4  0  0  0  0 
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  4 19  1  0  0  0  0 
  5  6  4  0  0  0  0 
  5 30  1  0  0  0  0 
  6 16  1  0  0  0  0 
  7  8  4  0  0  0  0 
  7 13  4  0  0  0  0 
  7 19  1  0  0  0  0 
  8  9  4  0  0  0  0 
  8 29  1  0  0  0  0 
  9 10  1  0  0  0  0 
  9 11  4  0  0  0  0 
 11 12  4  0  0  0  0 
 11 17  1  0  0  0  0 
 12 13  4  0  0  0  0 
 12 18  1  0  0  0  0 
 13 20  1  0  0  0  0 
 20 21  1  0  0  0  0 
 20 22  4  0  0  0  0 
 22 23  1  0  0  0  0 
 22 24  4  0  0  0  0 
 24 25  1  0  0  0  0 
 24 40  1  0  0  0  0 
 27 28  2  0  0  0  0 
 27 30  4  0  0  0  0 
 27 58  1  0  0  0  0 
 29 32  1  0  0  0  0 
 29 36  1  0  0  0  0 
 30 31  1  0  0  0  0 
 32 33  1  0  0  0  0 
 32 34  1  0  0  0  0 
 32 35  1  0  0  0  0 
 36 37  1  0  0  0  0 
 36 38  1  0  0  0  0 
 36 39  1  0  0  0  0 
 40 41  4  0  0  0  0 
 40 42  4  0  0  0  0 
 41 43  4  0  0  0  0 
 41 44  1  0  0  0  0 
 42 45  4  0  0  0  0 
 42 46  1  0  0  0  0 
 43 47  4  0  0  0  0 
 43 61  1  0  0  0  0 
 45 47  4  0  0  0  0 
 45 62  1  0  0  0  0 
 47 48  1  0  0  0  0 
 49 50  2  0  0  0  0 
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 49 51  1  0  0  0  0 
 49 52  4  0  0  0  0 
 51 54  1  0  0  0  0 
 52 53  1  0  0  0  0 
 52 58  1  0  0  0  0 
 54 55  1  0  0  0  0 
 54 56  1  0  0  0  0 
 54 57  1  0  0  0  0 
 58 59  1  0  0  0  0 
 58 60  1  0  0  0  0 
 59 69  1  0  0  0  0 
 59 73  1  0  0  0  0 
 59 77  1  0  0  0  0 
 61 63  1  0  0  0  0 
 61 64  1  0  0  0  0 
 61 65  1  0  0  0  0 
 62 66  1  0  0  0  0 
 62 67  1  0  0  0  0 
 62 68  1  0  0  0  0 
 69 70  1  0  0  0  0 
 69 71  1  0  0  0  0 
 69 72  1  0  0  0  0 
 73 74  1  0  0  0  0 
 73 75  1  0  0  0  0 
 73 76  1  0  0  0  0 
 77 78  1  0  0  0  0 
 77 79  1  0  0  0  0 
 77 80  1  0  0  0  0 
 81 82  4  0  0  0  0 
 81 98  2  0  0  0  0 
 81100  1  0  0  0  0 
 82 83  2  0  0  0  0 
 82 84  1  0  0  0  0 
 83 85  1  0  0  0  0 
 83 86  1  0  0  0  0 
 86 98  1  0  0  0  0 
 87 91  1  0  0  0  0 
 87 92  2  0  0  0  0 
 87 93  1  0  0  0  0 
 88 89  1  0  0  0  0 
 88 90  1  0  0  0  0 
 88 93  1  0  0  0  0 
 88 96  1  0  0  0  0 
 91 96  2  0  0  0  0 
 91103  1  0  0  0  0 
 93 94  1  0  0  0  0 
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 93 95  1  0  0  0  0 
 96 97  1  0  0  0  0 
 98 99  1  0  0  0  0 
100101  1  0  0  0  0 
100102  1  0  0  0  0 
100103  1  0  0  0  0 
103104  1  0  0  0  0 
103105  1  0  0  0  0 
 
Table D2.2  Catalyst (R)-2.36h + (R,S)-TS 1‡ .txt file from .mol file, B3LYP/6-31G(d), 
optimized. 
Sum of electronic and thermal enthalpies:  -3926.591928 a.u. 
Sum of  electronic and themal Free energies:  -3926.761664 a.u. 
KAI-TS1_w_Catalyst-EXTRA-t-butyl-B3LYP-RS-5 
 
Created by GaussView 5.0.8 
114117  0  0  0  0  0  0  0  0  0    0 
    0.4195    0.3239    0.0951 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.3567    0.8228   -0.8021 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.3864    1.6779   -0.3822 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.4356    2.0176    0.9718 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.4947    1.5182    1.9005 C   0  0  0  0  0  0  0  0  0  0  0  0 
    0.4870    0.6632    1.4455 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.3619    3.3872    0.6734 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.4252    3.1203   -0.6962 C   0  0  0  0  0  0  0  0  0  0  0  0 
    5.4624    3.7190   -1.4262 C   0  0  0  0  0  0  0  0  0  0  0  0 
    5.5341    3.5355   -2.4938 H   0  0  0  0  0  0  0  0  0  0  0  0 
    6.4069    4.5359   -0.8126 C   0  0  0  0  0  0  0  0  0  0  0  0 
    6.3387    4.7788    0.5579 C   0  0  0  0  0  0  0  0  0  0  0  0 
    5.3062    4.2205    1.3124 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.3676   -0.3387   -0.2527 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.2899    0.5459   -1.8495 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.2384    0.2834    2.1504 H   0  0  0  0  0  0  0  0  0  0  0  0 
    7.2080    4.9767   -1.3983 H   0  0  0  0  0  0  0  0  0  0  0  0 
    7.0776    5.3972    1.0499 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.3904    2.8615    1.4967 O   0  0  0  0  0  0  0  0  0  0  0  0 
    5.2010    4.3788    2.7118 N   0  0  0  0  0  0  0  0  0  0  0  0 
    4.9143    3.5348    3.2188 H   0  0  0  0  0  0  0  0  0  0  0  0 
    5.3976    5.4969    3.4670 C   0  0  0  0  0  0  0  0  0  0  0  0 
    5.6591    7.0510    2.8489 S   0  0  0  0  0  0  0  0  0  0  0  0 
    5.3623    5.2000    4.8083 N   0  0  0  0  0  0  0  0  0  0  0  0 
    5.3351    4.2022    5.0418 H   0  0  0  0  0  0  0  0  0  0  0  0 
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    4.6869    1.9562    4.8734 Cl  0  0  0  0  0  0  0  0  0  0  0  0 
    0.5963    1.9799    4.1601 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.5840    1.7433    3.8956 O   0  0  0  0  0  0  0  0  0  0  0  0 
    3.4030    2.2184   -1.3918 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.6216    1.8811    3.2627 N   0  0  0  0  0  0  0  0  0  0  0  0 
    2.5630    2.0852    3.6004 H   0  0  0  0  0  0  0  0  0  0  0  0 
    4.1427    1.0277   -2.0572 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.8723    1.3815   -2.7928 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.4383    0.3711   -2.5783 H   0  0  0  0  0  0  0  0  0  0  0  0 
    4.6743    0.4329   -1.3071 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.6575    3.0361   -2.4800 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.3587    3.4267   -3.2245 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.1264    3.8832   -2.0336 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.9267    2.4128   -3.0055 H   0  0  0  0  0  0  0  0  0  0  0  0 
    5.3804    6.0627    5.9206 C   0  0  0  0  0  0  0  0  0  0  0  0 
    6.0460    5.6158    7.0696 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.7028    7.2901    5.9529 C   0  0  0  0  0  0  0  0  0  0  0  0 
    6.0277    6.3854    8.2342 C   0  0  0  0  0  0  0  0  0  0  0  0 
    6.5809    4.6710    7.0490 H   0  0  0  0  0  0  0  0  0  0  0  0 
    4.7153    8.0548    7.1184 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.1666    7.6340    5.0803 H   0  0  0  0  0  0  0  0  0  0  0  0 
    5.3717    7.6142    8.2694 C   0  0  0  0  0  0  0  0  0  0  0  0 
    5.3665    8.2128    9.1718 H   0  0  0  0  0  0  0  0  0  0  0  0 
    0.7113    0.7539    7.4276 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.8987    0.6791    7.7361 O   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.3013    0.0335    7.9685 O   0  0  0  0  0  0  0  0  0  0  0  0 
    0.1972    1.6005    6.4963 N   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.7662    1.4514    6.2232 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.1010   -0.8932    9.0937 C   0  0  0  0  0  0  0  0  0  0  0  0 
    0.9951    2.4103    5.5844 C   0  0  0  0  0  0  0  0  0  0  0  0 
    0.7870    3.9505    5.8383 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.0461    2.1729    5.7649 H   0  0  0  0  0  0  0  0  0  0  0  0 
    6.6870    5.8481    9.4747 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.0378    9.3994    7.1238 C   0  0  0  0  0  0  0  0  0  0  0  0 
    7.8298    5.1848    9.1989 F   0  0  0  0  0  0  0  0  0  0  0  0 
    6.9842    6.8217   10.3606 F   0  0  0  0  0  0  0  0  0  0  0  0 
    5.8795    4.9650   10.1282 F   0  0  0  0  0  0  0  0  0  0  0  0 
    4.8864   10.3896    6.7578 F   0  0  0  0  0  0  0  0  0  0  0  0 
    3.5704    9.7226    8.3516 F   0  0  0  0  0  0  0  0  0  0  0  0 
    2.9925    9.4450    6.2692 F   0  0  0  0  0  0  0  0  0  0  0  0 
    1.3834    4.2866    7.2185 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.4635    4.0991    7.2404 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.2221    5.3455    7.4525 H   0  0  0  0  0  0  0  0  0  0  0  0 
    0.9167    3.6921    8.0109 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.7076    4.3243    5.8222 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.1779    4.0644    4.8690 H   0  0  0  0  0  0  0  0  0  0  0  0 
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   -1.2566    3.8173    6.6234 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.8201    5.4037    5.9766 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.5252    4.7679    4.7610 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.4682    5.8354    5.0031 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.5847    4.4963    4.7040 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.0852    4.6313    3.7672 H   0  0  0  0  0  0  0  0  0  0  0  0 
    5.9408   -1.7106    5.9597 C   0  0  0  0  0  0  0  0  0  0  0  0 
    5.9028   -3.1101    6.2153 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.6924   -3.3602    6.8030 C   0  0  0  0  0  0  0  0  0  0  0  0 
    6.6745   -3.8356    5.9996 H   0  0  0  0  0  0  0  0  0  0  0  0 
    4.2266   -4.2628    7.1706 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.9706   -2.2249    6.9424 O   0  0  0  0  0  0  0  0  0  0  0  0 
    6.6700    1.6996    7.7781 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.9116    0.5489    8.9776 C   0  0  0  0  0  0  0  0  0  0  0  0 
    5.0708    0.4115   10.0552 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.8591    0.3415    8.7704 H   0  0  0  0  0  0  0  0  0  0  0  0 
    6.8567    0.2707    7.7079 N   0  0  0  0  0  0  0  0  0  0  0  0 
    7.4760    2.4728    7.3245 O   0  0  0  0  0  0  0  0  0  0  0  0 
    5.3604    1.9371    8.4938 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.6647    2.3483    7.7539 H   0  0  0  0  0  0  0  0  0  0  0  0 
    5.4900    2.6752    9.2878 H   0  0  0  0  0  0  0  0  0  0  0  0 
    5.8347   -0.3981    8.2609 C   0  0  0  0  0  0  0  0  0  0  0  0 
    5.9702   -1.4305    8.5670 H   0  0  0  0  0  0  0  0  0  0  0  0 
    4.7454   -1.1923    6.4704 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.2296   -0.2635    6.2606 H   0  0  0  0  0  0  0  0  0  0  0  0 
    7.0954   -0.8739    5.5439 C   0  0  0  0  0  0  0  0  0  0  0  0 
    6.7613   -0.0114    4.9606 H   0  0  0  0  0  0  0  0  0  0  0  0 
    7.8202   -1.4480    4.9607 H   0  0  0  0  0  0  0  0  0  0  0  0 
    7.8315   -0.3449    6.8284 C   0  0  0  0  0  0  0  0  0  0  0  0 
    8.3233   -1.1683    7.3504 H   0  0  0  0  0  0  0  0  0  0  0  0 
    8.5683    0.4145    6.5654 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.5236   -1.3878    9.3712 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.5155   -2.1052   10.1982 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.1783   -0.5532    9.6419 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.9394   -1.8825    8.4875 H   0  0  0  0  0  0  0  0  0  0  0  0 
    0.4504   -0.1388   10.3080 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.4562    0.2396   10.1185 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.2017    0.7048   10.5594 H   0  0  0  0  0  0  0  0  0  0  0  0 
    0.4848   -0.8108   11.1726 H   0  0  0  0  0  0  0  0  0  0  0  0 
    0.7970   -2.0563    8.6630 C   0  0  0  0  0  0  0  0  0  0  0  0 
    0.3770   -2.5506    7.7801 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.8057   -1.7165    8.4257 H   0  0  0  0  0  0  0  0  0  0  0  0 
    0.8532   -2.7944    9.4710 H   0  0  0  0  0  0  0  0  0  0  0  0 
  1  2  4  0  0  0  0 
  1  6  4  0  0  0  0 
  1 14  1  0  0  0  0 
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  2  3  4  0  0  0  0 
  2 15  1  0  0  0  0 
  3  4  4  0  0  0  0 
  3 29  1  0  0  0  0 
  4  5  4  0  0  0  0 
  4 19  1  0  0  0  0 
  5  6  4  0  0  0  0 
  5 30  1  0  0  0  0 
  6 16  1  0  0  0  0 
  7  8  4  0  0  0  0 
  7 13  4  0  0  0  0 
  7 19  1  0  0  0  0 
  8  9  4  0  0  0  0 
  8 29  1  0  0  0  0 
  9 10  1  0  0  0  0 
  9 11  4  0  0  0  0 
 11 12  4  0  0  0  0 
 11 17  1  0  0  0  0 
 12 13  4  0  0  0  0 
 12 18  1  0  0  0  0 
 13 20  1  0  0  0  0 
 20 21  1  0  0  0  0 
 20 22  4  0  0  0  0 
 22 23  1  0  0  0  0 
 22 24  4  0  0  0  0 
 24 25  1  0  0  0  0 
 24 40  1  0  0  0  0 
 27 28  2  0  0  0  0 
 27 30  4  0  0  0  0 
 27 55  1  0  0  0  0 
 29 32  1  0  0  0  0 
 29 36  1  0  0  0  0 
 30 31  1  0  0  0  0 
 32 33  1  0  0  0  0 
 32 34  1  0  0  0  0 
 32 35  1  0  0  0  0 
 36 37  1  0  0  0  0 
 36 38  1  0  0  0  0 
 36 39  1  0  0  0  0 
 40 41  4  0  0  0  0 
 40 42  4  0  0  0  0 
 41 43  4  0  0  0  0 
 41 44  1  0  0  0  0 
 42 45  4  0  0  0  0 
 42 46  1  0  0  0  0 
 43 47  4  0  0  0  0 
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 43 58  1  0  0  0  0 
 45 47  4  0  0  0  0 
 45 59  1  0  0  0  0 
 47 48  1  0  0  0  0 
 49 50  2  0  0  0  0 
 49 51  1  0  0  0  0 
 49 52  4  0  0  0  0 
 51 54  1  0  0  0  0 
 52 53  1  0  0  0  0 
 52 55  1  0  0  0  0 
 54103  1  0  0  0  0 
 54107  1  0  0  0  0 
 54111  1  0  0  0  0 
 55 56  1  0  0  0  0 
 55 57  1  0  0  0  0 
 56 66  1  0  0  0  0 
 56 70  1  0  0  0  0 
 56 74  1  0  0  0  0 
 58 60  1  0  0  0  0 
 58 61  1  0  0  0  0 
 58 62  1  0  0  0  0 
 59 63  1  0  0  0  0 
 59 64  1  0  0  0  0 
 59 65  1  0  0  0  0 
 66 67  1  0  0  0  0 
 66 68  1  0  0  0  0 
 66 69  1  0  0  0  0 
 70 71  1  0  0  0  0 
 70 72  1  0  0  0  0 
 70 73  1  0  0  0  0 
 74 75  1  0  0  0  0 
 74 76  1  0  0  0  0 
 74 77  1  0  0  0  0 
 78 79  4  0  0  0  0 
 78 95  4  0  0  0  0 
 78 97  1  0  0  0  0 
 79 80  2  0  0  0  0 
 79 81  1  0  0  0  0 
 80 82  1  0  0  0  0 
 80 83  1  0  0  0  0 
 83 95  1  0  0  0  0 
 84 88  1  0  0  0  0 
 84 89  2  0  0  0  0 
 84 90  1  0  0  0  0 
 85 86  1  0  0  0  0 
 85 87  1  0  0  0  0 
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 85 90  1  0  0  0  0 
 85 93  1  0  0  0  0 
 88 93  4  0  0  0  0 
 88100  1  0  0  0  0 
 90 91  1  0  0  0  0 
 90 92  1  0  0  0  0 
 93 94  1  0  0  0  0 
 95 96  1  0  0  0  0 
 97 98  1  0  0  0  0 
 97 99  1  0  0  0  0 
 97100  1  0  0  0  0 
100101  1  0  0  0  0 
100102  1  0  0  0  0 
103104  1  0  0  0  0 
103105  1  0  0  0  0 
103106  1  0  0  0  0 
107108  1  0  0  0  0 
107109  1  0  0  0  0 
107110  1  0  0  0  0 
111112  1  0  0  0  0 
111113  1  0  0  0  0 
111114  1  0  0  0  0 
 
Table D2.3  Catalyst (R)-2.36h + (S,R)-TS 1‡ .txt file from .mol file, B3LYP/6-31G(d), 
optimized. 
Sum of electronic and thermal enthalpies:  -3926.589587 a.u. 
Sum of  electronic and themal Free energies:  -3926.761649 a.u. 
KAI-TS1_w-Catalyst-EXTRA-t-butyl-B3LYP-SR-Opti-2 
 
Created by GaussView 5.0.8 
114117  0  0  0  0  0  0  0  0  0    0 
   -0.1775   -0.1684    0.6535 C   0  0  0  0  0  0  0  0  0  0  0  0 
    0.9530    0.0685   -0.1199 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.7984    1.1580    0.1360 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.4640    2.0058    1.1955 C   0  0  0  0  0  0  0  0  0  0  0  0 
    0.3136    1.7882    1.9863 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.4979    0.6850    1.7075 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.3649    3.3948    0.8276 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.7969    2.6335   -0.2613 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.9728    3.0367   -0.9102 C   0  0  0  0  0  0  0  0  0  0  0  0 
    5.3272    2.4708   -1.7661 H   0  0  0  0  0  0  0  0  0  0  0  0 
    5.7013    4.1405   -0.4776 C   0  0  0  0  0  0  0  0  0  0  0  0 
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    5.2715    4.8725    0.6267 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.0921    4.5160    1.2823 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.8143   -1.0219    0.4404 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.1857   -0.6032   -0.9402 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.3792    0.5154    2.3094 H   0  0  0  0  0  0  0  0  0  0  0  0 
    6.6156    4.4244   -0.9898 H   0  0  0  0  0  0  0  0  0  0  0  0 
    5.8422    5.7177    0.9885 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.2181    3.1084    1.5373 O   0  0  0  0  0  0  0  0  0  0  0  0 
    3.6373    5.1720    2.4471 N   0  0  0  0  0  0  0  0  0  0  0  0 
    3.2495    4.5515    3.1636 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.6205    6.5102    2.7259 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.9165    7.7208    1.5828 S   0  0  0  0  0  0  0  0  0  0  0  0 
    3.2977    6.7216    4.0448 N   0  0  0  0  0  0  0  0  0  0  0  0 
    3.1020    5.8616    4.5708 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.4681    3.8006    5.2555 Cl  0  0  0  0  0  0  0  0  0  0  0  0 
   -1.2341    3.0140    3.4703 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.2699    2.5539    2.9876 O   0  0  0  0  0  0  0  0  0  0  0  0 
    3.0268    1.4031   -0.7443 C   0  0  0  0  0  0  0  0  0  0  0  0 
    0.0232    2.6813    3.0473 N   0  0  0  0  0  0  0  0  0  0  0  0 
    0.8149    3.1227    3.5162 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.9576    0.1629   -0.6820 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.8394    0.3044   -1.3148 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.4383   -0.7345   -1.0331 H   0  0  0  0  0  0  0  0  0  0  0  0 
    4.2972   -0.0169    0.3432 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.5677    1.6303   -2.2092 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.4279    1.7964   -2.8659 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.9100    2.5027   -2.2795 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.0228    0.7594   -2.5878 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.0398    7.8769    4.7949 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.4266    7.6559    6.0428 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.3707    9.1901    4.4306 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.1356    8.7187    6.8896 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.1741    6.6418    6.3352 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.0642   10.2436    5.2958 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.8580    9.3795    3.4856 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.4456   10.0308    6.5253 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.2130   10.8595    7.1820 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.2222    3.1882    6.7993 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.1788    3.2970    7.4402 O   0  0  0  0  0  0  0  0  0  0  0  0 
   -3.3957    2.6995    7.2683 O   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.3881    3.5654    5.5044 N   0  0  0  0  0  0  0  0  0  0  0  0 
   -3.2387    3.2688    5.0433 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -3.6056    2.3701    8.6876 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.3124    4.0210    4.6345 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.9877    4.7033    9.2227 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.7361    5.2055   10.5288 C   0  0  0  0  0  0  0  0  0  0  0  0 
  
  
286 
    1.3835    5.1156   10.7189 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.4614    5.5806   11.2369 H   0  0  0  0  0  0  0  0  0  0  0  0 
    0.7413    5.3737   11.5484 H   0  0  0  0  0  0  0  0  0  0  0  0 
    0.7683    4.5866    9.6392 O   0  0  0  0  0  0  0  0  0  0  0  0 
    3.5030    1.2184    7.3949 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.2945    1.2812    8.3943 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.0008    0.4699    9.0719 H   0  0  0  0  0  0  0  0  0  0  0  0 
    0.3867    1.8309    8.1294 H   0  0  0  0  0  0  0  0  0  0  0  0 
    3.5046    2.0273    8.5912 N   0  0  0  0  0  0  0  0  0  0  0  0 
    4.5089    0.9841    6.7769 O   0  0  0  0  0  0  0  0  0  0  0  0 
    2.0758    0.7693    7.1713 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.7358    1.2290    6.2380 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.0402   -0.3165    7.0518 H   0  0  0  0  0  0  0  0  0  0  0  0 
    2.2795    2.1576    9.1228 C   0  0  0  0  0  0  0  0  0  0  0  0 
    2.1743    2.4017   10.1754 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.7477    4.2830    8.7240 C   0  0  0  0  0  0  0  0  0  0  0  0 
    1.4117    4.1014    7.7116 H   0  0  0  0  0  0  0  0  0  0  0  0 
    4.2925    4.3525    8.6054 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.2507    4.4435    7.5169 H   0  0  0  0  0  0  0  0  0  0  0  0 
    5.1023    4.9784    8.9895 H   0  0  0  0  0  0  0  0  0  0  0  0 
    4.6307    2.8602    8.9626 C   0  0  0  0  0  0  0  0  0  0  0  0 
    4.8234    2.7624   10.0332 H   0  0  0  0  0  0  0  0  0  0  0  0 
    5.4984    2.5134    8.4007 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.5476    5.5008    4.1516 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.3873    3.9942    5.2152 H   0  0  0  0  0  0  0  0  0  0  0  0 
    1.5338    8.4385    8.2390 C   0  0  0  0  0  0  0  0  0  0  0  0 
    3.3703   11.6492    4.8483 C   0  0  0  0  0  0  0  0  0  0  0  0 
    0.7868    9.4696    8.6875 F   0  0  0  0  0  0  0  0  0  0  0  0 
    0.7393    7.3396    8.2244 F   0  0  0  0  0  0  0  0  0  0  0  0 
    2.4869    8.2095    9.1768 F   0  0  0  0  0  0  0  0  0  0  0  0 
    3.4645   12.5050    5.8909 F   0  0  0  0  0  0  0  0  0  0  0  0 
    2.4065   12.1339    4.0291 F   0  0  0  0  0  0  0  0  0  0  0  0 
    4.5331   11.7188    4.1633 F   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.5464    6.4157    5.3919 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.5993    6.3600    5.9399 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.6964    7.4581    5.0870 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.3537    6.1491    6.0817 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.8959    5.6495    3.4197 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.9530    5.0083    2.5353 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -3.7388    5.4022    4.0751 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -3.0263    6.6888    3.0963 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.4076    5.9262    3.2072 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.5159    6.9851    2.9462 H   0  0  0  0  0  0  0  0  0  0  0  0 
    0.5719    5.7959    3.6793 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -0.4112    5.3539    2.2734 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -5.0913    1.9995    8.7207 C   0  0  0  0  0  0  0  0  0  0  0  0 
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   -5.2927    1.1512    8.0584 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -5.3861    1.7229    9.7381 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -5.7075    2.8449    8.3983 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -3.3338    3.5959    9.5658 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.2792    3.8758    9.5422 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -3.9347    4.4471    9.2272 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -3.6159    3.3718   10.6006 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.7446    1.1672    9.0835 C   0  0  0  0  0  0  0  0  0  0  0  0 
   -3.0302    0.8247   10.0843 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -2.9002    0.3397    8.3830 H   0  0  0  0  0  0  0  0  0  0  0  0 
   -1.6854    1.4266    9.0958 H   0  0  0  0  0  0  0  0  0  0  0  0 
  1  2  4  0  0  0  0 
  1  6  4  0  0  0  0 
  1 14  1  0  0  0  0 
  2  3  4  0  0  0  0 
  2 15  1  0  0  0  0 
  3  4  4  0  0  0  0 
  3 29  1  0  0  0  0 
  4  5  4  0  0  0  0 
  4 19  1  0  0  0  0 
  5  6  4  0  0  0  0 
  5 30  1  0  0  0  0 
  6 16  1  0  0  0  0 
  7  8  4  0  0  0  0 
  7 13  4  0  0  0  0 
  7 19  1  0  0  0  0 
  8  9  4  0  0  0  0 
  8 29  1  0  0  0  0 
  9 10  1  0  0  0  0 
  9 11  4  0  0  0  0 
 11 12  4  0  0  0  0 
 11 17  1  0  0  0  0 
 12 13  4  0  0  0  0 
 12 18  1  0  0  0  0 
 13 20  1  0  0  0  0 
 20 21  1  0  0  0  0 
 20 22  4  0  0  0  0 
 22 23  1  0  0  0  0 
 22 24  4  0  0  0  0 
 24 25  1  0  0  0  0 
 24 40  1  0  0  0  0 
 27 28  2  0  0  0  0 
 27 30  4  0  0  0  0 
 27 55  1  0  0  0  0 
 29 32  1  0  0  0  0 
 29 36  1  0  0  0  0 
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 30 31  1  0  0  0  0 
 32 33  1  0  0  0  0 
 32 34  1  0  0  0  0 
 32 35  1  0  0  0  0 
 36 37  1  0  0  0  0 
 36 38  1  0  0  0  0 
 36 39  1  0  0  0  0 
 40 41  4  0  0  0  0 
 40 42  4  0  0  0  0 
 41 43  4  0  0  0  0 
 41 44  1  0  0  0  0 
 42 45  4  0  0  0  0 
 42 46  1  0  0  0  0 
 43 47  4  0  0  0  0 
 43 83  1  0  0  0  0 
 45 47  4  0  0  0  0 
 45 84  1  0  0  0  0 
 47 48  1  0  0  0  0 
 49 50  2  0  0  0  0 
 49 51  1  0  0  0  0 
 49 52  4  0  0  0  0 
 51 54  1  0  0  0  0 
 52 53  1  0  0  0  0 
 52 55  1  0  0  0  0 
 54103  1  0  0  0  0 
 54107  1  0  0  0  0 
 54111  1  0  0  0  0 
 55 81  1  0  0  0  0 
 55 82  1  0  0  0  0 
 56 57  4  0  0  0  0 
 56 73  4  0  0  0  0 
 56 75  1  0  0  0  0 
 57 58  2  0  0  0  0 
 57 59  1  0  0  0  0 
 58 60  1  0  0  0  0 
 58 61  1  0  0  0  0 
 61 73  1  0  0  0  0 
 62 66  1  0  0  0  0 
 62 67  2  0  0  0  0 
 62 68  1  0  0  0  0 
 63 64  1  0  0  0  0 
 63 65  1  0  0  0  0 
 63 68  1  0  0  0  0 
 63 71  1  0  0  0  0 
 66 71  4  0  0  0  0 
 66 78  1  0  0  0  0 
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 68 69  1  0  0  0  0 
 68 70  1  0  0  0  0 
 71 72  1  0  0  0  0 
 73 74  1  0  0  0  0 
 75 76  1  0  0  0  0 
 75 77  1  0  0  0  0 
 75 78  1  0  0  0  0 
 78 79  1  0  0  0  0 
 78 80  1  0  0  0  0 
 81 91  1  0  0  0  0 
 81 95  1  0  0  0  0 
 81 99  1  0  0  0  0 
 83 85  1  0  0  0  0 
 83 86  1  0  0  0  0 
 83 87  1  0  0  0  0 
 84 88  1  0  0  0  0 
 84 89  1  0  0  0  0 
 84 90  1  0  0  0  0 
 91 92  1  0  0  0  0 
 91 93  1  0  0  0  0 
 91 94  1  0  0  0  0 
 95 96  1  0  0  0  0 
 95 97  1  0  0  0  0 
 95 98  1  0  0  0  0 
 99100  1  0  0  0  0 
 99101  1  0  0  0  0 
 99102  1  0  0  0  0 
103104  1  0  0  0  0 
103105  1  0  0  0  0 
103106  1  0  0  0  0 
107108  1  0  0  0  0 
107109  1  0  0  0  0 
107110  1  0  0  0  0 
111112  1  0  0  0  0 
111113  1  0  0  0  0 
111114  1  0  0  0  0 
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Appendix E:  Chapter 2 HPLC Chromatograms for Products 2.62 
 
Figure E2.1  HPLC chromatogram for racemic 2.62. 
 
Figure E2.2  HPLC chromatogram for 2.62 after reaction in TBME using catalyst 2.37c. 
Table 2.7 
entry 5 
10% ee 
rac-2.62 
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Figure E2.3  HPLC chromatogram for 2.62 after reaction in TBME using catalyst 2.36h. 
 
 
Figure E2.4  HPLC chromatogram for 2.62 after reaction in ether using catalyst 2.36h. 
Table 2.9 
entry 5 
22% ee 
Table 2.7 
entry 6 
17% ee 
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Figure E2.5  HPLC chromatogram for 2.62 after reaction in THF using catalyst 2.36h. 
 
Figure E2.6  HPLC chromatogram for 2.62 after reaction in CPME using catalyst 2.36h. 
Table 2.9 
entry 6 
14% ee 
Table 2.9 
entry 7 
24% ee 
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Appendix F:  Chapter 3 X-Ray Structure Determination of Compound 
3.2•n-tridecane 
 
 
 
Compound 3.2, C141H84N16O8Cl16, crystallizes in the orthorhombic space group P21212 
(systematic absences h00:  h=odd and 0k0:  k=odd) with a=11.5344(7)Å, 
b=26.0993(15)Å, c=23.8255(15)Å, V=7172.4(8)Å
3
, Z=2, and dcalc=1.249 g/cm3 . X-ray 
intensity data were collected on a Bruker APEXII CCD area detector employing graphite-
monochromated Mo-Ka radiation (l=0.71073 Å) at a temperature of 100(1)K. 
Preliminary indexing was performed from a series of thirty-six 0.5° rotation frames with 
exposures of 10 seconds. A total of 3813 frames were collected with a crystal to detector 
distance of 37.5 mm, rotation widths of 0.5° and exposures of 20 seconds:  
 
scan type 2θ ω φ χ frames 
φ 24.50 7.41 41.35 28.88 681 
φ 19.50 327.79 238.81 36.30 283 
φ -23.00 315.83 12.48 28.88 588 
φ -23.00 328.34 44.17 79.39 658 
φ -28.00 256.33 24.06 34.46 715 
φ 32.00 89.94 342.59 -39.24 739 
ω 32.00 319.26 246.86 88.14 149 
N
N
Cl
Cl
OH
N
N
Cl
Cl
OH
4 +           C13H28
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 Rotation frames were integrated using SAINT,1 producing a listing of unaveraged F2 
and s(F2) values which were then passed to the SHELXTL2 program package for further 
processing and structure solution. A total of 207303 reflections were measured over the 
ranges 1.78 £ q £ 25.38°, -13 £ h £ 13, -31 £ k £ 31, -28 £ l £ 28 yielding 13149 unique 
reflections (Rint = 0.0456). The intensity data were corrected for Lorentz and polarization 
effects and for absorption using SADABS3  (minimum and maximum transmission 
0.6626, 0.7452). 
The structure was solved by direct methods (SHELXS-974). The asymmetric unit consists 
of two molecules of the title compound plus ½ of  C13H28 molecule (see Figure F3.1 for 
the atom numbering scheme).  The tridecane chain lies on a crystallographic 2-fold axis 
(at ½, ½, z).  Thus, the alkane chain interpenetrates two sets of two diphenazine 
molecules (see Figure F3.2).  One entire diphenazine molecule (C33-C64, N5-N8, O3, 
O4 and Cl5-Cl8) is disordered into two displaced fragments with refined occupancies of 
0.565 and 0.435).  The tridecane molecule also experiences a large amount of positional 
disorder; it was refined as a rigid group with isotropic thermal parameters.  There were 
several regions of disordered solvent for which a reliable disorder model could not be 
devised; the X-ray data were corrected for the presence of disordered solvent using 
SQUEEZE5.  Refinement was by full-matrix least squares based on F2 using SHELXL-
97.4.4  All reflections were used during refinement. The weighting scheme used was 
w=1/[s2(Fo2 )+ (0.0898P)2 + 70.3360P] where P = (Fo 2 + 2Fc2)/3. Non-hydrogen atoms 
were refined anisotropically and hydrogen atoms were refined using a riding model.  
Refinement converged to R1=0.1147 and wR2=0.2904 for 12778 observed reflections for 
which F > 4s(F) and R1=0.1162 and wR2=0.2913 and GOF =1.083 for all 13149 unique, 
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non-zero reflections and 1147 variables.6  The maximum D/s in the final cycle of least 
squares was 0.002 and the two most prominent peaks in the final difference Fourier were 
+0.936 and -0.628 e/Å3. 
Table F3.1 lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Table F3.2 and Table 
F3.2.  Anisotropic thermal parameters are in Table F3.4.  Table F3.5 and Table F3.6 list 
bond distances and bond angles.  Figure F3.3 shows thermal ellipsoids of iso- and 
anisotropically refined atoms. 
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Figure F3.1  Numbering scheme in the three molecules in the structure. 
 
Figure F3.2  Four associated molecules of the diphenazine plus one tridecane molecule 
(the crystallographic 2-fold is in the vertical direction). 
 
Figure F3.3  Thermal ellipsoids of iso- and anisotropically refined atoms.  
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Table F3.1  Summary of Structure Determination of  Compound 3.2. 
Empirical formula  C141H84N16O8Cl16 
Formula weight  2697.44 
Temperature  100(1) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P21212  
Cell constants:   
a  11.5344(7) Å 
b  26.0993(15) Å 
c  23.8255(15) Å 
Volume 7172.4(8) Å3 
Z 2 
Density (calculated) 1.249 Mg/m3 
Absorption coefficient 0.365 mm-1 
F(000) 2756 
Crystal size 0.38 x 0.18 x 0.04 mm3 
Theta range for data collection 1.78 to 25.38° 
Index ranges -13 £ h £ 13, -31 £ k £ 31, -28 £ l £ 28 
Reflections collected 207303 
Independent reflections 13149 [R(int) = 0.0456] 
Completeness to theta = 25.38° 99.7 %  
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Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.6626 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 13149 / 2739 / 1147 
Goodness-of-fit on F2 1.083 
Final R indices [I>2sigma(I)] R1 = 0.1147, wR2 = 0.2904 
R indices (all data) R1 = 0.1162, wR2 = 0.2913 
Absolute structure parameter 0.15(12) 
Largest diff. peak and hole 0.936 and -0.628 e.Å-3 
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Table F3.2  Refined Positional Parameters for Compound 3.2. 
 
  Atom x y z Ueq, Å2 
Cl1 0.95838(14) 0.38918(7) 0.40083(9) 0.0304(4) 
Cl2 0.73292(14) 0.45160(6) 0.37212(8) 0.0256(4) 
O1 0.0774(3) 0.24415(16) 0.45430(19) 0.0151(9) 
N1 0.7090(4) 0.23103(17) 0.42246(19) 0.0069(9) 
N2 0.5037(4) 0.28880(17) 0.4069(2) 0.0089(9) 
C1 0.1795(5) 0.2168(2) 0.4519(3) 0.0113(11) 
C2 0.1791(5) 0.1645(2) 0.4596(3) 0.0138(12) 
C3 0.2833(5) 0.1375(2) 0.4563(3) 0.0126(12) 
C4 0.3870(5) 0.1628(2) 0.4446(3) 0.0136(12) 
C5 0.4922(5) 0.1331(2) 0.4436(3) 0.0185(13) 
C6 0.5967(6) 0.1547(2) 0.4352(3) 0.0194(13) 
C7 0.6023(5) 0.2091(2) 0.4261(2) 0.0092(11) 
C8 0.7136(5) 0.2821(2) 0.4113(2) 0.0108(11) 
C9 0.8229(5) 0.3071(2) 0.4101(3) 0.0166(12) 
C10 0.8279(5) 0.3584(2) 0.3997(2) 0.0113(11) 
C11 0.7275(5) 0.3869(2) 0.3874(2) 0.0133(11) 
C12 0.6183(5) 0.3642(2) 0.3892(2) 0.0127(11) 
C13 0.6117(5) 0.3109(2) 0.4019(2) 0.0078(10) 
C14 0.5000(5) 0.2397(2) 0.4213(2) 0.0063(10) 
C15 0.3868(5) 0.2153(2) 0.4344(2) 0.0097(11) 
C16 0.2832(5) 0.2437(2) 0.4373(2) 0.0075(10) 
Cl3 0.0304(2) 0.12100(10) 0.14135(10) 0.0538(6) 
Cl4 0.1083(3) 0.06668(9) 0.25282(11) 0.0581(7) 
O2 0.3724(3) 0.31297(16) 0.51674(18) 0.0123(8) 
N3 0.1184(6) 0.2913(2) 0.2356(3) 0.0294(13) 
N4 0.1905(5) 0.2416(2) 0.3346(2) 0.0232(12) 
C17 0.2771(5) 0.3003(2) 0.4290(3) 0.0113(11) 
C18 0.3205(5) 0.3329(2) 0.4697(3) 0.0113(11) 
C19 0.3226(5) 0.3860(2) 0.4632(3) 0.0151(12) 
C20 0.2831(6) 0.4076(2) 0.4158(3) 0.0181(13) 
C21 0.2369(5) 0.3766(2) 0.3703(3) 0.0159(12) 
C22 0.1940(6) 0.3999(3) 0.3193(3) 0.0200(13) 
C23 0.1556(7) 0.3730(3) 0.2748(3) 0.0272(15) 
C24 0.1534(6) 0.3170(3) 0.2797(3) 0.0245(14) 
C25 0.1165(7) 0.2401(3) 0.2404(3) 0.0306(15) 
C26 0.0716(8) 0.2097(3) 0.1944(4) 0.0361(17) 
C27 0.0768(8) 0.1576(4) 0.1997(4) 0.0420(19) 
C28 0.1132(9) 0.1335(3) 0.2494(4) 0.0420(18) 
C29 0.1504(7) 0.1606(3) 0.2936(4) 0.0342(17) 
C30 0.1518(7) 0.2149(3) 0.2892(3) 0.0270(15) 
C31 0.1937(6) 0.2919(3) 0.3302(3) 0.0176(12) 
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C32 0.2338(5) 0.3227(2) 0.3784(3) 0.0117(11) 
Cl5 -0.0097(5) 0.3835(2) 0.0955(3) 0.0621(17) 
Cl6 0.2105(6) 0.4473(3) 0.1266(5) 0.0506(18) 
O3 0.8797(11) 0.2425(4) 0.0489(6) 0.050(4) 
N5 0.2453(11) 0.2280(4) 0.0752(7) 0.035(3) 
N6 0.4472(10) 0.2882(4) 0.0904(6) 0.025(2) 
C33 0.7758(11) 0.2165(5) 0.0527(6) 0.033(3) 
C34 0.7802(12) 0.1646(5) 0.0419(9) 0.033(3) 
C35 0.6770(11) 0.1367(5) 0.0433(8) 0.041(3) 
C36 0.5727(11) 0.1613(5) 0.0564(7) 0.034(3) 
C37 0.4662(12) 0.1334(5) 0.0577(9) 0.048(4) 
C38 0.3602(11) 0.1534(5) 0.0637(8) 0.042(4) 
C39 0.3525(12) 0.2069(4) 0.0745(7) 0.039(3) 
C40 0.2389(11) 0.2788(4) 0.0870(8) 0.030(3) 
C41 0.1306(11) 0.3030(5) 0.0861(8) 0.030(3) 
C42 0.1241(11) 0.3547(5) 0.0968(9) 0.036(3) 
C43 0.2242(12) 0.3833(5) 0.1092(9) 0.035(3) 
C44 0.3312(12) 0.3629(5) 0.1077(9) 0.030(3) 
C45 0.3389(11) 0.3097(5) 0.0931(8) 0.028(3) 
C46 0.4542(11) 0.2385(4) 0.0758(8) 0.037(3) 
C47 0.5696(11) 0.2147(4) 0.0677(6) 0.032(3) 
C48 0.6714(11) 0.2429(5) 0.0645(8) 0.035(3) 
Cl7 0.8900(9) 0.1109(3) 0.3607(4) 0.062(2) 
Cl8 0.7852(10) 0.0602(4) 0.2541(4) 0.056(2) 
O4 0.5840(14) 0.3143(5) -0.0137(5) 0.058(4) 
N7 0.8361(16) 0.2846(5) 0.2693(7) 0.037(3) 
N8 0.755(3) 0.2362(5) 0.1683(7) 0.029(4) 
C49 0.6402(15) 0.3343(5) 0.0327(5) 0.038(3) 
C50 0.6395(13) 0.3867(5) 0.0406(6) 0.040(3) 
C51 0.6851(15) 0.4063(5) 0.0913(6) 0.045(3) 
C52 0.7245(14) 0.3740(5) 0.1336(6) 0.038(3) 
C53 0.7715(16) 0.3945(6) 0.1848(7) 0.044(4) 
C54 0.8116(19) 0.3657(5) 0.2269(6) 0.040(4) 
C55 0.7943(19) 0.3114(5) 0.2245(7) 0.042(4) 
C56 0.826(3) 0.2332(5) 0.2646(9) 0.038(4) 
C57 0.858(3) 0.2027(5) 0.3107(8) 0.037(4) 
C58 0.8491(13) 0.1507(5) 0.3059(5) 0.032(3) 
C59 0.805(3) 0.1267(5) 0.2569(8) 0.043(4) 
C60 0.769(2) 0.1553(5) 0.2119(7) 0.041(3) 
C61 0.783(3) 0.2095(5) 0.2156(7) 0.031(4) 
C62 0.766(2) 0.2873(5) 0.1717(7) 0.036(3) 
C63 0.7169(14) 0.3199(5) 0.1270(5) 0.037(3) 
C64 0.6771(15) 0.3000(5) 0.0759(6) 0.036(3) 
Cl5' 0.0405(8) 0.3777(3) 0.1118(4) 0.063(2) 
Cl6' 0.2601(11) 0.4463(4) 0.1330(6) 0.066(3) 
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O3' 0.9316(13) 0.2615(6) 0.0619(7) 0.042(4) 
N5' 0.3017(15) 0.2292(6) 0.0710(11) 0.049(4) 
N6' 0.5005(14) 0.2938(5) 0.0861(8) 0.041(4) 
C33' 0.8317(15) 0.2331(7) 0.0546(10) 0.032(4) 
C34' 0.8427(16) 0.1816(6) 0.0434(9) 0.035(4) 
C35' 0.7436(16) 0.1508(7) 0.0368(13) 0.039(4) 
C36' 0.6349(15) 0.1717(6) 0.0454(9) 0.038(3) 
C37' 0.5319(15) 0.1403(6) 0.0427(9) 0.038(4) 
C38' 0.4250(16) 0.1592(6) 0.0467(11) 0.048(4) 
C39' 0.4109(14) 0.2124(6) 0.0599(11) 0.047(4) 
C40' 0.2946(15) 0.2788(6) 0.0867(11) 0.039(4) 
C41' 0.1827(15) 0.2993(6) 0.0922(12) 0.040(4) 
C42' 0.1748(13) 0.3509(6) 0.1049(11) 0.036(4) 
C43' 0.2719(14) 0.3812(6) 0.1179(11) 0.032(4) 
C44' 0.3808(15) 0.3641(6) 0.1083(16) 0.044(5) 
C45' 0.3911(14) 0.3106(6) 0.0971(12) 0.040(4) 
C46' 0.5090(13) 0.2438(6) 0.0745(10) 0.037(4) 
C47' 0.6233(14) 0.2240(6) 0.0593(10) 0.035(3) 
C48' 0.7215(14) 0.2540(6) 0.0674(10) 0.036(3) 
Cl7' 0.8509(17) 0.0920(5) 0.3594(5) 0.087(6) 
Cl8' 0.7479(13) 0.0534(4) 0.2419(6) 0.055(3) 
O4' 0.6558(14) 0.3355(5) -0.0080(5) 0.040(3) 
N7' 0.851(2) 0.2705(6) 0.2799(7) 0.050(5) 
N8' 0.741(4) 0.2371(6) 0.1793(10) 0.032(6) 
C49' 0.7008(19) 0.3458(6) 0.0440(6) 0.038(4) 
C50' 0.703(2) 0.3974(6) 0.0578(8) 0.043(4) 
C51' 0.748(2) 0.4107(6) 0.1103(7) 0.052(5) 
C52' 0.7726(19) 0.3745(6) 0.1508(7) 0.037(4) 
C53' 0.818(2) 0.3896(7) 0.2047(8) 0.045(5) 
C54' 0.839(3) 0.3572(6) 0.2469(10) 0.052(5) 
C55' 0.830(2) 0.3034(6) 0.2365(7) 0.037(4) 
C56' 0.821(5) 0.2210(7) 0.2715(12) 0.041(4) 
C57' 0.850(4) 0.1850(7) 0.3133(11) 0.041(5) 
C58' 0.819(2) 0.1346(6) 0.3057(8) 0.041(4) 
C59' 0.784(5) 0.1174(6) 0.2522(11) 0.047(6) 
C60' 0.749(3) 0.1511(6) 0.2116(9) 0.037(4) 
C61' 0.763(3) 0.2047(6) 0.2226(10) 0.033(5) 
C62' 0.770(3) 0.2863(6) 0.1867(7) 0.034(4) 
C63' 0.7645(18) 0.3216(5) 0.1383(6) 0.034(4) 
C64' 0.7237(16) 0.3076(6) 0.0852(6) 0.028(3) 
C65 0.5000 0.5000 0.2324(8) 0.164(14) 
C66 0.4982(13) 0.45144(16) 0.2682(6) 0.105(5) 
C67 0.4862(7) 0.402332(19) 0.2335(4) 0.155(9) 
C68 0.4842(12) 0.35339(16) 0.2689(4) 0.151(9) 
C69 0.4722(13) 0.30439(4) 0.2342(5) 0.188(12) 
  
  
302 
C70 0.4703(15) 0.25536(16) 0.2694(7) 0.30(2) 
C71 0.458(2) 0.20660(6) 0.2343(10) 0.29(2) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos g+2U13aa*cc*cos 
b+2U23bb*cc*cosa] 
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Table F3.3  Positional Parameters for Hydrogens in Compound 3.2. 
 
  Atom x y z Uiso, Å2 
H1 0.0233 0.2245 0.4601 0.023 
H2 0.1101 0.1474 0.4670 0.018 
H3 0.2836 0.1022 0.4618 0.017 
H5 0.4878 0.0979 0.4490 0.025 
H6 0.6638 0.1349 0.4354 0.026 
H9 0.8906 0.2886 0.4164 0.022 
H12 0.5517 0.3833 0.3823 0.017 
H2a 0.3941 0.3364 0.5371 0.018 
H19 0.3515 0.4065 0.4919 0.020 
H20 0.2854 0.4430 0.4120 0.024 
H22 0.1928 0.4355 0.3172 0.027 
H23 0.1314 0.3893 0.2421 0.036 
H26 0.0405 0.2251 0.1626 0.048 
H29 0.1746 0.1443 0.3263 0.046 
H3a 0.9314 0.2224 0.0404 0.075 
H34 0.8503 0.1486 0.0338 0.044 
H35 0.6777 0.1018 0.0356 0.055 
H37 0.4711 0.0980 0.0540 0.064 
H38 0.2941 0.1331 0.0609 0.056 
H41 0.0638 0.2843 0.0783 0.040 
H44 0.3968 0.3823 0.1156 0.039 
H4 0.5562 0.3377 -0.0323 0.087 
H50 0.6098 0.4085 0.0133 0.053 
H51 0.6889 0.4416 0.0964 0.060 
H53 0.7741 0.4299 0.1889 0.059 
H54 0.8499 0.3806 0.2571 0.054 
H57 0.8857 0.2176 0.3436 0.049 
H60 0.7373 0.1400 0.1802 0.054 
H3' 0.9882 0.2427 0.0584 0.063 
H34' 0.9161 0.1672 0.0401 0.047 
H35' 0.7511 0.1165 0.0266 0.052 
H37' 0.5408 0.1052 0.0378 0.051 
H38' 0.3608 0.1383 0.0410 0.064 
H41' 0.1169 0.2792 0.0876 0.053 
H44' 0.4448 0.3858 0.1088 0.059 
H4' 0.6557 0.3045 -0.0133 0.061 
H50' 0.6751 0.4221 0.0331 0.057 
H51' 0.7622 0.4451 0.1182 0.069 
H53' 0.8345 0.4241 0.2103 0.060 
H54' 0.8597 0.3694 0.2822 0.070 
H57' 0.8901 0.1951 0.3454 0.055 
H60' 0.7162 0.1396 0.1781 0.049 
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H65a 0.5680 0.4995 0.2084 0.218 
H65b 0.4320 0.5005 0.2084 0.218 
H66a 0.4341 0.4535 0.2945 0.140 
H66b 0.5693 0.4497 0.2899 0.140 
H67a 0.4151 0.4042 0.2119 0.206 
H67b 0.5503 0.4004 0.2073 0.206 
H68a 0.5553 0.3515 0.2906 0.200 
H68b 0.4201 0.3553 0.2951 0.200 
H69a 0.5363 0.3025 0.2079 0.250 
H69b 0.4012 0.3063 0.2125 0.250 
H70a 0.5413 0.2534 0.2911 0.402 
H70b 0.4061 0.2572 0.2957 0.402 
H71a 0.4575 0.1773 0.2586 0.439 
H71b 0.5224 0.2041 0.2088 0.439 
H71c 0.3871 0.2079 0.2134 0.439 
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Table F3.4  Refined Thermal Parameters (U's) for Compound 3.2. 
 
  Atom U11 U22 U33 U23 U13 U12 
Cl1 0.0129(7) 0.0211(8) 0.0572(11) 0.0031(8) 0.0040(8) -0.0098(7) 
Cl2 0.0154(7) 0.0113(7) 0.0501(10) 0.0046(7) 0.0073(7) -0.0048(6) 
O1 0.0063(17) 0.0163(19) 0.023(2) 0.0002(16) -0.0012(16) 0.0001(15) 
N1 0.0023(15) 0.0077(15) 0.0107(16) 0.0009(13) 0.0010(13) 0.0015(13) 
N2 0.0071(15) 0.0083(15) 0.0113(16) 0.0012(13) 0.0008(14) -0.0006(13) 
C1 0.0074(17) 0.0119(17) 0.0145(18) -0.0005(15) 0.0011(15) 0.0015(14) 
C2 0.0135(18) 0.0137(18) 0.0144(18) -0.0008(15) 0.0037(15) -0.0008(15) 
C3 0.0117(18) 0.0099(17) 0.0163(18) -0.0015(15) -0.0004(15) -0.0006(14) 
C4 0.0128(17) 0.0125(18) 0.0156(18) -0.0019(15) -0.0023(15) -0.0005(15) 
C5 0.0174(19) 0.0155(19) 0.023(2) 0.0021(16) -0.0008(16) -0.0017(15) 
C6 0.0177(19) 0.0168(19) 0.024(2) 0.0022(16) -0.0010(16) -0.0002(15) 
C7 0.0071(17) 0.0085(17) 0.0119(17) -0.0014(14) 0.0014(15) 0.0002(14) 
C8 0.0085(17) 0.0107(17) 0.0132(18) -0.0009(15) 0.0018(15) 0.0004(14) 
C9 0.0161(18) 0.0158(18) 0.0177(19) -0.0004(15) -0.0010(16) -0.0012(15) 
C10 0.0086(17) 0.0129(17) 0.0123(18) -0.0003(15) 0.0024(15) -0.0030(14) 
C11 0.0123(17) 0.0121(17) 0.0154(18) -0.0002(15) 0.0009(15) -0.0035(15) 
C12 0.0098(17) 0.0139(17) 0.0144(18) 0.0019(15) 0.0035(15) -0.0003(14) 
C13 0.0070(16) 0.0082(16) 0.0082(17) 0.0003(14) -0.0017(14) 0.0003(14) 
C14 0.0053(16) 0.0069(16) 0.0068(17) -0.0017(14) 0.0012(14) 0.0023(14) 
C15 0.0078(17) 0.0093(17) 0.0121(17) -0.0017(14) 0.0011(15) -0.0014(14) 
C16 0.0064(16) 0.0078(16) 0.0085(17) 0.0005(14) -0.0012(14) 0.0010(14) 
Cl3 0.0634(15) 0.0607(14) 0.0375(11) -0.0120(10) -0.0110(11) -0.0053(12) 
Cl4 0.0888(18) 0.0344(11) 0.0509(13) -0.0095(10) -0.0192(13) -0.0109(12) 
O2 0.0021(17) 0.0117(18) 0.0231(19) -0.0028(15) -0.0026(15) -0.0002(15) 
N3 0.029(2) 0.0317(19) 0.0274(19) 0.0015(15) -0.0028(16) -0.0012(16) 
N4 0.0228(19) 0.0231(18) 0.0237(18) -0.0005(15) -0.0040(15) -0.0017(15) 
C17 0.0081(17) 0.0116(17) 0.0143(17) -0.0006(14) -0.0012(15) 0.0017(14) 
C18 0.0069(17) 0.0114(17) 0.0157(18) 0.0005(14) 0.0003(15) 0.0010(15) 
C19 0.0117(18) 0.0148(18) 0.0187(18) -0.0024(15) 0.0028(15) -0.0019(15) 
C20 0.0154(19) 0.0160(18) 0.0229(19) 0.0015(15) 0.0017(16) -0.0001(15) 
C21 0.0126(18) 0.0163(18) 0.0186(18) 0.0024(15) 0.0020(15) -0.0015(15) 
C22 0.018(2) 0.0185(19) 0.0235(19) 0.0039(15) 0.0041(16) 0.0004(16) 
C23 0.028(2) 0.027(2) 0.027(2) 0.0028(16) -0.0013(16) -0.0005(16) 
C24 0.023(2) 0.026(2) 0.024(2) 0.0018(16) -0.0015(16) -0.0013(16) 
C25 0.031(2) 0.031(2) 0.029(2) 0.0005(16) -0.0017(17) 0.0002(17) 
C26 0.035(2) 0.038(2) 0.035(2) 0.0001(17) -0.0034(17) 0.0007(17) 
C27 0.043(2) 0.042(2) 0.041(2) -0.0011(17) -0.0028(17) -0.0009(17) 
C28 0.045(2) 0.040(2) 0.041(2) -0.0008(17) -0.0028(17) -0.0017(18) 
C29 0.036(2) 0.032(2) 0.034(2) 0.0016(16) -0.0013(17) -0.0013(17) 
C30 0.026(2) 0.028(2) 0.027(2) 0.0002(16) -0.0015(16) -0.0019(16) 
C31 0.0147(19) 0.0197(18) 0.0184(18) 0.0015(15) -0.0025(15) 0.0013(15) 
C32 0.0084(17) 0.0128(17) 0.0139(17) 0.0019(14) 0.0005(15) -0.0013(15) 
Cl5 0.021(3) 0.063(3) 0.102(5) -0.013(3) 0.010(3) 0.005(2) 
Cl6 0.043(4) 0.039(3) 0.069(4) -0.016(2) 0.016(4) 0.008(3) 
O3 0.036(7) 0.026(6) 0.087(10) 0.023(7) 0.015(8) 0.011(5) 
N5 0.026(6) 0.028(5) 0.052(7) 0.006(5) 0.009(7) -0.004(5) 
N6 0.025(3) 0.026(3) 0.025(3) 0.0013(18) -0.0003(19) 0.0010(18) 
C33 0.033(6) 0.029(5) 0.036(7) 0.018(6) -0.002(6) 0.017(5) 
C34 0.023(6) 0.037(6) 0.039(8) -0.008(8) -0.013(8) 0.017(5) 
C35 0.022(6) 0.044(7) 0.057(9) -0.002(7) -0.004(7) 0.016(5) 
C36 0.020(5) 0.041(6) 0.040(8) -0.012(7) -0.002(6) 0.017(5) 
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C37 0.030(6) 0.035(7) 0.080(11) -0.009(8) 0.004(8) 0.008(5) 
C38 0.014(6) 0.036(6) 0.077(11) 0.016(7) -0.003(7) -0.001(5) 
C39 0.037(6) 0.029(5) 0.051(8) 0.023(6) 0.000(7) 0.004(5) 
C40 0.019(6) 0.029(5) 0.042(7) 0.008(6) 0.017(8) -0.010(5) 
C41 0.018(6) 0.037(6) 0.036(8) 0.007(6) 0.013(7) -0.002(5) 
C42 0.026(6) 0.027(5) 0.054(9) 0.006(6) 0.000(8) -0.003(5) 
C43 0.035(6) 0.031(6) 0.038(8) -0.006(6) -0.001(9) 0.001(6) 
C44 0.029(7) 0.028(5) 0.032(7) -0.012(6) 0.000(9) -0.004(5) 
C45 0.022(6) 0.029(5) 0.032(7) 0.004(6) 0.001(7) -0.002(5) 
C46 0.030(6) 0.029(6) 0.052(8) 0.003(6) -0.019(8) 0.018(5) 
C47 0.033(6) 0.030(5) 0.031(7) 0.004(5) -0.004(6) 0.012(4) 
C48 0.031(6) 0.033(5) 0.042(7) 0.005(6) -0.013(8) 0.018(5) 
Cl7 0.082(5) 0.063(5) 0.040(3) 0.012(4) 0.003(3) 0.048(4) 
Cl8 0.087(7) 0.042(3) 0.039(4) 0.003(3) -0.021(3) 0.018(3) 
O4 0.092(11) 0.039(7) 0.043(7) 0.019(5) -0.016(6) -0.004(7) 
N7 0.038(3) 0.037(3) 0.037(3) -0.0005(18) 0.0004(19) 0.0016(19) 
N8 0.014(8) 0.040(5) 0.033(7) 0.007(5) 0.015(7) -0.005(6) 
C49 0.046(10) 0.038(6) 0.032(7) 0.013(5) 0.011(6) 0.008(7) 
C50 0.028(7) 0.033(6) 0.059(7) 0.008(6) 0.004(6) 0.013(6) 
C51 0.047(9) 0.041(7) 0.047(8) 0.009(5) 0.015(7) -0.006(7) 
C52 0.026(8) 0.042(6) 0.047(7) 0.007(5) 0.013(6) 0.006(6) 
C53 0.039(9) 0.042(7) 0.052(8) 0.017(6) 0.004(7) -0.014(7) 
C54 0.057(11) 0.037(6) 0.027(8) -0.001(5) 0.009(7) -0.006(8) 
C55 0.049(11) 0.037(6) 0.040(7) 0.004(5) 0.001(7) 0.005(7) 
C56 0.046(9) 0.033(6) 0.035(8) -0.003(6) 0.000(8) 0.013(9) 
C57 0.040(9) 0.039(6) 0.032(7) -0.006(6) 0.002(7) 0.016(11) 
C58 0.030(8) 0.037(6) 0.028(5) 0.002(5) 0.016(5) 0.016(7) 
C59 0.045(12) 0.041(6) 0.044(7) -0.001(6) -0.002(7) 0.006(9) 
C60 0.041(4) 0.040(4) 0.042(4) 0.0005(18) -0.0002(19) 0.0008(19) 
C61 0.032(10) 0.037(5) 0.025(6) 0.002(4) 0.010(7) -0.011(6) 
C62 0.035(4) 0.036(3) 0.037(3) 0.0010(18) 0.0003(19) -0.0008(19) 
C63 0.026(9) 0.046(5) 0.038(6) 0.008(5) 0.010(6) 0.001(6) 
C64 0.026(9) 0.035(5) 0.047(6) 0.011(5) -0.002(6) 0.012(5) 
Cl5' 0.028(4) 0.081(5) 0.079(5) -0.016(4) 0.001(4) 0.019(4) 
Cl6' 0.090(8) 0.041(4) 0.069(6) -0.012(4) 0.036(8) 0.003(5) 
O3' 0.035(7) 0.045(8) 0.046(9) 0.017(7) -0.005(7) -0.014(6) 
N5' 0.044(8) 0.036(7) 0.068(11) 0.016(8) -0.005(11) 0.005(7) 
N6' 0.033(7) 0.053(7) 0.036(9) -0.008(7) -0.006(8) 0.000(6) 
C33' 0.033(4) 0.032(4) 0.033(4) 0.0003(19) -0.0010(19) 0.0002(19) 
C34' 0.035(4) 0.035(4) 0.036(4) 0.0008(19) 0.0005(19) -0.0006(19) 
C35' 0.041(7) 0.025(8) 0.051(11) -0.001(9) -0.024(12) 0.004(6) 
C36' 0.041(6) 0.036(6) 0.036(9) 0.012(7) -0.004(8) -0.001(5) 
C37' 0.039(4) 0.038(4) 0.038(4) 0.0011(19) 0.0006(19) -0.0005(19) 
C38' 0.043(7) 0.040(8) 0.060(11) 0.006(9) 0.003(10) -0.006(7) 
C39' 0.033(7) 0.046(8) 0.063(12) 0.002(9) -0.012(9) 0.005(6) 
C40' 0.036(8) 0.039(7) 0.041(9) 0.005(8) 0.009(11) -0.002(6) 
C41' 0.033(8) 0.031(7) 0.056(11) 0.021(8) 0.008(12) -0.009(6) 
C42' 0.020(7) 0.039(7) 0.049(11) 0.015(8) 0.007(10) 0.003(6) 
C43' 0.025(7) 0.035(7) 0.037(11) 0.009(8) 0.011(10) -0.001(7) 
C44' 0.025(8) 0.047(7) 0.061(12) -0.005(9) 0.001(13) -0.004(7) 
C45' 0.033(8) 0.043(7) 0.044(10) 0.009(8) 0.012(11) -0.001(6) 
C46' 0.035(6) 0.041(7) 0.037(9) 0.008(7) -0.011(9) 0.004(6) 
C47' 0.035(4) 0.036(4) 0.035(4) 0.0006(19) -0.0005(19) 0.0001(18) 
C48' 0.035(6) 0.033(6) 0.041(9) 0.013(6) 0.004(9) 0.001(5) 
Cl7' 0.164(15) 0.066(7) 0.030(4) 0.024(5) 0.026(6) 0.066(8) 
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Cl8' 0.094(9) 0.027(3) 0.045(6) 0.007(3) -0.013(5) 0.014(4) 
O4' 0.055(10) 0.023(7) 0.044(8) 0.005(5) 0.004(7) 0.014(7) 
N7' 0.087(13) 0.042(7) 0.021(8) -0.002(6) 0.001(8) 0.001(10) 
N8' 0.022(12) 0.032(6) 0.043(10) 0.008(6) 0.004(11) 0.000(7) 
C49' 0.032(10) 0.037(6) 0.044(7) 0.011(6) 0.005(8) 0.003(8) 
C50' 0.043(4) 0.042(4) 0.043(4) 0.0009(19) 0.0006(19) -0.0006(19) 
C51' 0.071(14) 0.041(8) 0.045(9) 0.010(6) 0.002(9) -0.008(10) 
C52' 0.030(10) 0.038(6) 0.043(8) 0.012(6) 0.004(8) -0.020(8) 
C53' 0.052(13) 0.033(8) 0.051(10) 0.000(7) -0.004(10) 0.007(10) 
C54' 0.069(14) 0.039(7) 0.049(11) 0.006(7) -0.016(11) -0.019(10) 
C55' 0.052(13) 0.033(6) 0.025(8) -0.005(6) 0.009(7) 0.013(8) 
C56' 0.051(11) 0.040(7) 0.032(9) 0.001(6) 0.010(8) 0.001(11) 
C57' 0.054(12) 0.036(8) 0.034(9) -0.006(8) 0.004(9) 0.018(14) 
C58' 0.041(5) 0.041(4) 0.040(4) 0.0013(19) 0.0000(19) 0.0016(19) 
C59' 0.065(16) 0.035(7) 0.040(8) 0.004(7) -0.003(10) 0.000(10) 
C60' 0.037(4) 0.036(4) 0.038(4) 0.0006(18) -0.0003(19) 0.0008(19) 
C61' 0.030(12) 0.029(6) 0.039(9) 0.004(6) 0.008(9) 0.008(8) 
C62' 0.033(9) 0.031(6) 0.037(8) 0.005(6) 0.003(9) -0.008(7) 
C63' 0.019(10) 0.044(6) 0.041(7) 0.012(5) 0.003(7) -0.009(8) 
C64' 0.008(8) 0.034(5) 0.043(7) 0.010(5) 0.004(7) -0.002(5) 
The form of the anisotropic displacement parameter is: 
exp[-2p2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
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  Table F3.5  Bond Distances in Compound 3.2, Å. 
 
Cl1-C10  1.706(6) Cl2-C11  1.730(6) O1-C1  1.378(7) 
N1-C7  1.361(7) N1-C8  1.360(7) N2-C14  1.328(7) 
N2-C13  1.378(7) C1-C2  1.378(8) C1-C16  1.429(7) 
C2-C3  1.396(8) C3-C4  1.394(8) C4-C15  1.393(7) 
C4-C5  1.440(8) C5-C6  1.345(9) C6-C7  1.439(8) 
C7-C14  1.429(7) C8-C13  1.414(7) C8-C9  1.419(8) 
C9-C10  1.365(8) C10-C11  1.406(8) C11-C12  1.392(8) 
C12-C13  1.426(7) C14-C15  1.485(7) C15-C16  1.408(7) 
C16-C17  1.493(8) Cl3-C27  1.770(10) Cl4-C28  1.746(9) 
O2-C18  1.374(7) N3-C24  1.312(10) N3-C25  1.343(10) 
N4-C31  1.317(9) N4-C30  1.362(10) C17-C18  1.381(9) 
C17-C32  1.430(8) C18-C19  1.394(9) C19-C20  1.343(9) 
C20-C21  1.452(9) C21-C32  1.422(8) C21-C22  1.446(9) 
C22-C23  1.347(10) C23-C24  1.466(10) C24-C31  1.446(10) 
C25-C30  1.395(11) C25-C26  1.447(11) C26-C27  1.369(13) 
C27-C28  1.405(13) C28-C29  1.340(12) C29-C30  1.423(11) 
C31-C32  1.476(9) Cl5-C42  1.718(12) Cl6-C43  1.731(11) 
O3-C33  1.380(13) N5-C39  1.353(13) N5-C40  1.356(12) 
N6-C46  1.344(12) N6-C45  1.371(12) C33-C34  1.381(13) 
C33-C48  1.416(13) C34-C35  1.395(14) C35-C36  1.399(13) 
C36-C47  1.420(12) C36-C37  1.427(14) C37-C38  1.338(14) 
C38-C39  1.423(13) C39-C46  1.435(14) C40-C41  1.400(13) 
C40-C45  1.414(13) C41-C42  1.375(13) C42-C43  1.406(13) 
C43-C44  1.344(13) C44-C45  1.434(12) C46-C47  1.482(13) 
C47-C48  1.388(14) C48-C64  1.51(2) Cl7-C58  1.734(11) 
Cl8-C59  1.750(12) O4-C49  1.384(14) N7-C56  1.352(12) 
N7-C55  1.365(13) N8-C62  1.343(12) N8-C61  1.362(12) 
C49-C50  1.380(13) C49-C64  1.429(13) C50-C51  1.412(15) 
C51-C52  1.390(14) C52-C63  1.423(13) C52-C53  1.439(14) 
C53-C54  1.334(15) C54-C55  1.433(13) C55-C62  1.445(14) 
C56-C57  1.409(13) C56-C61  1.410(13) C57-C58  1.365(14) 
C58-C59  1.421(13) C59-C60  1.370(13) C60-C61  1.426(12) 
C62-C63  1.476(13) C63-C64  1.401(14) Cl5'-C42'  1.707(13) 
Cl6'-C43'  1.740(12) O3'-C33'  1.380(15) N5'-C40'  1.350(13) 
N5'-C39'  1.360(15) N6'-C46'  1.336(13) N6'-C45'  1.361(14) 
C33'-C34'  1.377(15) C33'-C48'  1.415(14) C34'-C35'  1.408(15) 
C35'-C36'  1.382(15) C36'-C47'  1.412(13) C36'-C37'  1.444(15) 
C37'-C38'  1.331(16) C38'-C39'  1.432(14) C39'-C46'  1.441(14) 
C40'-C41'  1.404(15) C40'-C45'  1.412(14) C41'-C42'  1.382(14) 
C42'-C43'  1.406(14) C43'-C44'  1.354(14) C44'-C45'  1.426(14) 
C46'-C47'  1.462(14) C47'-C48'  1.390(15) C48'-C64'  1.46(2) 
Cl7'-C58'  1.733(13) Cl8'-C59'  1.740(13) O4'-C49'  1.370(14) 
N7'-C56'  1.350(13) N7'-C55'  1.366(14) N8'-C62'  1.340(13) 
N8'-C61'  1.359(13) C49'-C50'  1.385(15) C49'-C64'  1.425(14) 
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C50'-C51'  1.401(16) C51'-C52'  1.380(14) C52'-C63'  1.416(14) 
C52'-C53'  1.443(15) C53'-C54'  1.336(16) C54'-C55'  1.431(14) 
C55'-C62'  1.444(14) C56'-C57'  1.411(14) C56'-C61'  1.412(14) 
C57'-C58'  1.375(15) C58'-C59'  1.411(14) C59'-C60'  1.372(14) 
C60'-C61'  1.432(13) C62'-C63'  1.475(14) C63'-C64'  1.398(15) 
C65-C66#1  1.528(7) C65-C66  1.5283 C66-C67  1.5316 
C67-C68  1.5305 C68-C69  1.5292 C69-C70  1.5307 
C70-C71  1.5301     
Table F3.6  Bond Angles in Compound 3.2, °. 
 
C7-N1-C8 117.4(4) C14-N2-
C13 
117.1(5) O1-C1-C2 120.3(5) 
O1-C1-C16 118.1(5) C2-C1-C16 121.4(5) C1-C2-C3 119.4(5) 
C4-C3-C2 120.7(5) C15-C4-C3 120.0(5) C15-C4-C5 121.9(5) 
C3-C4-C5 118.1(5) C6-C5-C4 122.2(6) C5-C6-C7 118.4(6) 
N1-C7-C14 120.5(5) N1-C7-C6 117.7(5) C14-C7-C6 121.8(5) 
N1-C8-C13 121.3(5) N1-C8-C9 119.2(5) C13-C8-C9 119.5(5) 
C10-C9-C8 119.4(5) C9-C10-
C11 
121.5(5) C9-C10-Cl1 119.7(5) 
C11-C10-
Cl1 
118.8(4) C12-C11-
C10 
121.0(5) C12-C11-
Cl2 
117.0(4) 
C10-C11-
Cl2 
122.0(4) C11-C12-
C13 
118.0(5) N2-C13-C8 121.1(5) 
N2-C13-
C12 
118.4(5) C8-C13-
C12 
120.5(5) N2-C14-C7 122.3(5) 
N2-C14-
C15 
119.7(5) C7-C14-
C15 
118.0(5) C4-C15-
C16 
120.7(5) 
C4-C15-
C14 
117.2(5) C16-C15-
C14 
122.1(5) C15-C16-
C1 
117.7(5) 
C15-C16-
C17 
123.6(5) C1-C16-
C17 
118.6(5) C24-N3-
C25 
116.5(7) 
C31-N4-
C30 
117.0(6) C18-C17-
C32 
117.8(5) C18-C17-
C16 
120.0(5) 
C32-C17-
C16 
122.1(5) O2-C18-
C17 
119.8(5) O2-C18-
C19 
117.3(5) 
C17-C18-
C19 
122.7(6) C20-C19-
C18 
120.4(6) C19-C20-
C21 
121.2(6) 
C32-C21-
C22 
121.4(6) C32-C21-
C20 
117.4(6) C22-C21-
C20 
121.3(6) 
C23-C22-
C21 
123.8(6) C22-C23-
C24 
117.5(7) N3-C24-
C31 
122.2(7) 
N3-C24-
C23 
116.8(7) C31-C24-
C23 
120.9(6) N3-C25-
C30 
122.3(7) 
N3-C25-
C26 
119.0(7) C30-C25-
C26 
118.6(7) C27-C26-
C25 
117.3(8) 
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C26-C27-
C28 
122.4(9) C26-C27-
Cl3 
116.8(7) C28-C27-
Cl3 
120.8(7) 
C29-C28-
C27 
121.4(8) C29-C28-
Cl4 
120.1(7) C27-C28-
Cl4 
118.5(7) 
C28-C29-
C30 
118.2(8) N4-C30-
C25 
121.2(7) N4-C30-
C29 
117.0(7) 
C25-C30-
C29 
121.8(7) N4-C31-
C24 
120.6(6) N4-C31-
C32 
119.2(6) 
C24-C31-
C32 
120.1(6) C21-C32-
C17 
120.6(5) C21-C32-
C31 
116.2(5) 
C17-C32-
C31 
123.0(5) C39-N5-
C40 
116.8(11) C46-N6-
C45 
117.4(10) 
C34-C33-
O3 
116.0(11) C34-C33-
C48 
123.1(12) O3-C33-
C48 
120.9(11) 
C33-C34-
C35 
118.4(12) C34-C35-
C36 
120.1(12) C35-C36-
C47 
120.8(11) 
C35-C36-
C37 
120.8(11) C47-C36-
C37 
118.4(10) C38-C37-
C36 
126.1(12) 
C37-C38-
C39 
117.4(12) N5-C39-
C38 
117.4(11) N5-C39-
C46 
120.8(10) 
C38-C39-
C46 
121.2(11) N5-C40-
C41 
119.1(11) N5-C40-
C45 
122.3(11) 
C41-C40-
C45 
118.2(9) C42-C41-
C40 
119.2(11) C41-C42-
C43 
121.0(11) 
C41-C42-
Cl5 
118.4(9) C43-C42-
Cl5 
120.6(8) C44-C43-
C42 
122.5(10) 
C44-C43-
Cl6 
118.3(9) C42-C43-
Cl6 
119.2(9) C43-C44-
C45 
116.5(11) 
N6-C45-
C40 
120.4(10) N6-C45-
C44 
117.6(10) C40-C45-
C44 
121.8(10) 
N6-C46-
C39 
120.8(11) N6-C46-
C47 
119.5(11) C39-C46-
C47 
119.3(9) 
C48-C47-
C36 
119.4(10) C48-C47-
C46 
122.9(10) C36-C47-
C46 
117.3(10) 
C47-C48-
C33 
118.1(11) C47-C48-
C64 
123.3(11) C33-C48-
C64 
118.5(13) 
C56-N7-
C55 
114.4(11) C62-N8-
C61 
115.8(11) C50-C49-
O4 
118.7(11) 
C50-C49-
C64 
121.7(12) O4-C49-
C64 
118.5(11) C49-C50-
C51 
118.2(12) 
C52-C51-
C50 
121.5(12) C51-C52-
C63 
120.1(12) C51-C52-
C53 
120.9(11) 
C63-C52-
C53 
119.0(11) C54-C53-
C52 
124.0(12) C53-C54-
C55 
118.6(13) 
N7-C55-
C54 
115.3(12) N7-C55-
C62 
122.5(11) C54-C55-
C62 
119.8(11) 
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N7-C56-
C57 
118.1(11) N7-C56-
C61 
122.4(11) C57-C56-
C61 
119.5(11) 
C58-C57-
C56 
118.3(11) C57-C58-
C59 
122.4(10) C57-C58-
Cl7 
120.7(10) 
C59-C58-
Cl7 
116.9(10) C60-C59-
C58 
120.7(11) C60-C59-
Cl8 
118.1(10) 
C58-C59-
Cl8 
121.0(10) C59-C60-
C61 
117.3(12) N8-C61-
C56 
122.9(11) 
N8-C61-
C60 
115.4(11) C56-C61-
C60 
121.6(11) N8-C62-
C55 
120.4(11) 
N8-C62-
C63 
119.5(12) C55-C62-
C63 
117.6(11) C64-C63-
C52 
119.0(11) 
C64-C63-
C62 
122.5(10) C52-C63-
C62 
118.0(11) C63-C64-
C49 
119.3(11) 
C63-C64-
C48 
122.4(11) C49-C64-
C48 
118.3(12) C40'-N5'-
C39' 
114.8(14) 
C46'-N6'-
C45' 
115.0(13) C34'-C33'-
O3' 
118.1(14) C34'-C33'-
C48' 
120.0(14) 
O3'-C33'-
C48' 
121.1(13) C33'-C34'-
C35' 
120.4(14) C36'-C35'-
C34' 
119.6(14) 
C35'-C36'-
C47' 
120.2(13) C35'-C36'-
C37' 
121.0(13) C47'-C36'-
C37' 
118.7(13) 
C38'-C37'-
C36' 
123.4(14) C37'-C38'-
C39' 
118.6(15) N5'-C39'-
C38' 
117.4(14) 
N5'-C39'-
C46' 
119.8(13) C38'-C39'-
C46' 
121.1(13) N5'-C40'-
C41' 
116.7(13) 
N5'-C40'-
C45' 
124.4(13) C41'-C40'-
C45' 
118.9(12) C42'-C41'-
C40' 
117.0(13) 
C41'-C42'-
C43' 
122.9(12) C41'-C42'-
Cl5' 
118.7(11) C43'-C42'-
Cl5' 
118.1(11) 
C44'-C43'-
C42' 
121.0(12) C44'-C43'-
Cl6' 
115.5(11) C42'-C43'-
Cl6' 
122.2(11) 
C43'-C44'-
C45' 
115.7(13) N6'-C45'-
C40' 
120.5(12) N6'-C45'-
C44' 
115.4(13) 
C40'-C45'-
C44' 
122.9(13) N6'-C46'-
C39' 
123.3(13) N6'-C46'-
C47' 
117.6(13) 
C39'-C46'-
C47' 
116.5(12) C48'-C47'-
C36' 
120.0(12) C48'-C47'-
C46' 
120.1(12) 
C36'-C47'-
C46' 
119.1(12) C47'-C48'-
C33' 
119.0(13) C47'-C48'-
C64' 
126.3(14) 
C33'-C48'-
C64' 
114.5(15) C56'-N7'-
C55' 
116.3(13) C62'-N8'-
C61' 
116.8(13) 
O4'-C49'-
C50' 
114.3(13) O4'-C49'-
C64' 
123.8(13) C50'-C49'-
C64' 
120.9(13) 
C49'-C50'-
C51' 
117.4(14) C52'-C51'-
C50' 
122.0(15) C51'-C52'-
C63' 
120.5(13) 
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C51'-C52'-
C53' 
120.6(13) C63'-C52'-
C53' 
118.6(12) C54'-C53'-
C52' 
124.3(14) 
C53'-C54'-
C55' 
118.5(15) N7'-C55'-
C54' 
118.2(13) N7'-C55'-
C62' 
121.0(12) 
C54'-C55'-
C62' 
118.8(13) N7'-C56'-
C57' 
118.2(14) N7'-C56'-
C61' 
122.1(13) 
C57'-C56'-
C61' 
119.7(12) C58'-C57'-
C56' 
118.8(14) C57'-C58'-
C59' 
119.8(13) 
C57'-C58'-
Cl7' 
117.5(12) C59'-C58'-
Cl7' 
121.6(12) C60'-C59'-
C58' 
121.3(14) 
C60'-C59'-
Cl8' 
116.3(13) C58'-C59'-
Cl8' 
120.1(12) C59'-C60'-
C61' 
117.5(13) 
N8'-C61'-
C56' 
121.9(13) N8'-C61'-
C60' 
116.6(13) C56'-C61'-
C60' 
120.1(13) 
N8'-C62'-
C55' 
121.6(12) N8'-C62'-
C63' 
119.0(13) C55'-C62'-
C63' 
118.1(12) 
C64'-C63'-
C52' 
117.8(12) C64'-C63'-
C62' 
123.9(12) C52'-C63'-
C62' 
116.2(12) 
C63'-C64'-
C49' 
120.2(13) C63'-C64'-
C48' 
121.2(15) C49'-C64'-
C48' 
117.8(15) 
C66#1-
C65-C66 
112.08(17) C65-C66-
C67 
113.2 C68-C67-
C66 
113.7 
C69-C68-
C67 
113.7 C68-C69-
C70 
113.8 C71-C70-
C69 
113.3 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,z    
 
1) Bruker (2009) SAINT. Bruker AXS Inc., Madison, Wisconsin, USA. 
2) Bruker (2009) SHELXTL. Bruker AXS Inc., Madison, Wisconsin, USA. 
3) Sheldrick, G.M. (2007) SADABS. University of Gottingen, Germany. 
4) Sheldrick, G.M. (2008) Acta Cryst. A64,112-122.  
5) R1 = S||Fo| - |Fc|| / S |Fo|; wR2 = [Sw(Fo2 - Fc2)2/Sw(Fo2)2]½;  GOF = [Sw(Fo2 - 
Fc2)2/(n - p)]½  where n = the number of reflections and p = the number of parameters 
refined. 
6) .v.d. Sluis, P. & A.L. Spek (1990). Acta. Cryst., A46, 194. 
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Appendix G:  Chapter 3 Additional DSC Data 
 
Note:  One to two full cycles were measured.  One cycle involves heating to the desired 
temperature and cooling back down to the initial temperature. 
 
 
Figure G3.1  DSC curve of 3.2•n-pentane, trial 1. 
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Figure G3.2  DSC curve of 3.2•n-pentane, trial 2. 
 
 
Figure G3.3  DSC curve of 3.2•n-pentane, only trial with pinhole in lid. 
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Figure G3.4  DSC curve of 3.2•n-hexane, under nitrogen atmosphere, only trial. 
 
 
Figure G3.5  DSC curve of 3.2•n-hexane, under air, trial 1.  
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Figure G3.6  DSC curve of 3.2•n-hexane, under air, trial 2. 
 
Figure G3.7  DSC curve of 3.2•n-hexane, only trial with pinhole in lid. 
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Figure G3.8  DSC curve of 3.2•n-heptane, under air, only trial. 
 
 
Figure G3.9  DSC curve of 3.2•n-nonane, under air, trial 1. 
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Figure G3.10  DSC curve of 3.2•n-nonane, under air, trial 2. 
 
 
Figure G3.11  DSC curve of 3.2•n-dodecane, under air, only trial. 
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Figure G3.12  DSC curve of 3.2•n-tridecane, under air, only trial. 
 
Figure G3.13  DSC curve of 3.2•n-tridecane, under nitrogen, only trial. 
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Figure G3.14  DSC curve of 3.2•n-tetradecane, under air, only trial. 
 
Figure G3.15  DSC curve of 3.2•n-tetradecane, under nitrogen, only trial. 
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Figure G3.16  DSC curve of n-hexane in pentadecane, under nitrogen, only trial. 
 
 
Figure G3.17  DSC curve of n-pentadecane, under nitrogen, only trial. 
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Figure G3.18  DSC curve of n-hexane in pentadecane, under air, only trial. 
 
 
Figure G3.19  DSC curve of n-pentane in pentadecane, under air, only trial. 
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Appendix H:  Chapter 3 Powder X-Ray Diffraction Data of Compound 3.2 
after Complex Formation with Linear Alkanes  
 
Figure H3.1  Powder XRD pattern of glass capillary (bottom/black) and 3.2 after 
exposure to cyclohexane (top/red). 
 
 
Table H3.1  PXRD data for 3.2 after exposure to cyclohexane. 
2-
Theta d(Å) BG Height H% Area A% FWHM XS(Å) 
31.71 2.8195 40 1015 100 35866 100 0.3 339 
 
 
3.2 after cyclohexane  
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Figure H3.2  Powder XRD pattern of 3.2•n-pentane. 
 
 
Table H3.2  PXRD data for 3.2•n-pentane. 
 
PEAK: 47(pts)/Parabolic Filter, Threshold=3.0, Cutoff=0.1%, 
BG=3/1.0, Peak-Top=Summit 
2-
Theta d(Å) BG Height H% Area A% FWHM XS(Å) 
5.451 16.2 35 30 1.7 481 0.5 0.136 >1000 
8.07 10.947 52 1722 100 93047 100 0.459 194 
8.54 10.3461 23 437 25.4 26466 28.4 0.514 171 
12.15 7.2786 13 106 6.1 3951 4.2 0.318 305 
13.36 6.622 19 635 36.9 42661 45.8 0.571 152 
14.24 6.2146 19 129 7.5 7436 8 0.491 181 
14.68 6.0294 19 73 4.2 2265 2.4 0.264 393 
15.59 5.6794 15 216 12.5 8671 9.3 0.341 280 
16.109 5.4976 17 60 3.5 5726 6.2 0.808 105 
17.49 5.0665 14 88 5.1 4056 4.4 0.39 238 
18.65 4.7539 12 183 10.6 16871 18.1 0.784 108 
19.15 4.6309 5 202 11.7 23500 25.3 0.991 85 
19.7 4.5028 5 101 5.9 1962 2.1 0.165 858 
21.69 4.094 5 658 38.2 26336 28.3 0.34 283 
23.12 3.8439 5 860 49.9 66988 72 0.662 131 
25.23 3.527 5 263 15.3 18488 19.9 0.597 148 
26.67 3.3398 5 138 8 15551 16.7 0.96 89 
26.91 3.3105 5 188 10.9 17449 18.8 0.79 109 
27.78 3.2088 9 68 4 3562 3.8 0.445 207 
29.56 3.0195 14 112 6.5 7560 8.1 0.576 155 
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30.86 2.8952 19 46 2.7 1744 1.9 0.324 307 
31.52 2.8361 19 127 7.4 8645 9.3 0.578 155 
32.561 2.7477 15 59 3.4 2075 2.2 0.298 343 
33.728 2.6553 15 34 2 1868 2 0.465 200 
33.929 2.64 15 36 2.1 2060 2.2 0.488 189 
35.941 2.4967 9 19 1.1 496 0.5 0.217 545 
36.679 2.4481 9 30 1.7 1115 1.2 0.316 322 
 
 
Figure H3.3  Powder XRD pattern of 3.2•n-hexane. 
 
Table H3.3  PXRD data for 3.2•n-hexane. 
 
2-
Theta d(Å) BG Height H% Area A% FWHM XS(Å) 
5.36 16.4736 25 290 1.8 9258 1.1 0.272 374 
8.07 10.947 99 15787 100 825350 100 0.444 202 
9.23 9.5737 99 613 3.9 20461 2.5 0.284 353 
10.98 8.0515 7 452 2.9 23175 2.8 0.435 207 
11.58 7.6355 7 117 0.7 3314 0.4 0.24 447 
12.17 7.2666 3 308 2 8434 1 0.232 470 
13.44 6.5827 1 6292 39.9 383716 46.5 0.518 170 
14.285 6.1952 1 681 4.3 14356 1.7 0.179 726 
14.82 5.9728 1 158 1 4364 0.5 0.234 466 
15.6 5.6758 2 1865 11.8 91833 11.1 0.418 218 
16.12 5.4938 2 818 5.2 83397 10.1 0.867 97 
16.69 5.3076 2 395 2.5 15139 1.8 0.326 297 
17.47 5.0722 2 1089 6.9 71080 8.6 0.555 158 
18.52 4.787 2 2287 14.5 110468 13.4 0.411 224 
19.03 4.6598 2 2422 15.3 406663 49.3 1.427 58 
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19.62 4.521 2 2576 16.3 303449 36.8 1.001 84 
20.56 4.3163 2 1099 7 48252 5.8 0.373 252 
21.7 4.0921 2 6994 44.3 468574 56.8 0.569 155 
23.18 3.8341 2 9463 59.9 757840 91.8 0.681 127 
24.41 3.6436 2 2872 18.2 206869 25.1 0.612 143 
25.26 3.5229 2 3523 22.3 360615 43.7 0.87 98 
25.7 3.4636 2 2423 15.3 315675 38.2 1.108 76 
26.72 3.3336 2 3090 19.6 334557 40.5 0.92 93 
27.59 3.2304 2 1666 10.6 113131 13.7 0.577 154 
28.14 3.1685 2 1516 9.6 117589 14.2 0.659 133 
29.38 3.0376 2 2009 12.7 153351 18.6 0.649 136 
30.17 2.9598 2 1413 8.9 94376 11.4 0.568 158 
30.9 2.8915 2 1114 7.1 59096 7.2 0.451 206 
31.61 2.8282 2 2844 18 177641 21.5 0.531 171 
32.49 2.7536 2 854 5.4 62645 7.6 0.623 143 
33.86 2.6452 2 748 4.7 58369 7.1 0.663 134 
 
 
Figure H3.4  Powder XRD pattern of 3.2•n-heptane. 
 
Table H3.4  PXRD data for 3.2•n-heptane. 
 
2-
Theta d(Å) BG Height H% Area A% FWHM XS(Å) 
8.02 11.0152 233 8245 100 455609 85.9 0.47 189 
8.51 10.3825 70 1673 20.3 90088 17 0.458 195 
10.74 8.2307 9 163 2 8508 1.6 0.443 203 
12.11 7.3025 9 554 6.7 23391 4.4 0.359 261 
13.42 6.5925 9 3463 42 210534 39.7 0.517 170 
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14.32 6.1801 9 811 9.8 54641 10.3 0.573 152 
15.59 5.6794 9 1116 13.5 52046 9.8 0.396 233 
16.13 5.4905 9 482 5.8 45221 8.5 0.797 106 
16.77 5.2824 9 386 4.7 16345 3.1 0.36 262 
17.579 5.041 9 447 5.4 32058 6 0.609 142 
18.51 4.7895 9 1287 15.6 61953 11.7 0.409 225 
19.09 4.6453 9 1569 19 236973 44.7 1.284 65 
19.65 4.5142 9 1321 16 157281 29.6 1.012 83 
20.54 4.3205 9 964 11.7 66099 12.5 0.583 150 
21.73 4.0865 9 4258 51.6 311943 58.8 0.623 140 
23.17 3.8357 9 5694 69.1 530518 100 0.792 108 
23.65 3.759 9 3310 40.1 412629 77.8 1.06 79 
24.44 3.6392 9 1544 18.7 44606 8.4 0.245 441 
25.25 3.5243 9 2312 28 198497 37.4 0.73 119 
26.71 3.3349 9 1706 20.7 182266 34.4 0.908 94 
27.489 3.242 9 761 9.2 40593 7.7 0.453 203 
28.21 3.1608 9 462 5.6 9456 1.8 0.174 788 
28.48 3.1315 9 373 4.5 8272 1.6 0.189 677 
29.37 3.0386 27 503 6.1 20372 3.8 0.344 283 
30.23 2.954 7 221 2.7 4885 0.9 0.188 684 
30.779 2.9026 7 181 2.2 1431 0.3 0.067 >1000 
31.58 2.8308 7 1110 13.5 45378 8.6 0.347 282 
32.46 2.756 7 209 2.5 7774 1.5 0.316 318 
33.86 2.6452 14 297 3.6 19296 3.6 0.553 164 
36.538 2.4572 10 115 1.4 5643 1.1 0.418 228 
 
 
Figure H3.5  Powder XRD pattern of 3.2•n-octane. 
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Table H3.5  PXRD data for 3.2•n-octane. 
2-
Theta d(Å) BG Height H% Area A% FWHM XS(Å) 
7.94 11.126 59 14893 100 773687 84 0.442 203 
9.08 9.7315 19 808 5.4 35804 3.9 0.377 246 
10.88 8.1252 19 801 5.4 35801 3.9 0.38 244 
11.55 7.6553 19 815 5.5 39908 4.3 0.416 219 
12.07 7.3264 19 794 5.3 73308 8 0.785 108 
12.38 7.144 19 906 6.1 61448 6.7 0.577 151 
12.98 6.8149 19 2322 15.6 210422 22.8 0.77 110 
13.34 6.6318 19 3658 24.6 307034 33.3 0.714 119 
13.98 6.3297 19 2069 13.9 112214 12.2 0.461 194 
14.4 6.1459 19 954 6.4 31015 3.4 0.276 368 
14.84 5.9647 19 556 3.7 18576 2 0.284 354 
15.53 5.7012 19 1651 11.1 99267 10.8 0.511 173 
16.02 5.528 19 885 5.9 80920 8.8 0.778 109 
16.71 5.3012 19 998 6.7 62074 6.7 0.529 167 
17.379 5.0985 19 599 4 54616 5.9 0.776 110 
18.53 4.7844 19 2454 16.5 237277 25.7 0.822 103 
19.02 4.6622 19 2513 16.9 380035 41.2 1.286 64 
20.53 4.3226 19 2062 13.8 114439 12.4 0.472 191 
21.14 4.1992 19 1817 12.2 119663 13 0.56 157 
21.83 4.0681 19 7188 48.3 505692 54.9 0.598 146 
23.07 3.8521 19 10051 67.5 921581 100 0.779 110 
23.755 3.7426 19 4099 27.5 268231 29.1 0.556 159 
24.315 3.6576 19 2571 17.3 92422 10 0.306 327 
25.15 3.538 19 3339 22.4 360799 39.1 0.918 93 
26.05 3.4178 19 2315 15.5 86883 9.4 0.319 310 
26.62 3.3459 19 3081 20.7 344177 37.3 0.95 90 
27.32 3.2618 19 2339 15.7 384000 41.7 1.395 60 
27.97 3.1874 19 1961 13.2 154652 16.8 0.67 131 
29.58 3.0175 19 2292 15.4 362508 39.3 1.345 63 
30.14 2.9627 19 1948 13.1 323933 35.1 1.414 60 
30.72 2.908 19 1845 12.4 81901 8.9 0.377 254 
31.5 2.8378 19 2848 19.1 282721 30.7 0.844 103 
32.25 2.7735 19 1527 10.3 109441 11.9 0.609 147 
33.22 2.6947 19 896 6 98623 10.7 0.936 92 
33.98 2.6361 19 872 5.9 73098 7.9 0.713 124 
34.735 2.5806 9 284 1.9 7785 0.8 0.233 489 
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Figure H3.6  Powder XRD pattern of 3.2•n-dodecane. 
 
 
Table H3.6  PXRD data for 3.2•n-dodecane. 
2-
Theta d(Å) BG Height H% Area A% FWHM XS(Å) 
8.07 10.947 339 6957 100 481791 79.6 0.589 147 
10.78 8.2002 37 218 3.1 8725 1.4 0.341 279 
12.08 7.3205 39 170 2.4 5656 0.9 0.283 356 
13.38 6.6121 57 4429 63.7 265060 43.8 0.509 174 
14.209 6.228 57 399 5.7 15513 2.6 0.331 291 
15.54 5.6976 13 1126 16.2 67618 11.2 0.51 173 
16.029 5.5247 13 316 4.5 27235 4.5 0.732 116 
17.45 5.078 13 566 8.1 31808 5.3 0.478 187 
18.39 4.8205 13 960 13.8 45329 7.5 0.401 230 
18.98 4.672 13 1486 21.4 193407 31.9 1.106 75 
19.51 4.5462 13 1707 24.5 200201 33.1 0.997 84 
20.36 4.3583 13 704 10.1 21997 3.6 0.265 392 
21.56 4.1184 13 4043 58.1 278854 46 0.586 150 
23.04 3.8571 13 5958 85.6 605558 100 0.864 98 
25.25 3.5243 13 2421 34.8 187665 31 0.659 132 
26.57 3.3521 13 1122 16.1 134481 22.2 1.019 83 
26.97 3.3033 13 834 12 105757 17.5 1.078 79 
28.04 3.1796 8 577 8.3 27488 4.5 0.405 232 
29.02 3.0744 8 322 4.6 20014 3.3 0.528 171 
29.99 2.9771 8 237 3.4 12888 2.1 0.463 199 
30.651 2.9145 8 113 1.6 2066 0.3 0.155 >1000 
31.48 2.8396 17 1082 15.6 53860 8.9 0.423 222 
32.35 2.7652 20 344 4.9 17897 3 0.442 211 
  
  
330 
33.492 2.6734 6 214 3.1 10939 1.8 0.434 216 
36.26 2.4755 51 180 2.6 13527 2.2 0.64 140 
 
 
Figure H3.7  Powder XRD pattern of 3.2•n-tridecane. 
 
Table H3.7  PXRD data for 3.2•n-tridecane. 
2-
Theta d(Å) BG Height H% Area A% FWHM XS(Å) 
7.97 11.0839 393 3896 86.4 118748 68.7 0.777 108 
13.4 6.6023 54 2541 56.4 66897 38.7 0.671 127 
15.529 5.7014 7 725 16.1 9934 5.7 0.35 271 
17.39 5.0953 24 165 3.6 4196 2.4 0.65 133 
18.305 4.8426 24 515 11.4 7101 4.1 0.352 270 
19.43 4.5647 24 1088 24.1 49125 28.4 1.151 72 
21.47 4.1354 24 2726 60.5 83399 48.3 0.78 110 
23.06 3.8538 24 4507 100 172815 100 0.978 86 
25.16 3.5367 24 1791 39.7 69309 40.1 0.987 86 
26.6 3.3484 24 862 19.1 35708 20.7 1.056 80 
29.21 3.0549 24 624 13.8 19531 11.3 0.798 108 
31.34 2.8519 24 1049 23.3 42994 24.9 1.045 82 
32.33 2.7668 24 638 14.2 15495 9 0.619 144 
33.349 2.6846 24 478 10.6 21646 12.5 1.154 74 
35.6 2.5198 24 126 2.8 4940 2.9 0.997 87 
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Figure H3.8  Powder XRD pattern of 3.2•n-pentadecane. 
 
Table H3.8  PXRD data for 3.2•n-pentadecane. 
2-
Theta d(Å) BG Height H% Area A% FWHM XS(Å) 
5.94 14.8667 27 199 1.4 9204 1 0.393 233 
8.07 10.947 175 14148 100 780702 84.7 0.469 190 
8.81 10.0292 175 1339 9.5 39286 4.3 0.249 423 
10.8 8.1852 8 366 2.6 25709 2.8 0.598 145 
11.07 7.986 11 340 2.4 23285 2.5 0.582 149 
12.03 7.3509 2 324 2.3 10575 1.1 0.278 364 
12.705 6.9617 2 928 6.6 14864 1.6 0.136 >1000 
13.37 6.617 2 6238 44.1 452941 49.1 0.617 140 
14.18 6.241 2 749 5.3 17357 1.9 0.197 613 
15.55 5.694 2 1861 13.2 68839 7.5 0.314 310 
16.59 5.3393 2 475 3.4 37249 4 0.666 129 
17.52 5.0579 2 743 5.2 34578 3.8 0.396 234 
18.37 4.8257 2 1728 12.2 88314 9.6 0.434 210 
19.03 4.6598 2 2479 17.5 324110 35.2 1.111 75 
19.54 4.5393 2 2759 19.5 288488 31.3 0.889 95 
20.31 4.3689 2 1315 9.3 62144 6.7 0.402 231 
21.55 4.1203 2 7029 49.7 441905 47.9 0.534 166 
23.13 3.8423 2 9342 66 921967 100 0.839 102 
24.23 3.6703 2 3352 23.7 195349 21.2 0.495 182 
25.17 3.5353 2 3945 27.9 343101 37.2 0.739 117 
26.11 3.4101 2 2259 16 270820 29.4 1.019 83 
26.59 3.3496 2 2739 19.4 375782 40.8 1.166 72 
27.125 3.2848 2 2128 15 80624 8.7 0.322 307 
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28.02 3.1819 2 1847 13.1 160909 17.5 0.74 117 
29.23 3.0528 2 2432 17.2 182330 19.8 0.637 139 
29.96 2.9801 2 1635 11.6 101906 11.1 0.53 170 
30.68 2.9118 2 1469 10.4 190543 20.7 1.102 77 
31.47 2.8404 2 3622 25.6 206743 22.4 0.485 189 
32.38 2.7627 2 1286 9.1 102499 11.1 0.678 131 
33.54 2.6697 2 966 6.8 94932 10.3 0.836 104 
34.12 2.6256 2 545 3.9 20537 2.2 0.32 314 
36.3 2.4728 8 215 1.5 14197 1.5 0.56 163 
 
 
Figure H3.9  XRD pattern generated from single crystal X-ray data of 3.2•n-hexane. 
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Figure H3.10  XRD pattern generated from single crystal X-ray data of 3.2•n-tridecane. 
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